Equity in access to medicines provision under the universal coverage scheme in Pathumthani Province, Thailand by Soonthorn, Surasak & Soonthorn, Surasak
Equity in Access to Medicines Provision 
under the Universal Coverage Scheme 
in Pathumthani Province, Thailand 
Ph. D. (Health Policy) 
October 2007 
Surasak Soonthom 
Department of Primary Care and Social Medicine 
Faculty of Medicine 
Imperial College London 
«,. + tä t ýý+ 
i 
ABSTRACT 
The Drug Management Cycle (DMC), proposed by the World Health Organisation, has 
been adopted and applied to all public health care providers in Thailand with the hope 
that it will improve equity of access to medicines. This study aims to assess the 
implementation of the DMC in the medicines supply system of public health care 
providers. Pathumthani Province and thus its 11 public health care providers were 
purposively selected for this study between 10th January and 19`x' February 2006. 
Qualitative data was obtained by semi-structured interviews with 22 health care 
stakeholders from all levels of health care providers. The interview centred on the 
processes of drug management and the roles of pharmacists in the DMC. In addition, 
quantitative data was collected from 400 respondents with diabetes or hypertension who 
were randomly selected from outpatient departments. Respondents were asked to answer 
a questionnaire and provide opinions on the quality of medicines, pharmacy services and 
overall health care services. 
The qualitative data was analysed by using the Content Analysis method. The findings 
show that availability and affordability of good quality medicines in public health care 
providers would enhance the equity of access to medicines. Moreover, access to 
medicines cannot be addressed in isolation either from the rest of the health system or 
from the overall health situation. The quantitative findings suggest that although the 
Universal Coverage Scheme (UCS) provides health care coverage for respondents, there 
are still out-of-pocket expenses incurred while accessing health care services. 
Nevertheless, respondents tended to be satisfied with the quality of drugs, pharmacy 
services and health care services provided by the public sector under the UCS. 
The findings show that the drug management system in the public health care 
providers of Pathumthani Province did not entirely comply with the DMC. The thesis 
therefore demonstrates the value of the DMC by illustrating its importance in the 
incorporation of complementary processes which aim to improve the efficiency of the 
drug management system and increase equity of access to medicines. 
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CHAPTER I 
General Introduction 
1.1 BACKGROUND 
When patients seek care from a health care provider, one indispensable component of 
care that they assume they will receive from their visits is medicine. In addition, a health 
care professional also expects to use medicines for treatment or employ them as one of 
the major tools to promote the efficacies of health care services and encourage patients to 
participate in health care activities. Medicines save lives and improve people's health 
when they are sick. These qualities enable medicines to help promote trust and 
participation in health care services. Although medicines on the whole are cost-effective, 
some can be very expensive, particularly those drugs used for the treatment of chronic or 
severe diseases such as hypertension, diabetes, heart disease, cancer or HIV infection. 
This further illustrates that medicines are different from other goods since a health care 
professional is usually needed to diagnose the clinical manifestations of a disease and 
decide which medicines are the most appropriate for each patient. 
Access to medicines is considered one of the most crucial agendas of the World Health 
Organisation (WHO) in the United Nations' Millennium Projects. The lack of access to 
life-saving and health-supporting medicines for the majority of the world population 
stands as a direct contradiction to the fundamental principle of health as a human right 
(WHO 2002b). WHO estimates that between 1.7 and 2 billion people worldwide have 
inadequate or no access to essential life-saving medicines and the vast majority of the 
people live in developing countries (UN Millennium Project 2005). One study reported 
that more than 10 million children die unnecessarily each year and almost all of them are 
from low-income or poor areas of middle-income countries. In fact, the majority die from 
a short list of preventable diseases such as acute respiratory diseases, diarrhoea, malaria, 
measles and causes related to malnutrition (Black, Morris, & Bryce 2003). In addition, 
illness decreases people's ability to work and also prevents children from getting the 
education they need. Women and children make up the majority of the poor, and their low 
status in many societies often means that they have even less access to medicines. Thus, 
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improving access to medicines must be a key component of any strategies to strengthen 
health care provision. 
Increasing the access to medicines in developing countries, especially for the poor, 
offers many challenges to the public sector. Often, the poorest people pay the highest out- 
of-pocket expenses for medicines because the public sector in some developing countries 
fails to provide affordable medicines. Although some people can probably afford 
medicines but they may not be available or they may be temporarily out-of-stock at a time 
when they are really needed (WHO 2004c). WHO also estimates that nearly one third of 
the world's population lacks access to the most basic essential medicines, whereas in the 
poorest parts of Africa and Asia this figure rises to approximately half of their total 
populations (WHO 2003). Therefore, the implementation of any strategies to alleviate 
inaccessibility to medicines should be centred on how to enhance the availability of good 
quality medicines with affordable prices under the existing settings which have limited 
resources (WHO 2000). 
To alleviate the problems, some developing countries have strived to establish health 
insurance schemes to ensure that people are able to access health care whenever they need 
it. Many countries apply the Universal Coverage Approach to their health care systems, 
intending to assure the population that they are all protected against financial risks when 
accessing health care services. It also helps to ensure that if high cost health care services 
are in need, services of adequate quality and quantity will be physically accessible and the 
cost of such services will not prevent persons from using them; neither will it worsen the 
financial circumstances of their families (Kutzin 2000c). Although the progress of 
expanding universal coverage has been going on for decades, the likelihood of an 
individual having inaccessibility to essential medicines is still fairly high and increasingly 
poses considerable concerns to many developing countries (WHO 2004a). 
Thailand is one of many developing countries that has reformed its health care system 
since 1997. The Universal Coverage Scheme (UCS), which is proclaimed by the Ministry 
of Public Health (MOPH) as the country's health care protocol to assure people of equal 
access to health care services, began in 2001. The aims of the UCS are to narrow the gap 
between the rich and the poor in access to the health care system and to ensure that all 
Thais receive efficient health care services when they need them, regardless of their 
income, social status or residency. The UCS comprises three sub-schemes, the Civil 
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Servants' Medical Benefit Scheme (CSMBS), the Social Security Scheme (SSS) and the 
Thirty Baht Scheme (TBS) (MOPH 2002). Through these sub-schemes, the majority of 
Thais are secured against financial risks for health care services including the costs of 
essential medicines. 
Although the majority of Thais are covered by the UCS, they may not be able to 
access medicines. Often, patients are prescribed their medications but the medicines 
themselves may not be available or affordable at all times or when they are in great 
demand (MOPH 2002). These are crucial concerns for the MOPH that could be resolved 
by an efficient drug management system which would improve the equity of access to 
medicines for all people under limited health care resources. The Drug Management 
Cycle (DMC), proposed by WHO, is an alternative approach and is in place in all public 
health care providers, aiming to establish an efficient drug management system in the 
public sector. 
During the past decades, the concept of using the DMC to improve the equity of 
access to medicines has exerted a powerful influence on the development of the drug 
management system in the Thai public health care system. In addition, WHO has 
encouraged health care providers to apply the DMC for managing drug supply with 
regard to patients' needs. According to the DMC, efficient drug management will be 
achieved by complying with the four major processes of it; which are selection, 
procurement, distribution and rational use of medicines. In addition, the DMC will 
improve the equity of access to medicines by ameliorating the availability and 
affordability of good quality medicines. 
However, the evidence from the studies regarding the implementation of the DMC for 
medicines management in the Thai public sector is limited. Hence, this thesis will 
discover the components from each process of the DMC that health care stakeholders 
considered to be vital in helping to improve the equity of access to medicines in 
Pathumthani Province. In addition, opinions obtained from health care users will reflect 
their attitudes towards the medicines supply system and health care services in public 
health care providers. Ultimately, the findings from this study will lead to 
recommendations for improving the drug management system in the public sector. This 
in turn will cause an increase in the equity of access to medicines. 
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1.2 AIMS AND OBJECTIVES OF THE THESIS 
This thesis aims to suggest the most effective approach for medicines management and 
reflect the roles of pharmacists towards improving equity of access to medicines in the 
public health care providers of Pathumthani Province, Thailand. To achieve these aims, 
the following objectives were set out: 
1. To describe and characterise the processes of medicines management in public health 
care providers of Pathumthani Province; 
2. To identify experiences of medicines management under the UCS in public health 
care providers and compare them to those with the DMC concept; 
3. To measure attitudes of health care users towards the medicines supply system, the 
pharmacy services and the overall health care services in public health care providers; 
4. To make proposals for: 
a) The revision of the roles of pharmacists in promoting equity in access to 
medicines provision under the UCS in Pathumthani Province; and 
b) Recommendations of applying the DMC to improve the equity of access to 
medicines in the public health care system under the UCS. 
1.3 OUTLINE OF THE THESIS 
The thesis comprises eight chapters. Chapter 2 reviews the general background of 
Thailand's health care system and describes the importance of the health care reform 
project. It was the impact of this project that encouraged the establishment of the UCS in 
later years. In addition, a brief summary of the UCS sub-schemes and their benefits to 
those registered are also presented. The general background of Pathumthani Province, 
which is the target site for this study, is also included in this chapter. 
Chapter 3 summarises the relevant concepts of equity in access to health care which 
are used to steer Thailand's health care system under the UCS. In addition, there is further 
explanation on how the UCS enhances equity of access to health care services. This is 
discussed alongside the experiences of some countries, particularly those developing 
countries in Asia, which apply the Universal Coverage Approach to their health care 
systems. 
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Chapter 4 focuses mainly on the essence of medicines in a health care system. In 
addition. the situations that many countries across the globe go through to establish an 
efficient medicines supply system are discussed. The DMC which is a guideline for drug 
management proposed by WHO is also explained in relation to the comparison of the 
experiences of both rich and poor countries implementing the guideline. 
Informed by the discussion in the three preceding chapters, Chapter 5 sets out the 
rationale and methods employed in the investigation of the situation of access to 
medicines supply in Thailand under the UCS. The study is designed to address the key 
practices proposed by health care stakeholders about each process of the DMC alongside 
a survey of patients' attitudes towards the medicines supply system in public health care 
providers. 
Chapter 6 presents qualitative findings from semi-structured interviews with health 
care stakeholders regarding the medicines supply system in public health care providers. 
These findings will reflect the major components of the DMC in managing drug supply. 
Chapter 7 shows the quantitative findings obtained from outpatients with hypertension 
(HT) or diabetes (DM) reflecting their opinions as health care users towards medicines 
management. They comment on drug quality, pharmacy services and health care services 
from public health care providers. 
Chapter 8 is the discussion of study findings and their implications for the health care 
system under the UCS. In addition, recommendations to improve the efficient drug supply 
system so that there is an increase in the equity of access to medicines in health care 
facilities are suggested based on these findings. 
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CHAPTER 2 
General Background of Thailand and its Health Care System 
2.1 INTRODUCTION 
The evolution of Thailand's health care system has been taking place for more than a 
century. The development started with using the wisdom of traditional village medicine, 
which led from the concept of self-care to the development of systematic health care 
services and modern medicine. At the initial phase of health care development, attempts 
to integrate modern medicine and public health services from the Ministry of Public 
Health (MOPH) to the local health care practices were focused on the self-care concept, 
which was adopted as the MOPH's principal health policy in later years. In addition, one 
of the most important health policies from the MOPH is the Universal Coverage Scheme 
(UCS) which has been implemented in the Thai health care system since April 2001. The 
extension of health care services has been centred on the Community-Based Approach, 
having a Primary Care Unit (PCU) as a centre of health care services for local people. All 
tasks performed by the MOPH during the past five years have been intended to expand 
health care coverage to all Thais. 
This chapter aims to present a general background of Thailand and its health care 
system. These include a brief description of the country's profiles, Thailand's health care 
system and its major implementations after health care reforms in 2001. In addition, key 
components of the Thai health care system and the general background of the UCS are 
also described. Since Pathumthani Province was selected as a target area for this study, its 
general background and provincial profile are presented in the last section of the chapter. 
2.2 THE KINGDOM OF THAILAND 
This section presents Thailand's general profile and aims to describe fundamental 
information about the country. The content is divided into four main categories: 
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" Geography 
" Demography 
" Thailand's Economy 
" Thailand's Administrative System. 
2.2.1 Geography 
The Kingdom of Thailand is situated in the heart of the Southeast Asian peninsula and 
covers an area of approximately 514,000 square kilometres, the same size as France or 
Texas (Figure 2.1). 
Figure 2.1: Political Map of Thailand 
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Data on housing and population in 2000 showed that the country comprised 76 
provinces, 795 districts, 81 sub-districts, 7,255 boroughs, and 69,866 villages (National 
Statistical Office 2001). The country shares borders with Laos and Cambodia in the east, 
the gulf of Thailand and Malaysia in the south, the Andaman Sea and the Union of 
Myanmar (Burma) in the west, and also with Laos and the Union of Myanmar in the 
north. Thailand stretches 1,650 kilometres from north to south, and from east to west is 
780 kilometres at its widest point (Bureau of Policy and Strategy 2006). The country is 
geographically divided into four regions - the northern, the north-eastern, the southern, 
and the central regions, comprising a total of 76 provinces and two special administrative 
areas (Bangkok and Pattaya). 
2.2.2 Demography 
Although Thailand is geographically divided into four administrative regions, its 
population is relatively homogeneous and about 75% of the total population is Thai 
(MOPH 2002). The predominant minority group in Thailand is Chinese, who make up 
about 14% of the population. There are also smaller ethnic groups of Lao, Khmer, 
Hindus, Sikhs and Malay (Coleman 2007). Data obtained from the National Statistics 
Office reported that the Thai population reached approximately 61.1 million in 2000, and 
is expected to increase to 72.5 million in 2020 (Table 2.1). 
Life expectancy for Thais over the past four decades changed dramatically. It has 
increased from 56.2 years in 1960 to 72.3 years in 2000 or approximately 16 years of 
additional life expectancy at birth within 40 years. Life expectancy at birth for Thais is 
predicted to increase to 74.4 in 2020, when women will still have higher life expectancy 
at birth than men (76.5 years for women and 72.2 years for men). The infant mortality 
rate has fallen from 84.3 to 22.0 per 1,000 live births between 1960 and 2000. This rate is 
expected to fall further to 7.5 per 1,000 live births in 2020 (Table 2.1). 
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Table 2.1: Demographic Data of the Thai Population between 1960 and 2020 
Characteristics 1960 1970 1980 1990 2000 2020* 
1) Total population 
(millions) 
- Male 
- Female 
2) Life expectancy at birth 
(years) 
- Male 
- Female 
3) Infant mortality rate (per 
1,000 live births) 
26.3 34.4 44.8 54.5 61.1 72.5 
13.1 17.1 22.3 27.1 30.1 N/A 
13.2 17.3 22.5 27.4 31.0 N/A 
56.2 59.7 63.3 66.2 72.3 74.4 
53.6 57.7 60.3 63.5 70.0 72.2 
58.7 61.6 66.3 68.8 75.0 76.5 
84.3 56.3 48.0 35.0 22.0 7.5 
Remark: - The asterisk denotes that an estimation of the computed figures is based on the population 
growth rate from previous years. 
- N/A indicates that the data are not available. 
Source: Modified from Health Policy in Thailand 2003 (Bureau of Policy and Strategy 2003) 
Compared to other neighbouring countries in ASEAN' Thailand had lower life 
expectancy at birth than Singapore, Brunei, Malaysia, and Vietnam respectively (Figure 
2.2). Moreover, Thailand's life expectancy at birth was 12 years less than that of Japan 
and about 10 years lower than the United Kingdom and the United States of America 
(WHO 2006b). 
'The Association of Southeast Asian Nations (ASEAN) is a geo-political and economic organisation 
including 10 countries which are located in Southeast Asia. ASEAN was formed on 8"' August 1967 by 
Indonesia, Malaysia, the Philippines, Singapore, and Thailand, as a display of solidarity against communist 
expansion in Vietnam and insurgency within their own borders. Its aims include the acceleration of 
economic growth, social progress, cultural development among its members and the promotion of regional 
peace. At the moment, the member of ASEAN comprises Brunei, Cambodia, Indonesia, Laos, Malaysia, 
Myanmar, the Philippines, Singapore, Thailand and Vietnam (ASEAN 2004). 
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The average annual growth rate in Thailand between 1994 and 2004 was 
approximately 1% which was the lowest among its neighbouring countries in the 
Southeast Asian region. However, Thailand's population growth rate was higher than the 
USA, China, the UK, and Japan (Figure 2.4). 
Figure 2.4: Comparison of the Average Annual Population Growth Rates (1994 to 2004) between 
Thailand and other ASEAN countries with Four Non-ASEAN countries 
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The dramatic change in Thailand's population growth rate since 1990 was caused by a 
family planning campaign. At that time, the MOPH implemented the campaign and 
encouraged couples to have a maximum of two children in a family (Bureau of Policy and 
Strategy 2006). Reasons to support such a campaign were related to socioeconomics in 
each family and inadequacy of resources. Moreover, the Cabinet determined to focus on 
the country's economic development, does so by allowing local and overseas 
businessmen to invest in medium to large scale industry. Consequently, low-skilled 
workers were required to fulfil the demands of industry which were not adequately 
supplied by the local population. Therefore, people from rural or agricultural areas 
migrated to larger cities, particularly Bangkok or some industrialised areas. As a result, 
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Figure 2.2: Comparison of Life Expectancy at Birth in 2004 between Thailand and other ASEAN 
Countries with Four Non-ASEAN Countries 
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The annual population growth rate of Thailand reduced steeply from 2.70% in 1960 to 
1.05% in 1990 (Figure 2.3). The rate has fallen further between 2000 and 2005 of which 
the annual population growth rate was less than 1%. 
Figure 2.3: Annual Population Growth Rates of Thailand between 1960 and 2005 
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lifestyle and familial characteristics in many parts of the country were altered from the 
joint or extended family2 to the nuclear family3. 
Societal trends suggested by marriage statistics were further verified by observed 
trends in fertility and a family size. The fertility rate had noticeably dropped from 33.1 
births per 1,000 women in 1993 to 24.8 in 2000. Likewise, family size also declined from 
5.6 members per household in 1960, to 4.4 in 1990 and 3.9 in 2000 (National Statistics 
Office 2000). This is partly because people from villages migrate to urban cities for better 
opportunities to find good jobs which offered them higher incomes than that from 
agriculture (Phoolcharoen 2005). Young adults tend to leave home for work in the private 
sector in Bangkok or other surrounding urban areas (Bureau of Policy and Strategy 2006). 
Changes in Thai demography can also be presented in population pyramids. In 1960, 
the majority of the Thai population was in the age range 0 to 19 years for both males and 
females, with an annual population growth rate of 2.7% (Figure 2.5). 
Figure 2.5: Thailand's Population Pyramids between 1960 and 2010 
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2A joint or an extended family is the network of relatives that acts as a close-knit community. Extended 
families can include, aside from parents and their children, cousins, aunts, uncles, grandparents, foster 
children and so forth (Greif 2005). 
3A nuclear family is presumably a perfect residential, social and economic unit consisted of merely an adult 
male, an adult female and their minor children. At the midpoint of the century, the virtues of this familial 
form were still being extolled from all quarters, particularly in North America (Haley 2000). 
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In 1990, the annual population growth rate sharply decreased to 1.05% (Figure 2.3). Thus, 
the population pyramid shows that the size of working-age population (aged 15 to 59 
years) had increased while the proportion of population aged between 0 and 4 years had 
decreased. Interestingly, the proportion of the elderly (aged over 70) had also increased in 
the same year. In 2000, the population pyramid shows a reduction of people aged between 
0 and 4 years, while the proportion of both the working-age (15 to 59 years) and the 
elderly (over 60 years) population increased. 
By 2020, the working-age population will be the majority group in the pyramid. In 
addition, the proportion of the elderly (aged over 60) will have risen in relation to the 
increase in life expectancy at birth of Thais (Figure 2.2). Approximately 15% of the 
population will be over the age of 60 in 2010 (Figure 2.5). This implies that Thailand will 
become an ageing population country in the near future, similar to the trends in many 
developed countries in Europe and Japan (Figure 2.6). The health problems present in 
these societies are more likely to occur in Thailand as medical technologies improve and 
people live longer. This will mean an increase in diseases such as diabetes and heart 
disease (Bureau of Policy and Strategy 2006). 
Figure 2.6: Comparison of Thailand's Population Pyramid with Sweden, Denmark and Japan 
in 2000 
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2.2.3 Thailand's Economy 
In the past, the Thai economy relied entirely upon agriculture. Small scale farming was 
only considered important for self-reliance, not for commercial or exporting purposes. 
However, the government has later encouraged farmers to increase manufacturing 
agricultural products for export. Moreover, the government has developed the five-year 
National Economic and Social Development Plans, focusing on comprehensive economic 
strategies for sustainable development of the economy. The first plan commenced in 1961 
and the current one is the Tenth National Economic and Social Development Plan, in 
place between 2007 and 2012. 
The Thai economy carried on its momentum in 2005 in line with an acceleration of 
private investment and an increase of demand for capacity expansion. Furthermore, 
export prospects are favourable in Thailand's key trading partners such as the USA, the 
European Union, and Japan (World Bank 2005). Although external risks to economic 
growth in 2005 were reduced due to the world economic recovery, problems of 
international terrorism and volatile world oil prices continued to be major concerns as 
they had affected the world economy in previous years. On the domestic side, risks to the 
economic growth are from possible imbalances or overheating in some sectors of the 
economy such as the real estate market and household debt (World Bank 2006). In 
addition, health problems from the risk of an avian flu outbreak still remain in Thailand 
and the Southeast Asian Region. This affects economic growth not only in Thailand, but 
also the whole ASEAN (WHO 2006b). 
2.2.4 Thailand's Administrative System 
Thailand is a democratic country with the King as Head of the State under the 
Constitution of the Kingdom of Thailand. The countrys administrative system comprises 
three hierarchies of administration: Central, Provincial, and Local Administration 
(Ministry of Interior 2005). 
Central Administration is regarded as the headquarters of all administrative systems 
including all ministries and the central government. Provincial Administration comprises 
76 provinces. 795 districts and 81 sub-districts. Local Administration refers to the 
autonomous administrative authority of the people in each administrative locality. These 
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localities are categorised into four types, provincial administration organisations, 
municipalities, sub-district administrative organisations and other types of local authority 
as designated by law (Ministry of Interior 2005). 
2.3 THE EMERGENCE OF THAILAND'S HEALTH CARE REFORM 
The aim of health care reform is to increase efficiency, equity, and effectiveness in the 
health sector and thus in health care. It has a wide appeal and has been adopted by health 
care systems in many countries. Although such countries display differences in income, 
social structure, and health care status, they are still undertaking or considering 
programmes of health sector reform. The factors which lead countries to reform their 
health care system vary. These reasons generally refer to a rapid alteration of 
demographic and epidemiologic patterns, a shift in economic stability of a country 
(including either fiscal crises or economic growth), and dramatic political transformation 
(Berman & Bir 1995). 
In Thailand, the reasons to reform the health care system were in relation to four key 
factors: the emergence and re-emergence of diseases, the new Constitution Act 1997, the 
Economic Crisis in 1997 and the increase in societal disparity caused by a rapid change in 
technology and development. A brief summary of these four factors are presented as 
follows: 
2.3.1 Emergence and Re-emergence of Diseases 
In the past decade, there were considerable changes in the context of Thailand's health 
care. Such changes included ageing of the population, alteration of disease patterns from 
communicable to chronic diseases, and diversification of people's needs for medical care. 
However, both communicable and non-communicable diseases continued to pose major 
challenges to the development of Thailand's health care system. Those infectious diseases 
that were prioritised as major health problems and required immediate concerns were 
malaria, AIDS, and tuberculosis (WHO 2006a). Conversely, an increase in the affluent 
middle class and a sedentary lifestyle as well as the ageing population has resulted in a 
rise in the prevalence of non-communicable diseases. Coronary artery diseases, cancer, 
diabetes mellitus, hypertension and accidents have become major causes of morbidity and 
mortality in Thailand. In addition, mental health problems and substance abuse were also 
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increasing and posing major challenges to the health of the Thai population. Hence, 
health promotion and protection requires greater attention and concerted efforts to address 
both non-communicable and communicable diseases. 
2.3.2 The new Constitution Act 1997 
The new Constitution Act (1997) establishes considerable opportunities for further 
progress in restructuring the relationship between state and civil societies. Such 
improvement in the development process of democracy is reflected by creating new 
institutions and mechanisms that provide greater accountability, transparency, 
representation and participation. Initiatives in these areas take their roots from the laws 
which are guided by profound principles pertaining to basic human rights and have paved 
the way for public development, which includes the reorientation of public health 
(Phoolcharoen 2004). 
Regarding the new Constitution Act 1997, the provisions of health care are prescribed 
in accordance with rights and liberties of the Thai people. Section 52 in the Constitution 
Act stipulates that: 
"... A person shall enjoy an equal right to receive standard public health services, and the indigent 
shall have the right to receive free medical treatment from public health facilities of the state, as 
provided by laws. The public health service by the state shall be provided thoroughly and 
efficiently and, for this purpose, participation by local government organisations and the private 
sector shall be promoted insofar as it is possible. The state shall prevent and eradicate harmful 
contagious disease for the public without charge, as provided by laws. " (Bureau of Policy and 
Strategy 2006) 
In addition, Section 82 proclaims that: 
"... The state shall thoroughly provide and promote standard and efficient public health services. " 
(Bureau of Policy and Strategy 2006) 
Having the new Constitution is merely the first phase of health care reform. The 
government has attempted to provide high priority to public health development and 
quality of life by emphasising the importance of health care service provision for all 
population groups. In addition, the machinery of the political reforms within the civil 
service was needed to propel an efficient and effective system. Although the public sector 
has been providing many benefits for the country over the past decades, globalisation and 
the economic crisis has highlighted areas where it has been too rigid, cumbersome and 
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ineffective in response to those demands and to the position of the country for its long 
term development. The health sector was also in this situation and therefore this led to the 
commencement of the health care reform project in 2000 (Phoolcharoen 2004). 
2.3.3 The Southeast Asian Economic Crisis in 1997 
The Southeast Asian Economic Crisis emerged from a complex set of factors that had 
begun to affect economic performance in several countries in the region during 1997. 
However, after recovery from the financial crisis, development in Thailand has 
progressed forwards at a good pace. However, such acceleration was focused on only 
urban growth which resulted in the shift in Thailand's economic strategy towards the 
promotion of exports in both services and manufacturing industries. Thais from rural 
areas had moved permanently to larger cities at a more rapid rate, resulting in the decline 
in agricultural growth and abandonment of agrarian areas. In 1999, the total number of 
migrants from the rural or agricultural sectors to the urban or industrialised areas was 
reported to be around one million (Bowornwathana 2000). 
Due to economic growth and the migration of Thais from rural to urban areas, 
strategies of how to handle complicated health problems needed to be revised and 
adjusted. For example, AIDS, traffic injuries, cancer, mental stress and environmental 
hazards had not been the important public health issues 30 years ago. However, they have 
become among the top ten causes of mortality for Thailand since 1990. In addition, the 
national health care system and proper management of health care resources needed to be 
revised at a time when the national budget was limited. These led to health care reform in 
2000 (MOPH 2002). 
2.3.4 The Increase in Societal Disparity Caused by Rapid Changes in Technology 
and Development 
Inequalities in the health status of Thais have risen within recent decades despite 
substantial gains in general public health. Primary health care under the 'Health for All' 
strategy, aimed at ensuring equitable health care for the whole population, was not able to 
respond to such situations. For instance, the Infant Mortality Rate (IMR) showed that 
health status was different in various population groups. IMR in non-municipal areas was 
1.85 times higher than that in municipal areas in 1992 (Phoolcharoen 2004). Although the 
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IMR has dropped by half in the past 20 years, the difference between the urban and rural 
areas has been widening. 
The misdistribution of radiotherapy for cancer treatment is another example of 
inequalities in Thailand's health care system. Although cancer has been one of the leading 
causes of death since the 1980s, 54% of radiotherapy units were installed in Bangkok. 
The other 46% were distributed to provincial cities at which qualified manpower was not 
available to operate them. However, from 2000 onwards, the MOPH has planned to revise 
its management of health care resources and the health care system. Thus, this is another 
reason for health care reform in 2000 (MOPH 2002). 
Using these four key reasons for health sector reform in Thailand, the reform plan was 
designed in the context of management mechanisms that are divided into five main areas. 
The first area covers the roles, functions and structures of the public sector. The aim is to 
restructure the public sector to become more oriented and more responsive to the public's 
needs. The second area refers to the budgetary management system, moving from input 
controls to a result-oriented system. The new system will be equipped with performance 
indicators and performance reporting systems supported by the use of advanced 
information technology. 
The third area to be reformed addresses human resources in the public sector. 
Competent public officials are to provide sound policies and management to support 
Thailand's sustainable development and competitiveness. Public officials should be able 
to work as a team, with vision, innovation and services in mind. The fourth area covers 
legal reform which emphasises effectiveness and efficiency of those rules and regulations 
in relation to the current situation. Lastly, the fifth area includes the culture and values of 
the public sector. Effective mechanisms to diagnose, detect, prevent and deal with 
corruption need to be focused on (Bureau of Policy and Strategy 2006). 
The notion to reform Thailand's health care system was, in fact, initially proposed in 
1997. However, the operational phase commenced in 2000 and was then developed into a 
national health care protocol called `the Universal Coverage Scheme (UCS) '. This 
scheme aims to improve quality of life for all segments of society which the Ministry of 
Public Health (MOPH) is responsible for. 
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2.4. THE UNIVERSAL COVERAGE SCHEME 
The Universal Coverage Scheme (UCS) in Thailand was initially implemented in 1983 
and was known during that time as the Health Card Scheme (HCS) or the Voluntary 
Health Card Scheme (VHCS) for farmers and workers in informal sectors at the 
community level. The scheme was supported from a matching fund which referred to the 
government revenue computed from the amount of VHCS cards sold by a health care 
provider within the past fiscal year. However, the price set for the VHCS card providing 
coverage to the whole family for one year was not sufficient for health care providers 
who were required to bear all health care costs, especially those supplying higher levels 
of care (MOPH 2002). Consequently, this led to revising the concept of Universal 
Coverage, its implementation and benefits for Thais. 
The fundamental motivations leading to the UCS implantation in 2001 comprise: 1) 
the Economic Crisis in Southeast Asia in 1997 which drives the country's revision of the 
administrative systems and introduces new initiatives such as sufficient economy 
(according to the King's proposal), educational system remodelling and health sector 
reform; 2) the Contemporary Constitution Act 1997 (Article 52) which establishes the 
entitlement of all Thais to receive adequate and efficient health care services according to 
needs, considering individual preferences and regardless of income, social status or 
residency; 3) the Eighth and the Ninth National Social and Economic Development Plans 
which emphasise the concepts of the sustainability of human-centred development; and 4) 
the National Election in 2001 of which the concept of the TBS was derived from a 
political party manifesto and was introduced to Thais in later years (MOPH 2002). 
The political platform, the `Thirty Baht Scheme (TBS)', was integrated into the health 
care system after the national election in 2000. The reorganisation of the health care 
systems and improvement of health services were identified as the most urgent in need of 
plans for tangible implementation (MOPH 2002). Health policy has been focused on 
sustainable development in health care and health investment, particularly for the public 
sector. The tasks have been centred mainly on health promotion and self-care, which are 
intended to work in harmony together with primary care units (PCUs) in communities. 
Part of this reform package is the TBS. This has been considered the ideal flagship project 
of the UCS in delivering health care services to the disadvantaged and the poor. 
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The goals of the UCS are to expand health service coverage and improve access to 
health care provisions. However, the MOPH has expected that these goals are attained by 
focusing on four major issues: 
" good health which covers physical, mental and spiritual status; 
" good physical and social environments, emphasising the importance of the 
environment to an individual's health status; 
0 good health by self-care, which refers to an individual's awareness of health status, 
perception and knowledge towards prevention of diseases; and 
0 good health care system, which is related to provision, delivery and accessibility of 
health care services. 
The UCS aims to provide a package of health services to Thai citizens either free of 
charge or with a 30 baht co-payment. The scheme has been developed from the four pre- 
existing health insurance schemes including: 
" the Civil Servants' Medical Benefit Scheme (CSMBS) 
" the Social Security Scheme (SSS) 
" the Voluntary Health Card Scheme (VHCS) 
" the Medical Welfare Card Scheme (MWS). 
VHCS and MWS have been combined, revised and re-launched under the current name, 
the 'Thirty Baht Scheme (TBS)'. Thus, after 2001, the UCS comprises three sub-schemes 
that are CSMBS, SSS and TBS. 
CSMBS provides health care benefit for public sector workers and their dependents. 
The payment mechanism is structured through Diagnostic-Related Groups (DRGs) and 
covers all treatment in public hospitals, including the provision of medicines listed in the 
National Essential Drug List (NEDL). For private sector workers, health care is provided 
through compulsory participation in SSS. Central funds are created from contributions 
made by both employers and employees with additional funding from the government 
which is drawn from general taxation. 
TBS covers Thais who are not able to receive benefits under CSMBS or SSS. It 
consolidated the existing MOPH's programmes, including MWS (for people on low 
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incomes and the disadvantaged) and VHCS (the 500 baht or £7 health card for a family), 
and also aimed to extend health care coverage and access to basic health care services to 
all Thai citizens. TBS covers the majority of patients and allows them to pay 30 baht 
(£0.45) per visit to a health care provider for the duration of their treatment regardless of 
whether they are inpatients or outpatients. TBS commenced in April 2001 with pilot 
projects in five provinces. 
On 1S` June 2001, the government expanded coverage to another 15 provinces 
including some major public hospitals in Bangkok Metropolitan4 and private hospitals. 
Subsequently, the last phase has been implemented in the remaining 55 provinces 
throughout the kingdom since ls` April 2002. At this stage, TBS covered all Bangkok 
Metropolitan's public hospitals, medical schools' hospitals, special institutions for 
particular diseases (e. g. the National Cancer Institution and the Hospital for Tropical 
Medicine) and some private health care providers. As a result, TBS has covered all public 
health care providers and more than 70% of private sectors throughout the kingdom 
(Bureau of Policy and Strategy 2006). 
Care under TBS is provided through a hierarchical network of health facilities, from 
the PCU level to the district level (district hospitals), provincial level (general hospitals or 
central hospitals) and regional level (regional hospitals or medical schools' hospitals). 
Private health care facilities have been encouraged to participate and the vast majority 
now do so. TBS aims to deliver an efficient and effective referral system from the PCU 
level upwards, through the hierarchy of health care providers, with each level acting as `a 
gatekeeper' for access to the next level up. 
In addition to seeking to expand health care networks and formalising the referral 
system, TBS has sought to extend coverage by driving forwards a process of population 
registration, undertaken by local health centres, based on information derived from the 
household registration database held by the Ministry of Interior. While maintaining the 
access rights of those participating in the pre-existing VHCS and MWS schemes, this 
process seeks to register previously uncovered groups. All registered persons are issued 
4Bangkok is a special administrative area and is not regarded as a province. The special area also includes 
the City of Pataya in Chonburi Province. Therefore, Thailand comprises 76 provinces and 2 special 
administrative areas (MOI 2004). 
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with the TBS card or the `Gold Card'5 which allows them to access care and indicates 
whether this is free of charge or whether they must make a 30 baht co-payment. People 
aged between 0 and 12 years, over 60 years, those with low incomes (less than 2,500 baht 
or £40 per month) and those with disabilities receive free services. The remainder co-pay 
30 baht per visit per treatment. 
Entitlement under the scheme is defined by the `Core Package' which lists diseases 
and services covered. The core package covers a range of health problems from minor 
illness such as common cold to life threatening diseases such as cancer or AIDS. A wide 
range of treatment and rehabilitation procedures can be accessed including heart 
operations, traditional medicines and drugs dependency services, as well as health 
promotion and preventive care such as occupational education and environmental 
sanitation in communities. The expansion of TBS to the Thai population is expected to 
narrow the gap between the rich and the poor, and to mitigate health problems in the Thai 
health care system. 
2.5 PATHUMTHANI PROVINCIAL PROFILE 
The previous sections gave an overall picture of the Thai health care system and changes 
that occurred after the implementation of the UCS in 2001. For this study, Pathumthani 
Province was purposively selected as a case study for the assessment of the DMC in 
managing drug supply under the UCS (see Chapter 5 for further details). The reasons for 
choosing Pathumthani Province were that it is located near Bangkok and represents the 
social class gradient in the region, including the urban, suburban and rural societies, 
which were expected to reflect the general characteristics of the central region and Thai 
society. This section contains a brief summary of Pathumthani provincial profile, its 
health care system and the changes that occurred after the implementation of the UCS in 
2001. 
2.5.1 General Profile 
Pathumthani Province is located in the Central Region of Thailand and is considered to be 
one of the most important provinces in the region (Department of Health Care Projects 
2004). The province comprises a range of rural and agricultural, suburban and urban 
'In fact, the TBS card is in yellow colour; therefore, it is called the 'Gold Card' by many patients 
(Pathumthani Provincial Health Office 2005). 
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areas. The implementation of any health care projects usually has to take into account 
local demands and needs. This section aims to provide basic information about 
Pathumthani Province, which is given in four categories: Geography, Demography, 
Economy and Education. 
2.5.1.1. Geography 
Pathumthani is one of 24 provinces in the Central Region. It is a neighbouring province of 
Bangkok and is also adjacent to Nonthaburi, Ayutthaya, Saraburi, Nakhon Nayok and 
Chachoengsao (Figure 2.7 and 2.8). 
Figure 2.7: Location of Pathumthani Province 
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Figure 2.8: Location of Pathumthani Province and its Neighbouring Provinces in the Central Region 
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Ayutthaya Province 
Nonthaburi Province 
Saraburi Province 
Remarks: The numbers in the map represent the locations of the districts and their boundaries of which: 
1= Muang Pathumthani (the city centre of the province) 
2= Klongluang 
3= Thunyaburi 
4= Nongsua 
5= Latlumkaew 
6= Lumlukka 
7= Samkok 
Source: Thailand 76 Provinces' Profile (MOI 2004) 
Pathumthani Province covers an area of approximately 1,521 square kilometres, having 
Muang Pathumthani district as a city centre (which is only 45 kilometres northwest of 
Bangkok). The province is administratively divided into seven districts6 (Amphoes) 
which include Muang Pathumthani, Klongluang, Thunyaburi Nongsua, Latlumkaew, 
Lumlukka and Samkok. 
2.5.1.2 Demography 
The distribution of population is among the basic data used for the provincial 
administration and the implementation of all health care tasks. Table 2.2 shows that 
6Regarding the Ministry of Interior (MOI)'s Administrative System information, one province comprises 
districts or Amphoes, ranging from 4 to more than 20 Amphoes. One Amphoes includes several sub- 
districts or Tambons. In addition, one Tambon refers to a group of villages and each village is regarded as 
the smallest unit of the administrative system. Hence, the administrative hierarchy in one province, from the 
highest to the lowest levels, comprises the provincial, district (Amphoe), sub-district (Tambon) and village, 
(MOI 2004). 
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Figure 2.9: Pathumthani Administrative Map 
Muang Pathumthani district (or the city centre) covers an area of only 121 square 
kilometres. The district itself is regarded as the heart of the province since major political 
and governmental organisations are located there. In addition, the provincial statistics in 
2004 reported that the average distribution of population per square kilometre in Muang 
Pathumthani district was approximately 1,200. This indicated that the district was 
classified as an area of dense population as in Thunyaburi (1,300 per square kilometre). 
Table 2.2: Pathumthani Administrative Data 2004 
District 
Number of 
Sub-districts 
Population 
Area 
(Km2) 
Population 
per Km2 
Distance to 
Muang 
District 
(Km) 
Distance 
to 
Bangkok 
(Km) 
Muang Pathumthani 14 146,941 120.15 1,223 0 45 
Latlumkaew 7 45,773 183.12 250 15 60 
Samkok 11 46,260 94.96 487 6 58 
Thunyaburi 6 146,525 112.12 1,307 26 30 
Nongsua 7 47,418 413.63 115 45 80 
Klongluang 7 138,695 299.15 464 22 35 
Lumlukka 8 160,089 297.71 538 37 30 
Total 60 731,701 1,520.86 N/A N/A N/A 
Average N/A N/A N/A 481 22 48 
Remark: - An average population per Km2 of Pathumthani Province is 481. 
- N/A denotes that data are not available. 
Source: Pathumthani Provincial Administration Support Department 2004 
Conversely, the population density per square kilometre in Nongsua and Latlumkaew 
was approximately 115 and 250 respectively. This may reflect that people tended to live 
in or near urbanised cities. In addition, the main factor which also caused the variation in 
the distribution of population in Pathumthani was the distance from each district to 
Bangkok. In Nong Sua district, for instance, being 80 kilometres from Bangkok resulted 
in it being the most remote district from either Muang Pathumthani or Bangkok. 
Therefore, it has the lowest population density. 
Nevertheless, the population density in some districts does not depend on the distance 
between the districts themselves and urban areas. For instance, although Latlumkaew is 
only 15 kilometres away from Pathumthani city centre, the population density was only 
250 per square kilometre. This was probably because the population preferred to live in 
Muang Pathumthani, which is more convenient in terms of access to essential facilities 
and transportation. Hence, people migrated from Latlumkaew to Muang Pathumthani 
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district and this resulted in the low population density in Latlumkaew (Pathumthani 
Province 2004). 
The population density in each district is a key factor that influences the provision of 
health care services (MOPH 2002). For example, the estimation of health care resources 
such as the budget for medicines purchase, the number of health care staff and the size of 
hospitals are computed from the number of populations registered in a district. However, 
health care services may not cover all the population in a province because there are 
always changes in the size of the population. Many migrant workers from other provinces 
or neighbouring countries migrate to Pathumthani Province, particularly in Muang 
Pathumthani and Thunyaburi districts. These people are not registered with the UCS in 
the province and thus are required to pay for all incurred costs if they use health care 
services. Many of these migrant workers are unable to afford these health care charges, 
especially people with chronic diseases that need long term treatment, such as diabetes, 
hypertension or heart disease. (Pathumthani Provincial Administration Support 2004). 
To alleviate these problems, the MOPH has implemented the Cross-Border Policy, 
which has been implemented by all public health care providers since 2004 (NHSO 
2006a). The new policy allowed people who registered with the UCS from different 
health care providers to access health care services from any public health care facilities 
participating in the UCS. Nonetheless, at the beginning of an implementation, health care 
services were limited to only particular criteria: 
9 Cases referred from the provincial network; 
" Emergency cases; and 
" Some high costly cases (must be authorised by a hospital director). 
By 2010, patients will be able to choose any health care providers in accordance with 
their preferences and convenience of access (NHSO 2004). Migrating from one place to 
another region will not hinder patients from using health care services since they may 
register with their local health care facilities or providers that participate in the UCS. 
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2.5.1.3 Economy 
Pathumthani was one of the provinces with the highest Gross Domestic Product (GDP) 
per capita in Thailand after Bangkok and Samutprakarn Province (Pathumthani Provincial 
Administration Support 2004). Table 2.3 shows both the GDP per capita by district and 
the overall GPD per capita between 2002 and 2004. Muang Pathumthani, Thunyaburi and 
Klongluang districts displayed the highest average GDP per capita between 2002 and 
2004, approximately 52,800 baht, 49,400 baht, and 45,200 baht (£750, £710 and £650) 
respectively. The other four districts, Nongsua, Latlumkaew, Lumlukka and Samkok, had 
an average GPD per capita less than 40,000 baht (£570). 
Table 2.3: Pathuinthani Provincial GDPper Capita between 2002 and 2004 by District 
Districts 
2002 
(Baht) 
2003 
(Baht) 
2004 
(Baht) 
Average GDP 
per capita 
(Baht) 
Nong Sua 30,422.43 31,377.89 31,616.51 31,138.94 
Latlumkaew 32,433.45 33,548.90 34,272.27 33,418.21 
Lumlukka 32,109.88 33,453.37 34,775.95 33,446.40 
Samkok 33,009.71 36,480.50 37,954.91 35,815.04 
Klong Luang 35,698.98 48,239.55 51,948.98 45,295.84 
Thunyaburi 45,650.12 49,233.77 53,427.02 49,436.97 
Muang Pathumthani 48,957.45 53,490.04 55,831.65 52,759.71 
Total GDP per Capita 258,282.02 285,824.02 
299,827.29 281,311.11 
(0,700) (£4,100) (£4,300) (£4,000) 
Source: Pathumthani Provincial Report (Department of Health Care Projects 2004) 
2.5.1.4 Education 
Pathumthani Province has a high concentration of higher education institutions, especially 
in the field of science and technology. The province is considered one of the most 
important educational and technology hubs of Thailand. Table 2.4 displays the number of 
all educational institutions in Pathumthani by level. 
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Table 2.4: Categorisation of Educational Institutions in Pathumthani Province in 2004 
Level of Educational Institutions Number of Institutions 
Primary schools 72 
Secondary/High schools 18 
Vocational schools 3 
Colleges and universities 9 
Source: Pathumthani Provincial Report (Department of Health Care Projects 2004) 
In Thailand, it is compulsory for children to study in both primary and secondary schools. 
This includes six years in a primary school and other six years at a high school. Students 
do not pay a tuition fee and are partly supported from the government for educational 
materials such as textbooks, notebooks or pencils. Thus, the government aims to increase 
the literacy rate to 99% by 2010 (Pathumthani Province 2004). 
Although there were many educational institutions located in the province, the 
provincial literacy rate was approximately 96% which was similar to the average for the 
country (Pathumthani Provincial Administration Support 2004). However, the literacy 
rate was a little lower than the three neighbouring provinces, Samutprakarn, Nonthaburi 
and Bangkok, which had literacy rates between 97% and 99% (Pathumthani Province 
2004). 
2.5.2 Health Care Profile 
Pathumthani's health care profile can be described in four categories: Administrative 
System, Health Care Providers, Health Care Staff and Health Statistics. 
2.5.2.1 Administrative System 
The health care system in Pathumthani Province is divided into three levels: provincial, 
district and primary care unit (PCU) or community (Figure 2.7). The hierarchy of health 
care administration at the provincial level starts from the Ministry of Public Health 
(MOPH), the headquarters of all health care policy. All policies and health care projects 
from the MOPH are then delegated down to Pathumthani Provincial Health Office as a 
local centre for health care administration. In addition, Pathumthani Provincial Health 
Office is also supervised by the Ministry of Interior (MOI) through Pathumthani City 
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Hall. As a result, there are two types of public health organisations between the 
organisations supervised by both the MOI and the MOPH, and institutions overseen by 
the MOPH only. The former includes district health offices and PCUs, while the latter 
refers to Pathumthani Hospital and all district hospitals in the province. Health care 
responsibilities at a district health office focus mainly on proactive health care tasks 
implemented in communities such as home health care and HIV prevention campaigns. 
In addition, a PCU, which is a fundamental unit in the health care system, also plays an 
important role in promoting all health care tasks to people in its communities. 
A district hospital is regarded as the main supplier of health care services for 
communities. Its responsibilities also include determining the standard practices in health 
care for all PCUs. The MOPH expects that a district hospital will work in collaboration 
with a district health office and villagers as one team in supporting a PCU and 
communities. Nevertheless, an overlapped administration between the MOI and the 
MOPH in the health administrative system at the district level posed considerable 
concerns to many health care workers. One serious issue was that in an emergency 
situation, the district health office needs to send its request to the district administrative 
office and may not be received an approval in time to deal with the urgent situation. 
Nevertheless, the advantage of having the MOI's involvement in the health care network 
is that it has the complete set of community-based data. While the MOPH's tasks are 
centred mainly on community development and emphasise proactive health care services, 
the MOI can assist health care providers at the district level by supplying them with data 
on communities, geography or even information about the strengths and weaknesses of 
communities. 
41 
Figure 2.10: Pathumthani's Heult!: Care Administrative System 
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2.5.2.2 Health Care Providers 
The size of public health care providers in Pathumthani Province varies depending on the 
distribution of population in each district. In addition, the number of inpatient's beds is 
used to determine the size of public health care providers at the district level, ranging 
from 10 to 120 beds. Table 2.5 displays the distribution of health care providers in 
Pathumthani Province. 
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Table 2.5: Distribution of Health Care Providers in Pathumthani Province by District (October 2004) 
District 
Number of Health Care Providers 
Public Hospitals PCUs Private Hospitals 
Total Health Care 
Providers 
Muang Pathumthani 1 (336 beds) 19 1 21 
Klong Luang I (10 beds) 11 2 14 
Thunyaburi 2 (30 and 120 beds) 6 6 14 
Nongsua 1 (30 beds) 8 0 9 
Latlumkaew 1 (10 beds) 11 0 12 
Lumlukka 1 (30 beds) 13 2 16 
Samkok 1 (10 beds) 10 0 11 
Total 8 78 11 97 
Source: Pathumthani Provincial Health Office Report 2004 
From Table 2.5, public hospitals refer to both provincial and district hospitals located 
in each district of the province. Pathumthani Hospital in Muang Pathumthani district is 
the largest public health care provider in the province, equipped with 336 inpatient's beds 
(Department of Health Care Projects 2004). Conversely, the size of district hospitals 
varies considerably, ranging from 10 to 120 beds. A 10-bedded hospital is regarded as the 
smallest size of public hospitals in the health care system. In Pathumthani Province, this 
type of hospital is located in Klongluang, Latlumkaew and Samkok districts, while 
Lumlukka and Nongsua district hospitals are categorised as a small-to-medium size 
hospital equipped with 30 inpatient's beds. Unlike other districts, Thunyaburi district has 
two public and six private hospitals. This is because the district includes one of the most 
densely populated areas and therefore demands for health care services from the 
population are high (Pathumthani Provincial Administration Support 2004). 
The difference in the size of public hospitals also determines their responsibilities. For 
instance, a 10-bedded hospital can perform only basic operations (e. g. vasectomies, 
caesareans or stitching of simple wounds) whereas more complicated treatments (e. g. 
chemotherapy or major surgery) are not carried out in the 10-bedded hospital. The 
referral system to the nearby 30-bedded hospital or Pathumthani Hospital is available as 
an alternative pathway to extend health care services. However, for remote areas, a PCU 
can also provide both curative care and health promotion for communities as well as its 
responsibility as a gatekeeper to control the number of patients before they proceed to the 
public hospitals. 
2.5.2.3 Health Care Staff 
Table 2.6 displays the distribution of full-time health care professionals in both public 
and private hospitals in Pathumthani Province. Although most of health care 
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professionals worked in the public hospitals, resident and technical nurses dominate the 
total number of health care professionals. Conversely, more doctors, dentists, and 
pharmacists tended to work in private hospitals than in the public sector. 
Table 2.6: Distribution of Health Care Professionals in Pathumthani Province (October 2004) 
Numbers of HCP 
Health Care Pathumthani's Thailand's 
Professionals (HCP) HCP per Capita* HCP per Capita 
Public Private Other Total 
Hospitals Hospitals Sectors 
Doctors 58 147 76 281 1: 2,600 1: 2,500 
Dentists 21 30 11 62 1: 11,800 1: 4,000 
Pharmacists 20 165 37 222 1: 3,300 1: 3,000 
Resident Nurses 396 94 123 613 1: 1,100 1: 300 
Technical Nurses 159 0 17 176 1: 4,200 1: 1,000 
Total 654 436 264 1,354 
Remark: *HCP per capita was computed based on the number of Pathumthani population in 2004 
which was 731,707. 
Source: Pathumthani Provincial Report 2004 
The distribution of health care professionals in Pathumthani Province can be 
explained by examining the number of health care professional per capita. For instance, 
one doctor was responsible for approximately 2,600 people, which was a little higher 
than the national standard of one doctor per 2,500 population. The data also show that a 
pharmacist and a dentist must serve 3,300 and 11,800 people in Pathumthani Province 
respectively. These ratios were higher than the national standard which was set to one 
dentist and one pharmacist to serve every 4,000 and 3,000 population respectively. It is 
noticeable that in Pathumthani Province one dentist must be responsible for 
approximately three times as many people as the national standard (one dentist per 4,000 
population), while the ratio of a pharmacist per population is not much different from the 
national standard. The same situation also occurred with technical and resident nurses. 
For example, the proportion of one resident nurse per 1,100 people was approximately 
three times lower than the national standard. This indicates an insufficient number of 
health care professionals in Pathumthani Province. 
2.5.2.4 Health Statistics 
Health statistics are important for health care planning and are often used as the 
indicators for measuring health status of the population. According to the routine data 
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obtained from Pathumthani Provincial Health Office, health statistics can be divided into 
three main categories: population, UCS budget, and UCS coverage. 
- Population 
The midyear population of Pathumthani Province in 2004 was 731,707, comprised 
approximately 394,000 females and 336,000 males (Pathumthani Province 2004). Figure 
2.11 shows that the majority of population is in the age range between 21 and 50 for both 
males and females. In addition, the second largest group is the population aged between 1 
and 20 years. For population aged over 50, there is the reduction in the number of both 
males and females, particularly among those who are over 80 years old. 
Figure 2.11: Population Pyramid of Pathumthani Province (October 2004) 
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- UCS Budget 
1.5 
The UCS budget is allocated to public health care providers for three major purposes: to 
support both inpatient and outpatient services, to support disease prevention and to use 
for health promotion in communities. The total UCS budget for the fiscal year 2004 
(between October 2003 and September 2004) for Pathumthani Province was 
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approximately 216 million baht (£3.5 million). The allocation of the UCS budget by 
district is shown in Table 2.7. 
Table 2.7: Proportion of Drug Budget to TICS Budget by Public Health Care Provider (Fiscal Year 
2004) 
`%% of Drug 
List of Public Health UCS Budget Drug Budget Budget to 
Care Providers (Million Baht) (Million Baht) UCS Budget 
Pathumthani 88.71 35.11 39.58 
Thunyaburi 23.15 8.51 36.75 
Latlumkaew 13.71 4.69 34.21 
Klongluang 12.74 4.21 33.05 
Prachathippat* 16.77 5.45 32.50 
Lumlukka 21.97 6.83 31.09 
Samkok 4.99 1.50 30.06 
Nongsua 33.84 9.96 29.43 
Total UCS Budget 215.88 76.26 35.53 
(£3.5 Million) (£1.2 Million) 
Remark: *Prachathippat Hospital is a 30-bedded district hospital located in Thunyaburi District. 
Source: Pathumthani Provincial Health Office Report 2004 
The UCS budget in each public hospital is calculated by using the data on both capitation 
and workload. The former refers to the population registered with the UCS. The latter is 
computed from the total amount of health care tasks archived by a public hospital 
according to its job description within one fiscal year. The UCS budget usually includes 
the drug budget which is allocated from Pathumthani Provincial Health Office. 
The comparison between the drug budget and the UCS budget in each public hospital 
is shown in Table 2.7. The total UCS budget in Pathumthani Province for the fiscal year 
2004 was 215.88 million baht (£3.5 million). In addition, 76.26 million baht (£1.2 
million) was spent on provincial drug purchases which represented 35.53% of the UCS 
budget. Muang Pathumthani and Thunyaburi districts display the highest proportion of 
drug budget to the UCS budget (39.58% and 36.75% respectively), while Nongsua and 
Samkok hospitals show the lowest proportion of 29.43% and 30.06% respectively. 
The average drug budget in Pathumthani Province was nearly 40% of the UCS budget 
due to three reasons. First, some essential drugs were protected by patent and were 
imported, particularly ARVs (Lopinavir/Ritonavir or Efavirenz) or cardiovascular drugs 
(e. g. Clopidogrel). Thus, the costs of these branded-name drugs are usually high and may 
take up to 13% of the total drug budget (Department of Health Care Projects 2004). 
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Second, the devaluation of the Thai currency? after the Economic Crisis in 1997 results in 
increasing the cost of most imported drugs. Consequently, public health care providers 
need a larger drug budget to purchase essential drugs, especially those were protected by 
patent (MOPH 2002). Lastly, polypharmacy or overprescribing of unnecessary drugs was 
caused by either misdiagnoses from doctors or insistent requests from patients. This does 
not only demonstrate the redundancy of drug prescription but also indicate the loss of 
drugs from the health care system. One study from the OPD of Pathumthani Hospital 
showed that 20 tablets of Paracetamol 500 mg appeared in more than 80% of 
prescriptions and approximately 60% of this proportion was prescribed in combination 
with muscle relaxants of (Pathumthani Provincial Administration Support 2004). 
From the drug budget in Pathumthani Province, drug groups that had the highest 
purchase value are listed in Table 2.8. 
Table 2.8: Drug Groups with the Highest Purchase Value in Pathumthani Province (Fiscal Year 2004) 
Rank Drug Groups 
Drug Purchase Value 
(Million Baht) 
% of Drug Purchase Value to 
the Total Drug Budget* 
1. Antibiotics 10.72 14.06 
2. Antihypertensives and 10.09 13.23 
Antidiabetes 
3. Rabies vaccines 8.34 10.94 
4. Intravenous solutions 5.12 6.71 
5. Antiretrovirals 1.96 2.57 
Remark: *The total drug budget in Pathumthani Province for the fiscal year 2004 was 76.26 million 
baht (£1.2 million). 
Source: Pathumthani Public Health Office 2004 
The highest drug purchase value was for antibiotics, approximately 14% of the total 
provincial drug budget. For antihypertensive and antidiabetes groups, the drug purchase 
value is similar to antibiotics. Rabies vaccines, intravenous solutions, and antiretroviral 
drugs were also commonly used and the percentages of the total provincial drug budget 
were approximately 11%, 7% and 3% respectively. However, intravenous solutions were 
prescribed to almost all cases admitted to the ward but were often discontinued after a 
small amount was used. A guideline for prescribing these solutions needs to be drafted by 
the PTC and complied with by GPs, supported by continued education in the use of 
intravenous solutions. 
'Before the Economic Crisis in 1997, the exchange rate of the Thai currency was US$ 1 equal to 25 baht. 
However, after the devaluation of the Thai baht, the exchange rate was approximately US$ 1 to 40 naht. 
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- Universal Health Coverage 
The Universal Coverage Scheme (UCS) is the MOPH's health care policy that aims to 
improve equity of access to health care services for Thai citizens. In addition, the UCS is 
committed to providing good quality health care either free of charge or with moderate 
co-payments for services. The UCS comprises three sub-schemes, the Civil Servants' 
Medical Benefit Scheme (CSMBS), the Thirty Baht Scheme (TBS) and the Social 
Security Scheme (SSS). 
Figure 2.12 displays the comparison between the overall UCS coverage in 
Pathumthani Province, based on the number of population registered with each UCS's 
sub-scheme and the national UCS coverage between 2001 and 2005. 
Figure 2.12: Comparison of the UCS Coverage in Pathumthani Province with the National Universal 
Coverage between 2001 and 2005 
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Source: Pathumthani Provincial Health Office Report (2005) 
In April 2001, Pathumthani Province was one among the first five provinces to 
participate in the first phase of the Thirty Baht Scheme (TBS). TBS helps to expand 
health care coverage to more people, particularly the poor and the disadvantaged. The 
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UCS in 2001 covered approximately 94.44% of the total population. However, in the 
following years, the UCS coverage declined slightly to 93.41%, 93.30% and 92.67% in 
2002,2003, and 2004 respectively. However, health care coverage in Pathumthani 
Province increased again in 2005 to 96.30%. The data from Figure 2.12 also show that 
the coverage of the UCS in Pathumthani Province was not dramatically changed for the 
first four years of the UCS implementation between 2001 and 2004. For the national data, 
health care coverage for Thai citizens between 2002 and 2003 was 87.57% and 91.41%. 
Nevertheless, in 2004, health care coverage increased to 93.91% and reached 97.08% in 
2005. The national UCS coverage in 2005 showed that it was higher than the UCS 
coverage in Pathumthani Province in the same year. 
2.6 CONCLUSION 
The health service system in Thailand has evolved from the primitive care supplied in 
small communities to an era of integration with western medicine and the implementation 
of the UCS in 2001. The components of Thailand's health service system include: health 
resources, administration systems, organisational structures, a financing system and its 
support systems, and health services. The motivation that pushed Thailand to reform its 
health system in 2000 comprises the emergence and re-emergence of diseases, the new 
Constitution Act 1997, the South-East Asian Economic Crisis 1997, and the increase in 
societal disparity caused by rapid change in technology and development. 
After health care reforms, implementation of universal health coverage is expected to 
alleviate inequalities in access to health care services among Thais. In past decades, these 
inequalities occurred due to differences in the supply of services between the insured and 
the uninsured. The situation was worsened by a widening gap between the rich and the 
poor. The MOPH's decision to reform the health system aims to reduce inequalities in the 
health sector. Therefore, the UCS has been in place in the health care system since 2001. 
The UCS comprises three sub-schemes, CSMBS, SSS and TBS. The MOPH has 
emphasised that TBS will expand health care coverage and will assist in improving equity 
in health care services for the majority of Thais. 
The next chapter is a summary of how universal coverage enhances equity in health 
care. Moreover, a discussion of key concepts of equity in access to health care will be 
presented. 
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CHAPTER 3 
Equity in Access to Health Care 
3.1 INTRODUCTION 
Chapter 2 describes the importance of the health care reform project and explains that 
there are four factors leading to the revision of the health care system: the Economic 
Crisis in 1997, the Constitution Act 1997, the Eighth and the Ninth Social and Economic 
Development Plans and the National Election in 2000. In addition, it shows that before 
health care reform in 2000, the majority of Thai citizens were worse off in terms of access 
to health care services. Although many Thais were previously covered by health 
insurance schemes, more than half of the total population had never enjoyed any health 
care benefits. From 2001, the implementation of the UCS, which comprises three sub- 
schemes, CSMBS, SSS and TBS, aimed to expand coverage to all groups of Thais, 
regardless of their income, social status or residency. Hence, expectations of the UCS are 
high and hopes are that the scheme will improve equity in access to health care. 
In this chapter, a summary is given of the relevant concepts of equity in access to 
health care which are used to steer Thailand's health care system after the implementation 
of the Health Care Reform Project in 2000. Moreover, an explanation and a discussion of 
how the universal coverage concept enhances equity in access to health care services are 
also presented along with examples of experiences from some countries, particularly 
those developing countries in Asia, which adapted this concept to their health care 
systems. 
3.2 WHAT DOES ACCESS TO HEALTH CARE MEAN? 
Although there are some serious efforts to clarify the terms 'access to health care' in 
multiple dimensions and meanings, the term has remained an ambiguous concept. 
Vagueness and various notions of the concept of `access' have somewhat hindered 
policymakers, health care workers and health care professionals from providing good 
health care services to patients. 
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To elaborate on the concept of access to health care, originally, some researchers 
tended to define access in terms of characteristics of the population (family, income, 
health care coverage and attitudes towards medical care) and emphasise the features of 
the health service system, such as health care resource distribution. Access is read off 
from patterns of distribution of health resources in the population (Daniels 1995). 
Alternatively, access to health care can refer to the ability of health care users to obtain 
health services when needed. Access to health care in this sense also applies to the degree 
to which individuals and populations can certainly obtain health care, despite various 
barriers including, financial (lack of health insurance or out-of-pocket expenses), cultural 
(language or culture) and geographical. such as long distances or any obstacles that hinder 
access to health care facilities (Wynia et al. 2004). Others argue that access to health care 
can best be assessed through outcome indicators of the individual's pathway through the 
health care system, such as satisfaction scores (Aday & Andersen 1975). This measure 
allows external validation of the importance of the system and its individual 
characteristics (Andersen et al. 1983). 
To clarify the term `access to health care', Andersen (1995) initially proposed a model 
derived from the Behavioural Model' in 1960 to assist in understanding why families 
decide to use health care services. The model was initially developed in the late 1960s to: 
1) explain why families use health care services; 2) define and measure equitable access 
to health care and 3) assist in developing policies to promote fair access to health care 
(Andersen 1995). The model originally focused on the family as a unit of analysis, since 
it was believed that whether one received medical care depended on the demographic, 
social and economic characteristics of that family (Andersen & Anderson 1967). The 
model was later altered to use the individual as the unit of analysis because of the 
difficulty in developing measures at the family level. 
Figure 3.1 elaborates the Behavioural Model which comprises four key components. 
The first component refers to Predisposing Characteristics, which include demographic 
factors, such as age or gender representing that people need health care services (Hulka & 
Wheat 1985). Social Structure denotes the capacity of an individual to cope with the 
presenting problems and using available resources to deal with them, by referring 
principally to educational background and ethnicity (Andersen 1974). 
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Figure 3.1: Behavioural Model (Andersen 1995) 
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Nonetheless, Guendelman (1991) later argued that the true meaning of social structure 
should have been construed as social networks, social interaction and culture in a 
particular society (Guendelman 1991). In terms of Health Beliefs, this denotes the 
attitudes, values and knowledge that people possess and which may influence their 
subsequent perception of the need and use of health care services. However, social 
psychologists have been concerned that health beliefs may possibly be misinterpreted, 
since they are not really as important in predicting and understanding the use of health 
care services as they are thought to be (Becker & Maiman 1983). In addition, some 
scientists propose that genetic factors should be added to predisposing characteristics 
(True et al. 1994). 
The second component of the Behavioural Model is Enabling Factors. Both 
Community and Personal Enabling Resources must be present for the use of health care 
services. Basically, health care staff and health care resources, including medicines, 
budgets and services, must be available in the area where people live or work. Then, there 
must also be the means for health care users to obtain such services and make use of them 
(Andersen 1995). Need is considered to be the third component of the Behavioural 
Model. At this stage, people perceive their own general health and functional state as well 
as their previous experiences of illness and then decide or evaluate their own situations of 
sufficient importance and magnitude before reaching the fourth component - Use of 
Health Services from health care providers (Gulliford et al. 2002). 
The concept of access to health care services, using the Behavioural Model proposed 
by Andersen, emphasises the decision process of users in access to health care services. 
Bodenheimer and Grumbach (2005) contest this notion and argue that access can also be 
52 
viewed from the supply side or health care service providers. They propose that access to 
health care can be focused on the availability of health care resources which includes, 
personnel and facilities that are: close to where people live, accessible by transportation, 
culturally acceptable and capable of providing proper care in a timely manner, and in a 
language spoken by those who need assistance (Bodenheimer & Grumbach 2005). 
Some researchers also argue that the Behavioural Model is best suited to explaining 
the demand side of consumers or patients towards their decision to obtain access to the 
health care system. One of these arguments, proposed by Guilliford et al (2002), states 
that access could be described as either the potential or the actual entry of any given 
individual or population group into the health care system and the use of available 
resources. In addition, there are three dimensions which reflect the tangible assessment of 
access to health care, by focusing on utilisation, outcomes and availability of health care 
services (Gulliford et al. 2002). The three dimensions of access to health care are 
described as follows: 
" Utilisation of Health Services 
" Outcomes of Health Services 
" Health Services Availability 
3.2.1 Utilisation of Health Services 
Some researchers propose that measuring access to health care should be based on 
utilisation of health services. In general, people could experience difficulties or 
inconveniences in accessing and using health services (Aday & Andersen 1981). Hence, 
Donabedian (1972) asserts that the proof of access is the use of services, not simply the 
presence of a facility (Donabedian 1972). To support this notion, Pechansky and Thomas 
(1981) developed this concept and proposed that access describes 'the degree of fit' 
between clients and the health care system. The degree of fit could be influenced by the 
acceptability, affordability, and accommodation of services. This concept asserts that 
access should be viewed beyond service availability and should encompass the personal, 
financial and organisational barriers to services utilisation (Penchansky & Thomas 1981). 
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Personal Barriers 
Regarding Pechansky and Thomas' approach, when a patient needs health services and 
later decides to seek medical care from a health care provider, the feasibility of them 
using the services is based on the balance between the individual's perceptions of needs 
and their attitudes, beliefs and past experiences with the health services (Mechanic 1978). 
Access to health care somewhat implies that the individual recognises and accepts their 
need for services, assents to a role as a service user and perceives that they are willing to 
use such a service. These processes are also affected by social and cultural influences, as 
well as environmental constraints (Gulliford 2003). 
For example, in Thailand, policy responses have shifted in recent years from striving 
to change patients' behaviour to understanding patients' needs and managing proper 
services in respect of their demands. For instance, the MOPH encourages public health 
care providers to work more closely with other public and private health care 
organisations in a province. In addition, an increase in the role of community pharmacists 
in drugstores, hotline services and a PCU (similar to a walk-in clinic in the UK) has been 
established after the implementation of the UCS since 2001 (Catford 2005). These 
channels allow patients to access the service for less serious conditions and thus diminish 
barriers to service utilisation. Some of these developments extend the concept of access 
beyond the notion of physical accessibility of services to include remote access through 
electronic media (Gulliford et al. 2002). 
Financial Barriers 
Financial obstacles among health care users can influence access to health services in 
both developed and developing countries. According to a survey by Blendon et al (2002), 
in five developed countries. Australia, Canada, New Zealand, the UK, and the USA, 
access to health care is influenced by the financial cost of using it. On all of these 
measures, low-income Americans were much more likely than their counterparts in the 
other four countries to report problems (Blendon et al. 2002). In addition, in the UK, there 
are still problems for people with low socioeconomic status, with additional charges for 
specific services such as eye tests, dental check-ups and prescriptions, although the health 
care system is essentially free at the point of use (Donelan et al. 1999). 
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In developing countries, the UCS in Thailand, for instance, promises that people 
insured by one of its three sub-schemes (CSMBS, SSS and TBS) will receive free 
medical care or will spend a maximum of the thirty-baht (£0.45) co-payment on all 
incurred costs. However, the free medical care is limited to merely diseases and 
medicines specified in the core package. Patients may need to pay for some extra charges 
if their prescribed medicines are classified in the non-essential drug category 
(Suraratdecha, Saithanu, & Tangcharoensathien 2005). The results from some low 
income countries in Africa also show that patients may be responsible for approximately 
74% of their health care cost per visit, while health expenditure by the government only 
accounts for about 20% (Cresse 1991). Interestingly, in many poor countries, patients 
may actually be more familiar with the incurred costs of health care than those in richer 
societies (Makinen et al. 2000). 
From the examples of both developed and developing societies, the impact of user 
charges and other costs of accessing care affect different socioeconomic groups in 
different ways. For some groups, such access may not be compromised, whereas for other 
costs could represent a significant deterrent. The impact of financial barriers relates to the 
magnitude of the costs and on the user's willingness and ability to pay. Nevertheless, 
equal costs of health care services do not necessarily guarantee equal access to them 
(Lundberg et al. 1998). 
Organisational Barriers 
Patients spending hours waiting to see doctors or queuing for vaccinations in some 
societies represent a problem with health system management in those organisations. 
Long waiting lists and waiting times may sometimes be indicative of organisational 
barriers to access, which may result from inefficient use of existing health care resource 
capacity or a failure to design services around the needs of patients (Gulliford et al. 
2002). For example, systematic variations in referral practices also act as barriers to 
accessing to health care, especially referral from the primary to the secondary care levels 
(Daniels et al. 2000). 
Forrest et al (2003) compared the referral of children to specialists in the UK with the 
USA and concluded that the low availability of specialists and long waiting lists in the 
UK are probably an important reason for the referral rate differences (Forrest et al. 2003). 
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Redesign in the way that clinical services are delivered, such as the replacement of 
waiting lists with a booking system and the introduction of a computerised system for 
allocation of patients' queues might do much to reduce organisational barriers of access 
(Gulliford et al. 2002). 
3.2.2 Outcomes of Health Services 
The processes of providing availability of care and the utilisation of health services 
represent the limiting part of the interaction between supply and demand sides. Rogers et 
al (1999) proposed the term `Optimal Access' and defined it as providing the right service 
at the right time in the right place (Rogers, Flowers, & Pencheon 1999). In addition, the 
term `access' is also construed by the US Institute of Medicine as `the timely use of 
personal health services to achieve the best possible outcomes' (Millman 1993). These 
definitions emphasise the right services and refer to the best possible outcomes obtained 
from both provision and utilisation of care. Using this dimension, access could be 
assessed by focusing on health outcomes, such as health status, rather than according to 
availability or usage of services (Goddard et al. 1998). 
3.2.3 Health Service Availability 
For health care users to access health services, there must be a sufficient supply of health 
care resources. According to this dimension, access to health care is concerned with the 
ready provision of services by health care providers. Availability of services is measured 
using indicators such as the number of doctors, hospital beds per capita, or the budget on 
medicines (Gulliford 2003). However, the quality of service is also an intrinsic element 
of access which might influence either the utilisation and outcomes from the access 
(Goddard & Smith 2001). 
An example showing the availability of health resources is the distribution of general 
practitioners (GPs) in Thailand. A high number of GPs choose to work in urban cities, 
such as Bangkok and its environs and this, therefore, has negative effects on the UCS and 
resulted in the decrease in the walk-in rate as well as the outcome of health care services 
(Wibulpolprasert & Pengpaibon 2003). In addition, a lack of doctors among district 
hospitals in remote areas, particularly in the northern region, could result in incomplete 
care or erratic treatment to patients, since nurses are used in place of GPs. 
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Similarly, there are large variations in the numbers of GPs per capita between the 
north and the south of England; they tend to be densely scattered in the urban areas 
(Department of Health 2001). These variations of GPs in both countries are an example of 
the importance of availability of health care resources which lead to their key concerns in 
the management of the health care system and shaping the method used to allocate 
resources, the amount of resources required for health care and the pattern in which the 
services should be configured at each level of care. Thus, appropriate administration of 
health care resources is key in the success of the availability of health care services and 
indeed affects health care users' access to the health system. 
Any concerns to ensure that health care resources are mobilised to meet the needs of 
different groups among the population are the theme of the concept of access. However, 
this study focuses on the dimension that access is centred on the availability of health 
services from the supply side. The reason is that variations in availability of health care 
resources often lead to inappropriate use of health care services and poor quality 
outcomes which may in turn deter future users and diminish their satisfaction towards the 
health care system. Therefore, the term `access' in this study is narrowed to availability of 
services from the supply side and focuses on the availability of medicines on the 
management of public health care providers. In addition, the central concept of access to 
health care services is examined through drug management in respect of the Drug 
Management Cycle (DMC), which is presented in Chapter 4. 
3.3 EQUITY IN ACCESS TO HEALTH CARE 
The concept of equity in access to health care is a central objective of the health care 
system and has been one of the UCS's key concerns since its inception in 2001. This 
notion remains somewhat ambiguous and it is not often straightforward to decide whether 
inequity of access poses significant problems in terms of health care. Thus, many 
countries experience inequalities in health care and strive to properly mitigate those 
existing unjust or unfair conditions of accessing the health care system. 
Inequalities in health care raise crucial concerns among, both developed and 
developing countries regarding the solutions to alleviate the problem. In addition, 
different countries use various indicators to assess equity such as, quality of care, income, 
or geography. In Asia, for instance, a significant inequalities of health status between sub- 
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populations in China was caused by geographic location and level of income (Liu, Hsiao, 
& Eggleston 1999). In Thailand, inequalities in the distribution of regional characteristics, 
the geographic distribution of medical staff (physicians and nurses), the number of patient 
beds in relation to the population, and the average death rates caused major problems, 
especially in the distribution of physicians to remote areas (Nishiura et al. 2004). 
Similarly, the distribution of health care resources and geographic hindrance caused 
inequality of access to health care in Vietnam (Hien et at. 1995). In addition, health care 
financing from the government was limited and thus some Vietnamese were required to 
pay more for the incurred health care costs (Segall et al. 2002). 
Inequalities in access to health services also exist in developed countries. However, 
the degree of such problems is different from those in the developing world. The results 
from a study of eight countries8 from the developed world suggested that inequity exists 
in most of these countries. Nonetheless, the results also illustrated that there is no simple 
one-to-one correspondence between a country's delivery system and the degree to which 
persons in equal need are treated the same (van Doorslaer & Wagstaff 1992a). A study of 
equity in health in the UK also emphasises the importance of gender equality and that it 
must be included in the policy to ensure universal access to reproductive health care, to 
reduce gender inequalities in terms of access to resources and to relax the constraints of 
rigidly defined gender roles (Doyal 2000). 
Problems of equal access to health care are different between developing and 
developed countries. The former was limited by the distribution of resources (e. g. budget, 
staff, and medicines) which in principle was due to an inadequate budget or improper 
management of health care resources. In addition, geographic settings could be an 
additional barrier that hinders people from accessing health care. In the latter case, 
although the health system may, at one level, guarantee that access to health care is 
available and ready to be used, being uninsured or excluded from the health system may 
pose significant negative consequences for access, such as on the out-of-pocket expenses 
(Schoen & Doty 2004). Obviously, the same factors, such as income or socioeconomic 
status of people from both developing and developed countries, still play an important 
role in worsening equity of access to health care. 
8Eight countries refer to the Denmark, France, the Netherlands, Portugal, Spain, Switzerland, the UK, and 
the USA (van Doorslaer & Wagstaff 1992b). 
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To alleviate inequalities among different groups of people in a society, some countries 
have reformed their health care systems and have implemented health care programmes. 
A good example that strives to enhance equity in access is Singapore. Access to needed 
care for people is explicitly guaranteed by the three-tier benefit packages - Medisave, 
Medishield, and Medifund. The first tier, the Medisave Scheme, provides basic acute care, 
which is partly funded by the government; the rest is an insurer's responsibility. Money 
that an insurer deposits to this fund will be used only for the owner and will not be 
transferred to other people. The second tier, the Medishield Scheme, is aimed to lessen the 
incurred cost for people who need a long term treatment or high cost care for chronic 
diseases. The last tier is the Medifund Scheme which refers to health care services used by 
the poor, funded by the government welfare system (Meng-Kin 1998; Pannarunothai, 
Patmasiriwat, & Srithamrongsawat 2004). Singapore's experience provides an interesting 
case study of a public private partnership, illustrating the achievement in national health 
goals while balancing concerns of equity of access and efficiency of health care (Lim 
2004). 
Another example is the study of 10 countries9 by van Doorslaer (2000). The results 
show that although there is a higher demand for the use of medical specialist services by 
higher-income groups and a higher use of GP care among lower-income groups, there is 
little or no evidence of significant inequity in the delivery of health care overall. These 
findings appear to be fairly general and emerge in countries with very diverse 
characteristics regarding access and provider incentives (van Doorslaer et al. 2000a). 
The pathway towards equity of access to health care, as shown by some countries 
above, is to promote equity or remedy inequalities by improving access to health care. 
Ensuring equity involves both the delivery of health care for which governments need to 
prioritise interventions and the financing system of health care services. Governments are 
required to put a policy in place that enables individuals to afford those interventions 
(Peabody et al. 1999a). In addition, many countries, particularly in Asia, invested in 
facility infrastructure and health manpower to extend direct public provision of free or 
low-priced health care services to the poor or those in rural areas (e. g. Indonesia, India, 
and the Philippines). Some countries increased the health insurance coverage for civil 
servants and others in the formal wage sector (e. g. Singapore and South Korea) or for 
farmer communes (e. g. China and Vietnam). Some governments, particularly in South- 
9Ten countries comprise Belgium, Denmark, Finland, Germany, Ireland, the Netherlands, Sweden, 
Switzerland, the UK, and the USA (van Doorslaer et al. 2000b). 
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Past Asia, have adopted the universal coverage concept and have initiated a community 
financing scheme (e. g. Thailand and Indonesia) (Kutzin 2000b; Peabody et al. 1999a). 
These investments indeed aim to lead to impressive gains in health status and to diminish 
inequalities among the population in terms of access to health care when it is needed. 
The concept of Universal Coverage, as mentioned before, has been widely adopted in 
many developing countries and is inevitably related to the concept of inequalities in 
health care. Further explanation of how universal coverage improves equity in access to 
health care is described in the next section. 
3.4 DID UNIVERSAL HEALTH COVERAGE IMPROVE EQUITY IN ACCESS 
TO HEALTH CARE? 
Over past decades, despite the remarkable achievements of health care improvement in 
many countries, huge inequalities of access to health care continue to afflict vulnerable 
populations. The burden of diseases, both communicable and non-communicable, takes a 
heavier toll on the poor. although the situation is much better than it was in the past. 
People continue to suffer premature death and disability from communicable diseases, 
childbearing, and other conditions, that are easy to treat through basic medical 
interventions (Peabody et al. 1999a). Such situations are obvious, particularly in 
developing countries, where rural residents generally have poorer living standards than 
their urban counterparts, therefore experiencing more severe health risks because of an 
inaccessibility to health care services and having to travel greater distances to visit health 
care providers, which may ultimately exclude them from the health care system 
altogether. This section discusses the experiences of some countries that have 
implemented the concept of Universal Coverage to improve equity in access to health 
care services. 
3.4.1 Time for Universal Coverage 
Before the 1970s, international efforts to improve health among the poor focused 
principally on programmes to control the major tropical diseases by increasing the 
number of health care facilities and personnel in poor countries. From the mid-1970s to 
the mid-1990s, many relevant efforts were centred mainly on primary health care which 
referred to low-technology, low-cost, community based and multi-sectoral solutions to the 
60 
most common and important health problems experienced by the poor (Kutzin 2000f). 
The growing attention paid to government services in developing countries over the past 
few years has produced a set of findings indicating that health care services usually 
favour the better off. Although the record of private services is not as well established, it 
still shows that these services seem to be even more oriented towards higher-income 
groups (Gwatkin, Bhuiya, & Victora 2004). As a result, the notion of expanding universal 
health coverage to the disadvantaged or the poor has been proposed and implemented in 
many countries, especially those in the developing world. 
Kutzin (2000) states that universal coverage, including health care insurance, could be 
construed as physical and financial access to good quality, essential health care for all 
members in a society. The meaning also involves protection against the risk that, if high 
cost health care services are needed, services of adequate quality and quantity will be 
physically accessible, and the cost of such services will not prevent people from using 
them or worsen their families' financial circumstances (Kutzin 2000d). Obviously, the 
question of implementing universal coverage in one country, especially in the developing 
world, is whether the economy of such a country can afford to finance the scheme. 
Conversely, the wealthier or developed countries adopted universal coverage at levels 
where relatively small portions of national income finance health care delivery. In 
addition, the wealthy countries were largely urbanised and had large wage sectors when 
they began to use universal coverage. Enrolment compliance and administration is easier 
in a wage sector where individuals were already paying taxes, which obviously facilitated 
the expansion of health care coverage (Peabody et al. 1999b). 
Although there are differences in both financing and administrative systems in health 
care services between developed and developing countries, the Republic of Korea (South 
Korea) was one of the very first developing countries that endeavoured to implement the 
Universal Coverage concept in 1977. The result showed one prevailing problem, which 
was that out-of-pocket payments among the population accounted for an estimated 65% 
of total spending on personal health care services. Nonetheless, overall results were 
impressive and health care coverage expanded to cover the entire population under 
National Health Insurance (Yang 1996). Despite having achieved Universal Coverage 
through National Health Insurance, data from the health insurance system indicated that 
Korean citizens did not actually have equal access to health care and financial protection 
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against the potentially high costs for some severe disease, injury, and long term chronic 
illness (Anderson 1989; Kwon 2003). 
Similarly, many developing countries in Asia, such as Indonesia, Thailand and 
Vietnam have also adopted the universal coverage concept, aiming at improving equal 
access to health care services. This is based on the idea that nobody, regardless of income, 
social status or residency, should be excluded from accessing basic health care services. 
However, as the experiences of South Korea have shown, problems in terms of fair access 
to health care services still exist in these countries. Thus, this raises the question of 
whether universal coverage has enhanced the equity of access to health care. 
3.4.2 Did Universal Coverage Improve Equity in Access to Health Care? 
Achieving equitable access to health care has been one of the most daunting challenges 
confronting health care development for decades. In addition, the notion of `Health for 
All by the Year 2000' had been embodied in WHO's policy and had motivated many 
countries across Asia and the rest of the world to reform their health care system before 
the year 2000. Several countries initiated health care reforms and later integrated 
universal coverage into their health care systems, while some reported that they were not 
ready for such reforms. South Korea, Malaysia and Thailand are examples of some of the 
countries that were pioneers in applying the universal coverage concept to their health 
care systems. 
So, did universal coverage increase equity in access to health care? Results from the 
studies of some countries in Asia reported that health care coverage was significantly 
expanded to protect more people (Peabody et al. 1999a). In other words, this reflected an 
elevation in the number of people who were insured under the UCS. For instance, South 
Korea achieved universal coverage through employer mandates and the creation of 
medical insurance societies. About 90% of the population receive care through one of 
these societies and the remaining 10%, who were unable to pay, were able to receive 
insurance coverage from the government (Anderson 1989). Similarly, for Malaysia, the 
majority of their citizens were covered by one of the governmental health care schemes 
(Hanafiah 1996; van de Walle 1994). Conversely, for Thailand. only about 70% of the 
total population was insured under one of the four health insurance sub-schemes in 2000 
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but coverage increased dramatically from 1995 when health care coverage was about 50% 
(Sreshthaputra & Indraratna 2001). 
Although the number of people insured through universal coverage in the developing 
countries was increasing, quality of care and financial support to the health care system 
were crucial concerns. The main problems in South Korea, for example, were due to an 
unequal distribution of health care facilities particularly between the urban and the rural 
areas and the inappropriate use of health care resources. As a result, the quality of health 
care services was inconsistent at the initial phase of the UCS (Anderson 1989). In 
Malaysia, the country had claimed that everyone was entitled to use public health care 
services. Nonetheless, inequalities in access to health care provisions existed because of 
the inefficient distribution of resources, especially to remote areas (Hanafiah 1996). 
Similar problems also occurred in Indonesia and Thailand where most of the 
disadvantaged and the poor were not insured and shouldered all incurred medical care 
costs (Pannarunothai & Mills 1997). 
The past experiences from the four countries that adopted the universal coverage 
concept provide good examples of how universal coverage can increase equity in access 
to health care by at least improving the extent of health care coverage to the poor. 
Nevertheless, Kutzin (2000) proposes that to enhance equity of access to health care, 
policymakers should focus on universal coverage in two principal dimensions; the depth 
and the breadth of coverage (Kutzin 2000e). Depth of coverage refers to the extent to 
which services are available to people without letting them incur out-of-pocket payments, 
while breadth of coverage means that the proportion of the total population has effective 
access to health care and financial risk protection. Thus, expanding health insurance to 
cover more disadvantaged groups in a society is considered to `deepen' or `broaden' 
effective services and population coverage. However, expansion of the depth and the 
breadth of coverage is limited by availability of health care resources and the efficiency 
with which these resources are allocated and managed in the health care system (Kutzin 
2000a; Peabody et al. 1999b). 
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3.5 CONCLUSION 
Equity in access to health care from this study emphasises that access is centred on 
availability of health care resources from the supply side. Experiences from some 
countries, especially in Asia, have shown that to improve equity of access to health care 
services, the concept of universal coverage is key and is used to steer the health care 
system. This notion focuses on expanding health care coverage to all groups in the society 
or `depth of coverage', and providing free or only minimal charges for health care 
services or 'breadth of coverage'. However, both depth and breadth of coverage are still 
confined by the availability of health care resources and the management strategy of 
health care providers (the suppliers). To represent health care resource administration, 
this study focuses on the management of medicines in public health care providers of 
Pathumthani Province. Thailand. Medicines are so important because they are one of the 
most essential components in the health care system, using more than one third of the 
total fiscal budget and they are uniquely different from other commodities. An 
explanation of why medicines are so crucial in a health care system and how they are 
involved in enhancing people's equity of access to health care is presented in Chapter 4. 
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CHAPTER 4 
Medicines Management: A Challenging Strategy towards 
Equity in Access to Medicines Provision 
4.1 INTRODUCTION 
Chapter 2 describes the evolution of Thailand's health care system and explains the 
development of the UCS from past to present. The UCS, in place since 2001, has intended 
to expand health care coverage to the disadvantaged and the poor, and is expected to 
alleviate health care problems by increasing equity in access to health care services for all 
Thais. Chapter 3 is a summary of approaches taken to promote equal access to the health 
care system. It includes the role of universal coverage in improving equity in health care, 
which has benefited by international experiences from both developed and developing 
countries. 
This chapter focuses mainly on the importance of medicines10,11 in a health care 
system and discusses the situations that many countries across the globe endure to 
establish an efficient medicines supply system. In addition, a guideline for managing drug 
supply proposed by WHO, the Drug Management Cycle (DMC), which aims to elevate 
equity in access to the provision of medicines for the entire population, is also described. 
The experiences of both rich and poor countries of the implementation of the DMC to 
improve equity in access to medicines supply for their citizens are also presented in turn. 
4.2 THE IMPORTANCE OF MEDICINES IN A HEALTH CARE SYSTEM 
The definition of `medicines' is substances used for treating illness, which are believed to 
contain the power of healing in themselves and this power can be conveyed to anyone 
"'In this study, the terms medicines, drugs, pharmaceuticals and medications, are used interchangeably to 
refer to substances or any forms of medical preparations intended to treat or cure diseases which can be 
prescribed or dispensed by health care professionals (WHO 2000). 
''The WHO's term 'essential medicines' is construed as `medicines' by this study. Since in most 
developing countries, non-essential medicines exist and are prescribed or dispensed in both public and 
private health care facilities. Using the broader term can convey a more precise definition of medicines 
supply in the health care system (WHO 1997e). 
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who gains access to them (van der Geest & Whyte 1989). As a result, medicines are 
considered so essential to health care in terms of their mental and physical curative 
effects, that a health care programme without them is almost impossible (Whyte, Geest, & 
Hardon 2003). In a review of essential drug programmes in developing countries, 
Mamdani & Walker (1985) emphasise that curative medication is so crucial that it is 
central in attracting people to use health care services: 
"... The success of primary health care workers in their promotive and preventive roles depends, to 
a large extent, on their ability to provide credible front-line curative services. This in turn 
necessitates a constant timely supply of appropriate drugs in adequate amounts. " (Mamdani & 
Walker 1985) 
Although medicines are considered requisite to both health care services and patients, 
not all patients are able to access medicines supplied by health care providers. O'Conner 
(1997) emphasises that some avoidable health care tragedies with known causes arise 
everyday due to scarcity or mismanagement of health care resources such as medicines. 
To some extent, a shortage of proper medicines is responsible for children dying of 
preventable diseases or adults suffering from treatable illnesses (O'Connor 1997). 
Conversely, although medicines are available, the people in need may not be able to 
afford them. 
The World Health Organisation (WHO) once estimated that one third of the world's 
population lacked access to medicines and that over 50% of the population in the 
developing countries in Africa and Asia did not have access to even the most basic 
essential medicines (WHO 1997e). Although 25% to 65% of the total health expenditure 
from these developing countries is spent on purchasing medicines, the government health 
budgets are still too low to provide adequate medicines and often the poor are not able to 
afford those that are costly (WHO 2000). As a result, hundreds of millions of people from 
developing countries do not have regular access to medicines, while many of those who 
are able to gain access obtain the wrong treatment, receive inadequate medicines for their 
illness, or do not adhere to treatment (WHO 1997e). 
Inaccessibility to a supply of medicines also poses substantial concerns to 
industrialised countries. Nonetheless, the problems that have arisen in developed 
countries are centred mainly on the rise in demands for quality health care, especially by 
ageing populations (Hogerzeil 2004b). As a result, the increase in needs for better 
medicines, particularly for chronic diseases (while people in poorer countries require only 
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basic medicines) has elevated total drug consumption in rich countries. For instance, the 
rising cost of drugs for chronic illnesses, such as antihypertensive and antidiabetes 
medication between 1998 and 2001, resulted in increasing prescription costs in the U. S. 
and England by 62% and 30%, respectively (Reidenberg & Walley 2004). However, most 
industrialised countries are able to handle the increase in pharmaceutical demand and cost 
since the proportion of drug budgets to GDP is still relatively higher than the same 
proportion in developing countries. 
Medicines are considered to be one of the most important components of a health care 
system but are distinctive from other health care resources, such as efficient health care 
services or qualified health care staff. Four major reasons highlighting the essence and 
indispensability of medicines in the health care system are summarised below: 
4.2.1 Medicines Save Lives and Improve Health 
The most crucial causes of illness, disability, premature death, and other health-related 
problems in many parts of the world could have been prevented, treated or alleviated if 
people had accessed appropriate medicines. Although the pattern of health problems 
among countries varies, outpatient and primary care services throughout the world usually 
come across the same sets of health problems for which medicines have an important 
role, such as respiratory infections, measles, malaria, and maternal and prenatal mortality 
(WHO 1997e). Mortality figures across developing countries show that the substantial 
burden of illness can be diminished if low cost pharmaceuticals are available, carefully 
selected and appropriately used. For example, 98% of all deaths in children younger than 
15 years, 83% and 59% of deaths of people aged 15 to 59 years and 70 years, 
respectively, occurred in developing countries and the major causes were infectious and 
parasitic diseases (Murray & Lopez 1997). 
Improper use of medicines could have adverse results, so worsening the overall health 
status at both domestic and international levels. For example, international surveillance 
reports, such as the SENTRY Antimicrobial Surveillance Programme, reported that 
antimicrobial resistance is becoming a global problem (Sirinavin & Dowell 2004). In 
Vietnam, children were treated inappropriately with antibiotics, which contributed to a 
significant level of resistance and resulted in many children suffering from resistant 
respiratory infections (Larsson et al. 2000). A cross-national study in Europe also 
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reported that higher rates of antibiotic resistance were evident in high consuming 
countries, such as France, Greece, Luxembourg, Italy, and Belgium, which, in turn 
illustrates the connection between higher antibiotic consumption and high levels of 
resistance (Goossens et al. 2005). Another study showed that the largest increases in 
antimicrobial resistance outside Europe were reported from Asia, South America and 
Africa; for some particular strains, the largest increase was in North America (Frimodt- 
Moller et al. 2007). 
In summary, medicines have two roles, life saving and improving health status. First, 
medicines can treat a large number of people with a various range of health care 
problems. As a result, medicines are perceived as an essential component of a health care 
system by both health care providers and health care users. Secondly, medicines can lead 
the way to a successful treatment if they are employed in the proper way, since each 
medicine has a specific efficacy to treat a disease. Once medicines are prescribed and 
used, patients expect that their illness will be relieved although undesirable consequences, 
such as side effects or drug interactions, are inevitable. 
4.2.2 Medicines Promote Trust and Participation in Health Services 
The credibility of health care workers depends upon their ability to save lives and gain 
trust from patients. Hence, medicines are a crucial component of health care and they 
have helped health care users and their communities utilise their health care services 
effectively. Apart from the direct impact on an individual's health, availability of 
medicines at a health care provider attracts patients to obtain preventive and public health 
messages. When there is a shortage in the supply of medicines or they fail to be 
prescribed, the number of patients using health care services drops and therefore 
satisfaction towards a health care provider declines. Melrose (1982) reviewed the state of 
the public supply of medicines in various countries and remarked that: 
"... The most obvious consequence of rural dispensaries running out of drugs is that people stop 
going to them. Meanwhile, governments have to go on paying for health facilities that are under- 
used and paramedics find it double hard gaining acceptance as health educators when they cannot 
deliver basic drugs. " (Melrose 1982) 
Household and patient surveys in Africa, Asia, and Latin America reported that 
availability of medicines in health care facilities is a major determinant affecting people's 
decision to use health care services (WHO 1997e). In addition, there may be a link 
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between the availability of medicines provision and the high level of satisfaction with the 
care that health care users received. A rural health survey in some Asian countries 
reported that the villagers valued medicines more than the health workers (Attridge & 
Preker 2005). In Africa, one survey revealed that patients preferred to use more expensive 
health care providers, since they relied on the availability of medicines which were 
provided promptly for them at any time (Foster 1991). 
Availability and affordability of medicines in a health care system also cause impacts 
on patients' attitudes towards health care services indirectly, as well as having 
pharmacological effects. Health care users are more likely to be satisfied if they receive 
all medicines that are listed on the prescription, at an affordable price or free of charge. In 
addition, the availability of medicines in health care facilities may encourage health care 
users to access and participate in other health care activities, such as health promotion 
including, daily exercise, quitting smoking, or sex education. 
4.2.3 Medicines are Costly 
The manufacturing of medicines involves many processes, particularly in the Research 
and Development (R&D) phase, which takes a long time and high investment. Therefore, 
some medicines are very expensive since the price includes the charges for manufacturing 
and R&D. As a result, cost can influence the decision of an individual, a household, a 
government, or a country on whether to purchase a particular medicine. 
At the individual and the household levels, medicines can lead to individuals' out-of- 
pocket health expenditure (WHO 1997e). The major proportion of household health 
expenditure is focused on medicines, while only a small amount is spent on the fees of the 
care provider and transportation costs (Diarra & Coulibaly 1990). In the USA, one study 
reported that out-of-pocket costs among patients account for approximately one fifth of 
health care expenditures and they are increasing. Previous research also suggests that 
these costs are associated principally with medications and have become a serious 
economic burden among some patients (Alexander, Casalino, & Meltzer 2003). 
In many developed countries, a full course of antibiotic treatment for pneumonia can 
be bought for the equivalent of two to three hours' wages, while it takes up to one 
month's salary in a developing country. Moreover, treatment for HIV infection for one 
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year consumes the equivalent of four to six months' salary in industrialised countries, but 
can take up to 30 years of income for patients in developing countries (WHO 2004b). 
Interestingly, the difference is that in developed countries, the majority of drug costs can 
be reimbursed, while the majority of household in most developing countries must buy 
medicines using their out-of-pocket money (WHO 2004a). 
At the government level, data obtained from ministries of public health in most 
developing countries reported that expenditure on medicines is second only to staff 
salaries and benefits, accounting for 50% to 90% of non-personnel costs (WHO 1997d). 
Medicines expenditures, therefore, represent the largest proportion over which ministries 
have year-to-year discretionary control (Berman 1997). Consequently, due to the high 
cost of medicines, they are considered to be crucial and vulnerable to fluctuations in 
relation to the availability of public funding and, inevitably, to various political pressures 
(WHO 1997g). 
At the national level, the overall spending on medicines is approximately 10% to 20% 
of the total health expenditure among the Organisation for Economic Co-operation and 
Development (OECD) or industrialised countries (Huber & Orosz 2003; Reinhardt, 
Hussey, & Anderson 2002). Conversely, pharmaceutical budgets in eight developing 
countries in Africa represent one-third of the total public and private health expenditures 
(Makinen 2000). Although, the proportion of budgets for medicines from the eight 
developing countries is higher than the OECD, people in those countries are still unable 
to access medicines provisions. However, if accessibility is possible, another obstacle that 
hinders people from obtaining medicines is the unaffordable price of the medication. 
4.2.4 Medicines are Different from Other Consumer Products 
Medicines have their own characteristics which are different from other consumer 
products. Firstly, consumers or patients do not generally select medicines for their 
treatment themselves because they are always prescribed by doctors, pharmacists, or 
trained health care professionals. Although patients may wish to choose their own 
medicines, they are not trained to judge the appropriateness, safety, quality or value for 
money spent on such medicines. In addition, neither GPs nor pharmacists are trained to 
independently evaluate the quality, safety, or efficacy of vital medicines, particularly for 
the launch of new products. Furthermore, uncertainty of illness can lead to patients 
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demanding medicines from health care professionals or to buying costly medicines for 
themselves, when using cheaper or no medication would achieve the same results or 
better treatments. Finally, patients are not able to determine the possible consequences if 
they are not prescribed the required medication; neither can they identify the potential 
side effects after using their medicines (WHO 1997g). 
Medicines are one of the most important components in the health care system, 
impacting both directly and indirectly on health care services. The former is related to 
efficacy of treatment, which is demonstrated through their pharmacological effects and 
potencies, including side effects or drugs interactions. The latter is the consequences of 
healing characteristics and credibility of medicines, which refers to the availability and 
affordability of such medicines to patients through a health care system. In addition, 
indirect impact can lead to patients' participation in other health care activities besides 
curative care, such as health promotion or other preventive care projects. 
4.3 WHY WORRY ABOUT MEDICINES? 
As medicines improve health status, save lives, and promote trust among health care 
users; therefore, they are perceived to be an integral part of the health care system. In 
addition, medicines are costly and different from other commodities as they are usually 
prescribed by trained health care professionals. However, worries about medicines still 
concern governments because even now there are widespread difficulties with health care 
users regarding medicines supply, such as lack of access, poor quality, irrational use and 
waste of medicines, which ultimately means medicines are not used to their full potential 
in many settings (WHO 2002a). 
4.3.1 Lack of Access to Medicines Provision 
The number of pharmaceutical products in the world market has been increasing with 
rapid growth in both medicines consumption and expenditure. In 2003, global pharmacy 
market sales growth came to 6%, with North America as the key driver of such growth. In 
Europe, sales in Germany, the UK and Spain increased most rapidly; led by Spain, which 
experienced growth of 11 % (Martin 2004). Conversely, some developing countries, such 
as India and China, which together, account for about half the poor population in the 
world, have experienced dramatic growth in the pharmaceutical market. The domestic 
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pharmaceutical market in India is worth approximately US$4.3 (£2.2) billion, 75% of 
which is supplied by Indian firms and the remainder by multi-national corporations. In 
2002, China's domestic market was worth approximately US$6.1 (£3.1) billion with a 
market growth of 18% per annum, and increased to US$10 (£5) billion in 2004 (Grace 
2004). 
Despite the enormous expansion of the international pharmaceutical market taking 
place in almost every part of the world, not everybody is able to obtain medicines they 
really need. This could be for several reasons. They are unavailable or too expensive; 
there are inadequate facilities; or there is no trained professional to prescribe them. For 
instance, the poor in China, the majority of population, often could not access 
antiretroviral medicines equally due to differences in medical costs (Dionisio et al. 2006). 
In addition, a study in Yunan Province, China, reported that the government promised 
free AIDS drugs but the available therapies had serious limitations (Cohen 2004). The 
same situation of HIV/AIDS is much worse in poorer areas of Africa since about 25 
million African people are not able to access the medication they require (Attaran & 
Gillespie-White 2001). Conversely, the situation is much better in Thailand where those 
infected with HIV are prescribed free antiretrovirals under the UCS (King & Ardphoon 
2004). 
WHO has stipulated that access to a supply of medicines at health care facilities is 
considered one of the basic human rights that a country must provide for its citizens, 
which is supported by Quick et al. (2002) who states that: 
"... Access to essential medicines is part of the progressive fulfilment of the fundamental right to 
health. " (Quick et al. 2002) 
Therefore, a lack of access to medicines provision can lead to deaths of millions of 
children and adults each year from diseases that could have been prevented, treated or 
relieved with effective and inexpensive medicines. A well-established medicines supply 
system must be introduced to enhance accessibility to drugs and to alleviate the supply 
problem, particularly in developing countries (WHO 1997e). 
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4.3.2 Poor Quality of Medicines 
Serious and widespread problems in the quality of medicines exist throughout the globe, 
in both developed and developing countries. For example, in the USA, problems of 
people using poor quality medicines in small and large communities alike, occurred in all 
parts of the country (Chassin, Galvin, & and the National Roundtable on Health Care 
Quality 1998). In Africa, the quality of medicines available is inadequate in terms of the 
content of the active ingredient. In addition, there is widespread counterfeiting of 
medicines, and excessive decomposition of the active ingredients as a result of high 
temperatures, humidity and poor quality assurance during the manufacture of medicinal 
products (Taylor et al. 2001). 
One study focusing on medicines from Thailand and Nigeria also showed that 
decomposition was the major cause of poor quality in a number of drugs, as well as poor 
manufacturing processes, which in turn, can lead to treatment failure and drug resistance 
(Shakoor, Taylor, & Behrens 1997). Conversely, the UK National Audit Office (NAO) 
declared that the quality of medicines in the UK is generally high due to the 
internationally recognised rigorous licensing and inspection regime for laboratories, 
production factories and wholesale warehouses (Bourn et al. 2003). 
Poor quality of medicines can be accidental, without intention to delude, but neglected 
controls in manufacturing processes may be catastrophic, as shown by a case in recent 
decades where Acetaminophen syrup was contaminated by mistake with a lethal 
ingredient (Pecoul et al. 1999). However, poor quality of medicines arises due to a lack of 
effective drug legislation and regulations, and a functioning drug regulatory authority, 
with adequate resources and infrastructure to impose upon them. Without these 
components, substandard and counterfeit products can circulate freely in a country. In 
addition, inappropriate handling, storage and distribution can alter the quality of 
medicines. All these factors may generate serious health consequences and lead to a waste 
of resources. 
4.3.3 Irrational Use of Medicines 
Although there are people who have access to drugs, they may not receive the right 
medicines and the right dosage when they need them. In fact, many people buy, or are 
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prescribed and dispensed medicines that are not appropriate for their needs. Some people 
use several medicines (polypharmacy), sometimes more than they need; while others 
receive fewer types of medication than they really require to treat their diseases. The 
problems of irrational use of medicines can be viewed in three dimensions: overuse of 
medicines, multi-drug use or polypharmacy and incorrect drug use. 
Overuse of Medicines arises as a consequence of overprescribing and 
overconsumption. It particularly concerns the use of drugs such as antibiotics, 
antidiarrhoeals, painkillers, injections, and cough remedies (Ross-Degnan et al. 1997). In 
many developing countries, the volume of sales of these drugs exceeds the incidence of 
diseases they are supposed to treat and leads to subsequent problems, such as drug 
resistance or drug intolerance in many patients (Le Grand, Hogerzeil, & Haaijer-Ruskamp 
1999). 
Multi-drug Use or Polypharmacy is where the number of drugs per prescription is 
often more than needed. Polypharmacy is also common among consumers who purchase 
their drugs from the private sector, which may have resulted in them receiving repeated 
drugs. A severe example occurred in Thailand a decade ago where grocery or 
convenience stores provided a set of drugs in one pack, consisting of three to ten kinds of 
medicines, claiming that they were antimalarial drugs (Kamolratanakul, Dhanamun, & 
Thaithong 1992). Negative consequences of polypharmacy are: drug overdose, fatal side 
effects and severe drug interaction. 
Incorrect Drug Use refers to when a patient takes their medication incorrectly, such as 
taking the adult dose of antibiotics or antidiarrhoeals instead of the paediatric dose or vice 
versa depending on the age of the patient (Hardon 1987). Incorrect drug use occurs with 
incorrect prescribing as well as by inappropriate use from health care users themselves. 
Worries about lack of access to medicines, poor quality, and irrational use of 
medicines pose serious problems, which highlight the importance of a well-established 
medicines supply system. One solution proposed by WHO to reduce the degree of distress 
caused by medicines is to consistently provide high quality medications which are 
available in health care facilities at all time with affordable prices for patients under a 
proper drug management system. 
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4.4 AVAILABILITY OF MEDICINES IN A HEALTH CARE SYSTEM 
Worries about medicines from many regions of the world highlight the importance and 
global awareness of access to medicines provision. The problem of improper management 
of the supply of medicines is not only that there are no medicines available in health care 
facilities, but there are more serious concerns about the medicines management process 
and equal distribution of medicines to people who are in need. 
The expectation that medicines can fulfil the demand in health care for the majority of 
the population depends on the availability of medicines in health care facilities at the right 
time, in adequate amounts, with appropriate dosage forms and at affordable prices. Thus, 
WHO has proposed the concept of Essential Drugs (ED), which is intended to be flexible 
and adaptable to many different situations in managing drug supply, depending on 
national circumstances. 
"... Essential Drugs are those that satisfy the priority health needs of the population. They are 
selected with due regard to disease prevalence, evidence of efficacy and safety, and comparative 
cost-effectiveness. " (WHO 2002a) 
The WHO's term 'Essential Drugs' is construed as `medicines or drugs' in this study. In 
most developing countries, non-essential medicines exist and are prescribed or dispensed 
in both public and private health care facilities. Therefore, using broader terms can 
convey a more precise definition of medicines supply in a health care system. 
However, this study is based principally on the model of medicines management in 
respect of the WHO's essential medicines concept, the Drug Management Cycle (DMC), 
which has been adopted by the Thai MOPH as one of the key strategies to improve access 
to medicines in Thailand since the implementation of the UCS in 2001. 
4.4.1 The Drug Management Cycle 
Although medicines may constitute up to 40% of the total health care budget in 
developing countries, access to medicines is still limited in some populations. Effective 
management makes a significant difference in all aspects of drug supply with regard to 
the DMC, which has been applied in most developed and developing countries across the 
globe (WHO 1997g). 
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There are some positive consequences of effective medicines management, which is 
illustrated by the fact that in Brazil, the eastern Caribbean, Mozambique and Thailand, it 
has been reported that governments could save 40% to 60% in drug costs. In addition, 
availability of medicines in Bhutan, Belize and Zimbabwe has significantly improved 
(Kanji et al. 1992). Furthermore, the redesigning of the drug delivery systems in 
Indonesia, Peru and South Africa has demonstrated an increase in reliability and 
efficiency of medicines management (WHO 1997e). 
Although much has been achieved in increasing efficient medicines supply for 
everyone in developing countries within the past two decades, huge gaps still remain 
between demands for medicines and their supply, particularly among the poor and less 
urbanised populations. As a result, WHO has proposed a strategy to alleviate and 
overcome problems of medicines management called the Drug Management Cycle 
(DMC), which focuses on the provision of medicines in health care facilities. The DMC 
comprises four processes, selection, procurement, distribution and use of medicines 
(Figure 4.1) and aims to ensure availability, affordability and rational use of medicines 
supply, which in turn will provide equal access to medicines for all populations. 
Figure 4.1: Drug Management Cycle 
Management 
Support 
I. 
Source: Managing Drug Supply (WHO 1997e) 
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Distribution 
4.4.1.1 Selection 
WHO has estimated that as many as 70% of pharmaceuticals in the world market today 
are `mimic' or duplicative drugs which offer no therapeutic benefit over other existing 
medicines preparations. Some of these medicines demonstrate high toxicity in relation to 
the potencies of their therapeutic effects. Often, many new products are used for trivial 
treatments not relevant to the basic needs of the people and are always more costly than 
other necessary medicines (WHO 1997e). With so many drugs available in the market by 
various indications and consequences regarding their use, a proper drug selection method 
is required to determine the amount of medicines provision in a health care system. 
Drug selection is the initial process of the DMC, aiming principally to determine a 
limit in the number of medicines required to meet the demand of health care users. In 
general, there are two processes in undertaking drug selection; the Evaluation of Demand 
and the Provision of a Medicines List. The former refers to an estimation of the demand 
for medicines in a health care provider using data on medicines consumption from 
previous fiscal years. These medicines are classified into categories according to their 
pharmacological effects. The latter is focused on shaping the drug list based on criteria 
such as, market approval, efficacy, safety and cost of medicines. In general, the Pharmacy 
and Therapeutic Committee (PTC) 12 is responsible for medicines selection process. 
The process in which medicines are selected is considered to be important because 
precise estimation of medicines demand and an appropriate drug list, when compliant 
with the WHO's essential medicines model, can substantially improve prescribing quality 
and lead to better health outcomes (Laing, Hogerzeil, & Ross-Degnan 2001). However, in 
developing countries, pharmaceuticals have the second largest budget in the health system 
after salaries and more than 50% of the pharmaceutical budget is spent on imported drugs 
frone industrialised countries. Therefore, it might not be possible for some drug items in 
the essential drug list to be reasonably truly economical (WHO 2004c). 
Secondly, new essential medicines are extremely expensive, even with differential 
pricing. Examples include L umefantrine-Artemisinine which is approximately 25 times 
'2The Pharmacy and Therapeutic Committee (PTC) comprises health care professionals such as doctors, 
pharmacists, dentists, nurses, and other medicines-related health care staff. The PTC is responsible for 
determining drug items allowed to be given by a certain health care provider and categorising them to 
create the drug list (WHO 1997d). 
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more expensive than Chloroquine, the first line antimalarial drug it is supposed to replace, 
while Atovaquone-Proguanil is about 400 times as expensive (Hogerzeil 2004a). Life 
saving antiretroviral combinations cost £83 to £138 per year whereas 38 developing 
countries have less than £l per person per annum available for all medicines (WHO 
2004c). Although the essential drug model has been criticised because of the high prices 
of new medicines (e. g. antiretrovirals or drugs for cancer) and the out of date of some 
medicines on the essential medicines list. the drug items listed in the WHO's essential 
medicines model is still useful as a guideline for the drug selection process and has 
enormous implications in shaping health care facilities' drug lists in many developing 
countries. 
4.4.1.2 Procurement 
The medicines procurement process is a major determinant in drug availability and health 
care costs. In most developing countries, drug purchases reflect the single largest health 
care expenditure after staff costs. Its definition refers to the process of acquiring supplies 
from public or private sources, or through direct purchases from manufacturers, 
distributors or pharmaceutical agencies (WHO 1997g). The medicines procurement 
process is best described in three components. 
a) Procurement Methods 
Various mechanisms have been used by a health care provider to acquire drugs. However, 
there are four major methods proposed by WHO that are generally applied to the 
procurement process, Open Tender, Restricted Tender, Competitive Negotiations, and 
Direct Procurement. 
Open Tender is a formal procedure where any medicines manufacturers or their 
representatives propose their quotations for the provision of medicines to health care 
facilities. Only drug suppliers who quoted the best prices with satisfactory offers will be 
awarded the contract. Restricted Tender is the method that requires the suppliers to be 
approved in advance by a health care provider. They must comply with Good 
Manufacturing Practice (GMP) and have good prequalification records, including past 
supply performance and financial viability. In Competitive Negotiation, a buyer or a 
health care provider approaches a limited number of selected suppliers (typically at least 
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three) directly for price quotations and bargains for the best prices of drugs. The last 
method is Direct Procurement, which is the simplest, but most expensive method. It is a 
direct purchase from only a single supplier, either at the quoted price or at a negotiable 
rate (WHO 1997b). 
Many countries strive to establish the most efficient medicines procurement system by 
using a combination of methods such as using Open Tender for general drugs and 
Restricted Tender for those more costly medicines. For example, in Benin, the Central 
Purchasing Office was established in 1991 as a single, national sales agency for essential 
drugs and medical supplies, intended for public facilities and non-profit organisations. 
Direct Procurement is applied when the total value of medicines purchases is up to 
US$70,000 (£35,000), whereas the competitive negotiation method is used when the 
value is between US$70,000 and $500,000 (£35,000 and £250,000). The restricted tender 
method will be imposed if the total value of medicines procurement is over US$500,000 
(Hessou & Fargier 1994). 
Some countries, such as Thailand, use the Procurement in Bulk or Pooled Purchase 
Procedure to reduce drug costs. This method is generally used for a larger procurement 
volume where it is possible to obtain better rates from drug suppliers on selected drugs. 
Pooled-Purchase volume is determined by total drug consumption records collected from 
all health care providers in the Pooled-Purchase area. However, some argue that if the 
medicine selection process is not well-organised, Pooled Purchase may only represent 
drug volume from larger health care providers and not from all smaller hospitals or PCUs. 
In addition, the contract between health care providers and medicines suppliers for drug 
purchase must be continued although the same generic drugs are also available in the 
market with competitive prices (Department of Health Care Projects 2004). 
When deciding which method is to be used for the procurement process, there should 
be an awareness of transparency in tenders. A survey by WHO in the mid-1990s found 
various complaints from drug suppliers. For example, in Latin America, the process for 
evaluating tender offers and awarding contracts with public hospitals was not 
straightforward. In addition, some countries experienced a tendering offer that was 
heavily centralised, with a procurement office deciding which drugs to purchase, rather 
than the decision coming from health care facilities' representatives (WHO 2000). Also, 
the procurement office did not award contracts for all items on the tender list. However, 
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adoption of appropriate tendering methods depends mainly on the necessity and 
suitability of the health care system in a particular country. 
b) Quality Assurance 
Medicines are dynamic products since their quality varies sensitively in accordance with 
environments. The purpose of quality assurance in the drug supply system is to ensure 
that all drugs delivered to patients are safe and can maintain their original quality. In 
general, all medicines suppliers need to submit the Quality Assurance (QA) certificate to 
a health care provider before they are awarded contracts. 
The practice in different countries varies considerably. For example, in Indonesia, 
Malaysia, and Thailand, QA and GMP certificates must be submitted prior to contract 
approvals by health care providers or the MOPH's representatives (Tiptaradol. S., 
Abhigantaphand, & Ungboriboonpisal 2004). Conversely, in Bhutan, due to the lack of a 
central drug assurance agency, samples of drug products that have been tested in Bangkok 
or Calcutta, show failure rates of drugs varying from 4% to 15% (WHO 1997e). 
Quality assurance of the medicines supply system is a responsibility shared by health 
care providers and medicines suppliers. A comprehensive quality assurance programme 
must ensure that drugs are selected based on safety and efficacy in a dosage form with the 
longest possible shelf life. Furthermore, the drugs purchased should be acquired from 
reliable commercial suppliers and meet specified quality standards at the time of delivery 
to ensure that the drugs still have their optimal potency when used for treating patients. 
c) Sources of Funds 
Procurement programmes cannot function effectively when the budget is inadequate. In 
many developing countries, financial support for drug procurement in a public health care 
provider depends solely on governmental budgets; with drugs provided free of charge or 
with a little co-payment for both inpatient and outpatient services. The ideal is that 
financial support should be sufficient for providing satisfactory medicines for all health 
care providers in a health care system. Nevertheless, few developing countries have 
achieved this goal in providing a sufficient budget capability to purchase drugs and cover 
all the needs of their populations. 
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At the global level, 60% of health care is publicly financed and the share increases 
with national income. For health care, particularly medicines, private spending or patient 
out-of-pocket expenses show a higher share of health financing in lower income countries 
and reflect problems in sources of funds in medicines procurement (Velasquez, Madrid, 
& Jonathan 1998). Public financing through national and local government budgets is a 
major but sometimes inadequate source of drug financing. Alternatively, voluntary health 
care programmes that require patients to co-pay for their incurred costs and other local 
financing, such as drug donation, can contribute to improving the overall health care and 
drug financing situation. 
Funding options for drugs are similar to those for health care in general. Thus, the 
funds are obtained from government revenues at national and local levels, direct payment 
by patients as a fee for services, health insurance as national social insurance or voluntary 
insurance, employers and other voluntary local financing, and donors and development 
loan (WHO 2004c). However, with limited health care resources, expenditures on 
preventive services are more cost-effective than drug treatment, even at the primary care 
level. To provide sustainable drug financing for pharmaceuticals, particularly among 
publicly funded countries, health promotion needs to be implemented alongside curative 
care (MOPH 2002). 
Effective procurement is a collaborative process between health care professionals, 
medicines suppliers and the public sector. The choices of a purchasing model are not 
always simple decisions since they may differ from one level of the supplier system to 
another. A government must also balance the costs of the quality assurance procedure 
against the benefit of having safe and effective drugs. Similarly, whoever finances the 
drugs should be assured that every effort has been made to ensure there is a better use of 
available health care resources and that such resources are sustainable. 
4.4.1.3 Distribution 
Drug distribution commences when drugs are despatched from manufacturers or suppliers 
and ends when drugs consumption information is reported back to the procurement unit. 
The goal of drug distribution is to allocate, store, and deliver drugs to all units in a health 
care provider corresponding to their demands. The distribution process is focused on two 
major components, distribution systems and storage. 
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a) Distribution Systems 
Effective drug distribution relies on a well-managed distribution system which in turn 
helps to maintain a constant supply of drugs, minimise drug losses and keep drugs in 
good condition throughout the distribution process. This system also provides information 
so that an estimation of drug needs can be calculated. The decision for drug distribution 
must be made based on which levels of the health care system will order the drugs and 
who will passively receive these drugs, which are distributed from a higher level. 
Nevertheless, this study focuses on two basic drug distribution systems, the Pull and the 
Push Systems, since they are widely adopted in public health care providers and are 
comprehensive models for drug distribution to/from health care providers in Thailand. 
The Pull System 
The Pull System is where each operational unit in a health care provider determines what 
types and quantities of drugs are needed and places orders with the supply sources. 
Alternatively, this system is called an Independent Demand or a Requisition System 
(WHO 1997e). 
The Push System 
The Push System emphasises that supply sources at some levels in a health care provider 
determine what types and quantities of drugs will be delivered to operational units. A 
delivery plan is made at the beginning of a planning period and medicines supplies are 
delivered according to such a plan (WHO 1997e). 
The Pull System is a decentralisation of drug demand estimation to operational units 
under the supervision of a health care provider. This allows each unit to independently 
determine their own demand, inspect the stock, and submit requisitions to a central store 
(usually refers to the pharmacy department), indicating their pharmaceutical 
requirements. The Pull System requires that sufficient medicines supplies are available at 
a supply source or a central store to meet all programmes' need. However, health care 
staff in each operational unit must be competent in assessing need, controlling the 
inventory and collecting drug use records. In addition, health care staff from both a 
supply source and an operational unit should work in collaboration with each other to 
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ensure the check and balance system is operated efficiently. This will prevent drug loss, 
which is further supported by the regular inventory inspection performed in all 
operational units. 
Conversely, the Push System is the centralised drug distribution system, which means 
the medicines supply source determines the demands for all operational units. This 
system is applicable to an operational unit where health care workers are not competent in 
inventory control. Furthermore, the Push System is most suitable when demand 
considerably exceeds supply causing the rationing of medicines to all operational units. 
Nonetheless, a problem for the Push System sometimes occurs when there are too many 
operational units under one supply source's supervision. Spaces to store drugs and 
inventory control could cause delays and errors in the distribution process (WHO 1997d). 
However, reasons why one system is better chosen for the medicines distribution 
process than another system depend on the health care system in a country. Some health 
care providers apply a system which is a combination of the Push and the Pull Systems 
because the majority of the medicines supply are at public health care facilities. The 
selected system varies in relation to the appropriateness and feasibility of medicines 
distribution. The Pull System is applied to all operational units within a health care 
provider, such as OPD, IPD, and accident and emergency department (A&E). Conversely, 
the Push System is used particularly for a PCU, which is an operational unit outside a 
public hospital where the drug supply source is located. 
b) Storage 
After selecting the appropriate system for the distribution of medicines, storage 
management of medicines is the next stage of the distribution process. Effective storage 
aims to safeguard stored medicines against loss, damage, theft or wastage and to manage 
the reliable movement of this supply from sources to users in the least expensive way. A 
fully developed medicines storage system applying in the public health sector comprises 
three major components. Firstly, there is an inventory management system, which refers 
to the process of obtaining medicines from the central stock and monitoring their turnover 
rate and quality. Secondly, there is a stock control system, which involves the monitoring 
of the flow of medicines used within the health care system. Lastly, there is a 
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performance monitoring system, which is the process to check if the storage system is 
operating effectively. 
Although members of health care staff at the supply source have been striving to 
manage medicines storage, a lack of appropriate facilities could lead to degradation in the 
quality of medicines. For instance, in remote areas of Thailand, Chloramphenicol eye 
drops, which is an ophthalmic solution and has an extreme thermal sensitivity, was kept 
outside a refrigerator, in a non-air-conditioned storage room. As a result, when the MOPH 
randomly inspected the quality of this drug, the results showed that the drug contained 
only 40% to 60% of the labelled amount of active ingredient (MOPH 2004). Therefore, 
the MOPH has supported necessary storage facilities, added a guideline for drug storage 
at the appendix of the national essential drug list and encourages all public health care 
providers to pay more attention to the nature of drugs and their storage condition (MOPH 
2002). 
4.4.1.4 Rational Use of Medicines 
After selection, procurement and distribution of medicines to operational units in a health 
care provider, the last process of the DMC is the use of medicines. According to WHO's 
definition, use of medicines is construed not only as the process of prescribing or 
dispensing medicines to patients but also includes that patients should receive medication 
appropriately in relation to their clinical needs, in a dose that meets their own individual 
requirements, for an adequate period of time, and at the lowest cost to them and their 
community (Werko 1995; WHO 1997e). 
WHO has proposed the following criteria as a guideline for a health care provider to 
achieve rational drug use: 
- Correct drugs - prescribed drugs must be the same as what the doctor has specified in 
a prescription including, strength, dosage forms, and quantity; 
Appropriate indication; 
Appropriate drugs - considering efficacy, safety, suitability for patients and cost; 
Appropriate dosage, administration and duration of treatment; 
Appropriate to patients - no severe adverse drug reaction or if unavoidable, these side 
effects must be minimal and manageable; 
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Correct dispensing including information about the drugs provided for patients and; 
Patient adherence to treatment - concerning patients' compliance to medical regimen. 
Rational drug use is the process that needs collaboration between health care 
professionals (e. g. doctors, dentists, nurses and pharmacists) and patients. These 
professionals or prescribers are expected to understand patients' health problems. In 
addition, patients' health problems should be defined and diagnosed with possible options 
of treatment. Then, the best drug for patients is selected based on efficacy, safety, 
suitability and cost, including route of administration and duration of treatment. 
In terms of rational drug use in patients, the ultimate goal is that patients adhere to 
treatment and use medicines correctly. Adherence occurs if patients and their community 
understand and appreciate the value of prescribed drugs for specific purposes. However, 
problems always arise when patients do not discern their diseases and medication regimen 
correctly. As a result, treatment failure as in some chronic diseases, particularly 
hypertension, diabetes and heart disease, can occur and lead to stepping backwards to the 
initial phase of treatment (MOPH 2002). Moreover, this leads to a waste of health care 
resources; not only prescribed drugs and budgets but also health care staff and time. 
According to the first three processes of the DMC, selection, procurement, and 
distribution of medicines, there are two key components in the health care system that 
play a crucial role in medicines provision which are a health care provider (including 
medicines supply sources and operational units) and drug companies. Conversely, rational 
use of drugs includes patient involvement in health care activities as one of its major 
components. Patient adherence to treatment is one key concern that requires a well- 
established collaboration between health care providers, drug suppliers and consumers, to 
achieve a sustainable betterment in rational drug use. 
4.4.1.5 Management Support 
The preceding sections on selection, procurement, distribution and use of medicines 
presented the technical core of the DMC. However, each process in the DMC requires 
good management support for organisations, the financing system, information and 
human resources. Firstly, an organisation has the principal function of being a place 
where drugs are stored and distributed from. Thus, provision of a proper area for keeping 
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drugs is one of the most crucial supports that a health care provider needs to be aware of. 
For instance, a central medicines supply unit should be equipped with air conditioning, 
particularly in countries in tropical regions, to maintain drug quality and extend the shelf 
life of drugs until they are delivered to patients. 
Secondly, a drug financing system should be centred mainly on efforts to make better 
use of available funds or budgets. In general, public financing through national and local 
government budgets is a major pathway for drug funding but sometimes it is not an 
appropriate source. For instance, Thailand had a problem of inadequate budgets, which 
are totally from taxation, to purchase costly antiretroviral drugs to supply all public health 
care providers before 2000. The insufficiency of the drug budget was partly due to the 
consequences of the Economic Crisis from previous years. However, the government 
asked for financial support from the World Bank and called for drug donations from the 
private sector (MOPH 2002). Alternatively, user charges may exist to help the 
government fund the medicines management system. However, an argument against 
applying this concept to solve insufficient funding problems is that it may pose many 
difficulties to patients and hinder them from accessing to medicines. Voluntary and other 
local financing, including private donors, should be used to improve the overall health 
care and drug financing situation (WHO 1997b). 
A Drug Management Information System (DMIS) should also be included as a 
planning process for a drug supply system. The DMIS is an organised system for 
collecting, processing, reporting and using information for decision-making, based on the 
information needed from users at each level of the health care system. An example of this 
is a Drug Information Centre (DIC) in all public hospitals of Pathumthani Province, 
Thailand, where clinical drug data and statistics of drug consumption (e. g. adverse drug 
reactions, drug interactions or proportions of EDs to NEDs) are collected, recorded and 
analysed. Finally, human resource management is an important and challenging task for 
members of health care staff. Effective supervision, such as supportive tutorials (in terms 
of knowledge in pharmacology, indications of new drugs and dispensing skills) executed 
by heads of each department to their subordinates, may improve the outcome of health 
care service. 
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Well-designed management support is central to the DMC (selection, procurement, 
distribution and use), which can lead to sustainable achievement in medicines provision 
and improve equity in access to medicines supply in the health care system. 
4.5 EQUITY IN ACCESS TO MEDICINES PROVISION: EXPERIENCES FROM 
BOTH RICH AND POOR COUNTRIES 
The World Health Organisation (WHO) estimates that one-third of the world population 
lacks access to medicines they need. Increasing access to essential medicines is a crucial 
part of global efforts to improve health, particularly in developing countries and to tackle 
key diseases, such as HIV/AIDS and tuberculosis (Department for International 
Development 2004). In addition, it is also vital in helping to manage high prevalence 
chronic diseases, such as hypertension, diabetes or heart disease (MOPH 2002). 
Therefore, major efforts have been made to provide basic medicines provision for various 
diseases. This has been done by emphasising the importance of the use of essential 
medicines and their generics, a well-established medicines supply system and the rational 
use of medicines. 
4.5.1 The Use of Essential Medicines and their Generics 
In 1981, Kenya was one of the first African countries to introduce the WHO's essential 
medicines concept and add the essential drug list to the national health policy. In addition, 
the Kenyan government has encouraged the establishment of an efficient medicines 
supply system by integrating the DMC into the previous drug management process 
(WHO 1997e). Conversely, South Africa's essential medicines policy was confined to a 
limited list which had been used in the public sector since the mid-1980s. An amendment 
of the contemporary South African national drug policy means that the policy is now 
committed to using essential medicines and has expanded to include some 2,600 items 
since 1996 (Laing et al. 2003). 
Although the WHO's concept of essential medicines is widely accepted in many 
countries, there are substantial concerns regarding the stringent implementation of this 
policy, particularly in developing countries. One of these concerns is focused on new life- 
saving drugs such as antiretroviral [e. g. Maraviroc and Raltegravir (Opar 2007)], which 
may not be included in the national drug list because they have not been approved by 
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WHO. In addition, these new drugs could be more effective, have fewer adverse drug 
reactions and represent a better quality of care than former generations had. Moreover, 
they may also lower overall costs by lessening patient's needs for other health care 
services (Kass-Bartelmes, Bosco, & Ruthford 2002). 
WHO has recommended that both developed and developing countries use generic 
drugs as they may help to decrease drug costs and improve both availability and 
accessibility of medicines with affordable prices to all citizens. A generic drug is identical 
or bioequivalent to a brand name drug in terms of dosage form, safety, strength, route of 
administration, quality, performance characteristics and indication of use. Although 
generic drugs are chemically identical to their branded counterparts, they are typically 
sold at substantially lower prices than the branded form (Haas et al. 2005). In addition, 
the concept of generic drugs is supported by Medecins Sans Frontieres, who agrees that 
the development of such drugs is a less costly and more sustainable method of supplying 
necessary drugs (Guilloux & Moon 2000). 
Many developing countries implement the generic drug concept in their health care 
systems. For example, in Indonesia, the 1989 Decree, which encourages public health 
care facilities to prescribe and dispense generic drugs, was proposed by the Indonesian 
government in the hope that people living in poverty might obtain sustainable access to 
drugs at low prices (WHO/DAP 1989). Similarly, the Generic Act of 1988, imposed due 
to a unanimous decision made by the Philippines' Congress, ordered the mandatory use of 
generic drugs in public health care providers (WHO 1997e). In Thailand, the MOPH has 
strived to improve the quality of generic drugs which is achieved by both the provincial 
procurement system and the expansion of the mandatory GMP policy to all drugs 
companies, which has been occurring since 1989 (Wibulpolprasert 2000). 
Some industrialised countries also adopted the generic drug concept. In Denmark, for 
example, generic drug substitution was possible with a doctor's agreement and 
represented 60% of the prescription volume with 30% of the sale value (WHO 1997d). 
For Germany and the Netherlands, generic drug substitution was strongly encouraged and 
20% to 40% of prescriptions contained such generic medication (WHO 1997e). In the 
USA, generic drugs dispensing is very much supported by the 1984 Drug Price 
Competition and Patent Term Restoration Act (Waxman-Hatch Act) which facilitates 
registration of generic drugs (Frank & Salkever 1997). Moreover, the U. S. Congressional 
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Budget Office reported that generic drugs save consumers an estimated US$8 (£4) to $10 
(£5) billion a year at retail pharmacies (FDA 2007). Conversely, countries such as 
Belgium, France and Italy tended to use generic drugs for less than 2% of prescriptions 
(WHO 1997e). 
Although the implementation of a generic drugs policy has been expected to lower 
drug costs and encourage people to utilise health care services with affordable prices, this 
policy may be inappropriately generalised to some countries without local drug 
manufacturers. In addition, a number of new medicines are still expensive, limitedly 
manufactured or no longer in production because the market is not profitable 
(Kindermans & Matthys 2001). For instance, the Bhutanese government relies principally 
on generic drug importation from India and Thailand and needed to spend more budgets 
on generic drugs due to an unavailability of domestic medicines manufacturers. In 
addition, drugs imported from other places are also sent to the central laboratories in other 
countries for quality inspection which could obviously increase the health care costs 
(WHO 1997b). 
In countries where the generic drugs programme has already been implemented, it may 
take some time for patients to become familiar with the new drugs. However, the most 
important concern is centred on the quality of drugs and whether they are generic or have 
trade names they must be within the specified standards for safety, efficiency and 
affordability for all populations. 
4.5.2 A Well-Established Medicines Supply System 
Over past decades, experiences gained by many countries in the field of managing the 
supply of medicines emphasise the importance of equal access to available and affordable 
medicines. To achieve this goal, basic drug management concepts have been integrated 
into national health policies in countries as diverse as Cuba, India, Norway, Papua New 
Guinea, Peru and Sri Lanka (WHO 1997e). In addition, extensive lessons have been 
learned from these countries, for example, a national drug policy provides a sound 
foundation for managing drug supplies; proper drug selection underlies all other 
improvements and effective management saves money and improves the performances of 
a drug supply system (WHO 1997g). 
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For instance, the Tamil Nadu Medical Services Corporation (TNMSC) in India, 
established in 1995, aims to contain the increase in drug cost and diminish the shortage of 
medicines. TNMSC is responsible for purchasing and supplying drugs to all public health 
care facilities. Drugs are procured through tender and delivered directly to district level 
stores on the basis that a 5% charge is required to fund its own operations. However, 
TNMSC has helped the Indian government considerably in reducing drug costs while also 
maintaining a reliable drugs supply to all health care facilities (Bennett & Muraleedharam 
1997). The Zimbabwe Essential Drugs Action Programme (ZEDAP) uses different 
systems for different categories of drugs. Drugs with high demand are procured, stocked 
and distributed in bulk through the central medical store. For those that are of high-cost 
but have a lower demand, direct delivery to health care facilities is applied; whereas for 
special items, an annual tender is conducted to secure the drug price for the year. The 
results of drug management demonstrate that drugs are more available in health care 
facilities and more affordable for patients than they were many decades ago (WHO 
1997e). 
To establish a drug supply system in a country, there is no complete answer to state 
perfectly which method is the best approach. Application depends upon other components 
such as the structure of the health care system, the political sphere, current health 
situations, sources of funds and geographic barriers. Using a mix of systems may incur 
higher costs than applying only one system but could enhance capability for drug 
management and balance the use of health care resources. Nonetheless, one pathway 
towards achieving equity in access to medicines provision is to create a drug supply 
system based on the DMC with its four principal processes, selection, procurement, 
distribution and rational use of drugs. 
4.5.3 Rational Use of Medicines 
The rational use of medicines requires that patients receive medications in response to 
their clinical requirements, in doses that meet their own needs, for an adequate period of 
time and at the lowest cost to them and their communities (WHO 2002a). Interestingly, 
80% of all drugs used in developing countries were purchased by people for themselves 
or family members without prescriptions (WHO 1997c). 
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To promote rational use of medicines in a country, collaboration between health care 
staff and consumers is key for successful implementation. For health care staff, a study 
focusing on frequent errors in treating common diseases that occurred in primary health 
care practices in Mexico revealed that an educational strategy is required to improve GPs' 
prescribing practices for acute diarrhoea (AD) and acute respiratory infection (ARI). The 
strategy was largely based on promoting active involvement of GPs and related staff in 
group work and a literature review on AD and ARI (Guiscafre et al. 1997). In the 
Netherlands, the Rational Use of Drugs (RUD) groups were established and aimed to 
share and review clinical drug data among members (WHO 1997f). For Columbia, the 
rational drug use curriculum has been added to pharmacy schools to emphasise the 
importance of inclusion of essential drugs concept in the undergraduate curricula (WHO 
1997a). 
To achieve rational drug use by consumers, the Thai MOPH developed an intervention 
which involved collaboration between pharmacists in district hospitals, village drug 
cooperatives, village health volunteers, local grocery owners and villagers. It aimed to 
reduce the use of pre-packed mixtures of drugs or `universal medicines' (comprising three 
to five kinds of drugs, e. g. Aspirin, Diazepam, Tetracycline, muscle relaxants, and 
steroids, believed by some patients to cure every disease once taken) sold in convenient 
stores (Suchaithanavanich 1997). In South Africa, the HIV project called the 'Ithemba', 
which is funded by the USA, the UK and South Africa, is a clinical assessment of the use 
of antiretrovirals (ARVs) among patients. The project has achieved a9% success rate of 
patient adherence to treatment and the rules associated with it since the ARV programme 
started (Government of South Africa 1996). 
Experiences from both developed and developing countries indicate that to accomplish 
the goal of equal access to medicines supply, collaboration between the government, the 
private sector and health care users is required. The government designs and implements 
health care projects, such as the essential drug list or generic drug policy, while the 
private sector (e. g. drug suppliers) should fulfil drug demand from health care facilities 
by delivering high-quality medicines with affordable prices. Health care users are 
expected to have basic knowledge in self-care and must adhere to the treatment given by 
their health care providers. This results in a desirable model of a public-private 
partnership, leading to an improvement of access to health care services, which in turn 
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allows health care users to participate more in other health care activities, including 
access to a supply of medicines. 
4.6 CONCLUSION 
Medicines are indispensable to a health care system and its patients because of their 
beneficial properties. Medicines can improve health status, save lives and promote trust in 
patients of a health care provider. Unlike other commodities, consumers are not supposed 
to choose medicines in respect of their need but trained or highly skilled health care 
professionals such as doctors, pharmacists or dentists are responsible for selecting 
appropriate medicines on behalf of the consumers or patients. 
As medicines are special goods, many developing countries try to establish a proper 
medicines supply system for their citizens. An appropriate system for each country is 
centred mainly on the WHO proposed model of the DMC which aims to elevate equal 
access to essential medicines provision in the public health care system. The DMC 
comprises four stages, selection, procurement, distribution and use of medicines, which 
are controlled by the management support system. 
Experiences from both developed and developing countries concerning equity in 
access to drug supply are centred on the use of essential drugs, the generic drug policy, 
management of the drug supply system and rational use of medicines. Consumer 
involvements in health care activities may also enhance perceptions and adherence to 
treatment among patients, which could lead to an increase in participation in health care 
activities, including the ultimate goal of sustainable access to medicines provision in 
public health care providers. 
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CHAPTER 5 
Methodology 
5.1 INTRODUCTION 
Chapter 2, describes the general background of the Thai health care system including the 
necessity of the health care reform project and the Universal Coverage Scheme (UCS), 
which was implemented in 2001. The health reforms aim to improve the quality of health 
and narrow the gap between the rich and the poor in access to health care services. In 
addition, the UCS is an approach to assure Thais that their basic health care needs are 
definitely secured and fulfilled through one of the national health insurance sub-schemes. 
Chapter 3 discusses the key concepts of access to health care which emphasise the 
necessity of equal access to health care services supplied by health care providers. 
Medicines play an important role as one of the indispensable components of the health 
care system by being able to save lives, improve health and elicit trust from health care 
users. Chapter 4 describes the essence of medicines to this extent and discusses an 
approach proposed by the World Health Organisation (WHO) to improve access to 
medicines provision, which is the Drug Management Cycle (DMC). The DMC is widely 
used as a guideline by many countries but evidence from developing countries reported 
that the DMC, to some extent, did not alleviate inaccessibility to a supply of basic 
medicines. 
This chapter describes the methods used to investigate access to medicines supply 
under the UCS in public health care providers in Thailand. The study is designed to 
address those theoretical and practical problems with the medicines supply system under 
the DMC, originally described in Chapter 4, alongside a survey of patients' attitudes 
towards the medicines provision under the DMC in public health care providers. Both 
qualitative and quantitative surveys were approved by Pathumthani Province for data 
collection between 10th January and 19th February 2006 (see Appendix A). The discussion 
of the study method is followed by the presentation of qualitative and quantitative 
findings in Chapter 6 and Chapter 7 respectively. 
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5.2 HYPOTHESIS AND RESEARCH QUESTIONS 
The UCS has been in place in Thailand since 2001 as a subsequent scheme of the health 
care reform project launched in 1997. It aims to narrow the gap and improve equity in 
access to health care for all Thais. This thesis focuses on an implementation of the DMC 
in respect of the UCS, which is intended to expand medicines supply to cover all the Thai 
population and enhance equity in access to health care services. 
The study examines whether the DMC helps improve equity in access to medicines 
under the UCS and the research questions are: 
1. What were the processes of medicines management in Pathumthani Province? 
2. How did public health care providers in Pathumthani Province apply the DMC to 
their health care systems? 
3. What were the changes in the medicines management process after the 
implementation of the UCS in Pathumthani Province? 
4. What were the roles of pharmacists in promoting equity in access to medicines 
provision in Pathumthani Province? 
5. What were attitudes of health care users towards the medicines supply system, the 
pharmacy services and the overall health care services in public health care providers 
of Pathumthani Province? 
6. What recommendations can be made, using the results of this study, to provinces 
wishing to apply the DMC as a means of improving equity in access to medicines in 
the public health care system under the UCS? 
5.3 AIMS AND OBJECTIVES 
The primary aims of the research are to identify factors that influence the performance of 
the DMC in the processes of selection, procurement, distribution and use of medicines 
and to assess the attitudes of health care users towards care received, particularly when 
the medicines were prescribed from public health care providers. 
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The specific research objectives were: 
1. to investigate the process of medicines management in public health care providers of 
Pathumthani Province after the implementation of the UCS; 
2. to describe and compare differences and similarities of the medicines management 
system between the pre-existing system and the DMC; 
3. to assess the extent to which the DMC improved equity in access to medicines supply 
in Pathumthani Province; 
4. to identify the roles of pharmacists in the public sector in enhancing equity of access 
to medicines provision; 
5. to assess the level of health care users' attitudes towards the medicines management 
system in public health care providers of Pathumthani Province and; 
6. to propose recommendations of the DMC adaptation to the public health sector in 
Pathumthani and other provinces. 
5.4 OVERVIEW OF STUDY DESIGN 
To achieve the aims listed above, a survey was carried out in public health care providers 
of Pathumthani Province. The study involved a two-month field survey using semi- 
structured interviews with health care stakeholders alongside a questionnaire, which was 
given to health care users to obtain opinions towards medicines management and the 
performance of health care services in the public sector. These methods are described 
later but in brief, the methods address the above aims and objectives as follows: 
The semi-structured interviews were conducted with, (a) policy administrators from 
Pathumthani Provincial Health Office, (b) health care administrators from Pathumthani 
Hospital, (c) hospital directors from district hospitals, (d) heads of the community 
pharmacy departments in district hospitals and (e) heads of the PCUs. These interviews 
were employed to investigate the process of managing drug supply, to describe and to 
compare differences and similarities of the medicines management system between the 
pre-existing method and the DMC. Comments and proposals from the interview were 
used to, assess how much the DMC improves equity of access to medicines provision, 
identify the roles of pharmacists in the public sector and investigate factors impeding 
health care users from accessing to medicines provision. Both data from the semi- 
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structured interviews and the questionnaire were used to propose recommendations for 
the proper application of the DMC to the public sector. 
The study started in early 2004 with a review of related literature and research to find out 
which methodology was appropriate for the field survey. The decision to use a 
combination of both qualitative and quantitative methods was then made. In addition, the 
author consulted with supervisors and statistical advisors to determine which methods 
were suitable for the health care providers and patients who were the subjects in the 
study. The letter for ethical approval from Pathumthani Province and the letter for 
permission for the pilot study from BMA and Vajira Hospital were sent off in November 
2005. After approvals in December 2005, data collection was conducted between 10th 
January and 19th February 2006 at all public health care providers in Pathumthani 
Province. Data analysis was done between May and December 2006, following by the 
discussion of findings in early 2007. 
5.4.1 Study Setting 
The semi-structured interview was undertaken at all public health care providers in 
Pathumthani Province including Pathumthani Provincial Health Office, Pathumthani 
Hospital, district hospitals and PCUs. The health care stakeholders that participated in the 
interview were selected from members of the Pharmacy and Therapeutic Committee 
(PTC) who are involved in the medicines management process at the district and 
provincial levels. In addition, the questionnaire was applied to OPD patients who had 
hypertension or diabetes at public health care providers in Pathumthani Province, 
excluding the provincial health office because its responsibility does not relate to the 
provision of curative care or treatment for patients. 
5.4.2 Study Population 
A total of 22 members of health care staff in the PTC were purposively selected to 
participate in the semi-structured interview. These members of staff were selected by the 
chair of the PTC13 in each health care provider. Respondents comprised three policy 
administrators from Pathumthani Provincial Health Office, three health care staff from 
Pathumthani Hospital, two heads of the PCUs, seven heads of the pharmacy departments 
13In general, the PTC comprises 8 to 12 members selected from operational units' representatives. 
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and seven hospital directors from district hospitals. All 22 respondents agreed to 
participate in the semi-structured interview. In addition, 400 OPD patients from eight 
public hospitals14 in Pathumthani Province were randomly chosen to complete the 
questionnaire about their attitudes towards the quality of medicines, services from the 
pharmacy department and the overall health care services from public health care 
providers. The details for both qualitative and quantitative investigations are described in 
the next topics. 
5.5 QUALITATIVE INVESTIGATION 
The qualitative component regarding health care stakeholders' opinions towards the DMC 
under the UCS was investigated by using the semi-structured interview as explained in 
Figure 5.1. 
Figure 5.1: Study Profile of the Semi-structured Interview 
Provincial Level 
(6 members of health 
care staff) 
Pathumthani 
Provincial Health 
Office 
(3 policy 
administrators) 
'athumthani IlospW 
(3 members of health 
care staff) 
Semi-structured 
Interview 
(22 members of health 
care staff) 
District Level 
(7 HPs and 7 HDs) 
10-bedded Hospitals I 30-bedded hospitals 
(3 HPs and 3 HDs) (3 HPs and 3 HDs) 
PCU or Community 
Level 
(2 HPCUs) 
120-bedded Hospital 
(I HP and I HD) 
Klongluang I lospital - Lumlukka Hospital - Thunyaburi Hospital 
Latlumkaew Hospital - Nongsua Hospital 
Samkok Hospital - Prachathippat 
Remark: - HP, HD, and HPCU refer to a head of the pharmacy department, a hospital director, and a head of the 
PCU respectively. 
- *Prachathippat Hospital is located in Thunyaburi district. 
"Eight public hospitals in Pathumthani Province comprise Pathumthani Hospital and other seven district 
hospitals located in six districts. 
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The detail of objectives, sample, data collection method and analysis employed in this 
study are described in turn below. 
5.5.1 Objectives 
The primary objective of the semi-structured interview was to describe the process behind 
the implementation of the DMC in Pathumthani Province and to obtain accounts of how 
decisions were reached during each key stage of the DMC (selection, procurement, 
distribution and use). The intention was to use this data to describe the practical drug 
management system in Pathumthani Province, comparing it with the DMC guideline. 
This guideline was expected to reflect the much realistic medicines supply situation. The 
inclusion of this qualitative investigation was particularly important in providing: more 
understanding of the actual process of the DMC implementation, the extent to which the 
DMC may have differed from the intended process and what factors may have accounted 
for any disparities between the intended and the actual processes of the DMC. 
5.5.2 Sample 
The study sample automatically included public health care stakeholders who were key 
members of the PTC at the provincial level and health care staff from district and 
community levels. They were studied for two months from January 2006. Figure 5.1 
illustrates that the study sample for the semi-structured interview comprised 22 health 
care stakeholders, of which six were members of health care staff from the provincial 
level, including, three policy administrators from Pathumthani Provincial Health Office 
and three members of health care staff from Pathumthani Hospital. In addition, 14 
respondents at the district level comprised seven heads of the pharmacy departments and 
seven hospital directors from six districts, whereas two heads of the PCUs were selected 
from the community level. 
5.5.3 Data Collection 
The list of questions for the semi-structured interviews was originally drafted in English 
and was then translated into Thai by the author. The translated versions of all questions 
were then given to a linguistic expert in Thailand for back translation to validate the 
identical meaning and preciseness of the translation between the English and Thai 
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versions. After approval, the list of questions was pre-tested with four health care 
stakeholders comprising two hospital administrators and two pharmacists at Bangkok 
Metropolitan Administration (BMA) and Vajira Hospital in Bangkok. 
After an adjustment of the question list, the semi-structured interviews were conducted 
with health care stakeholders in Pathumthani Province at the provincial, district and 
community levels. Interviews were based on topic lists drafted after a literature review of 
the DMC. Questioning was carried out by the author and structured to cover key themes 
of the DMC at the said levels but was also responsive to issues emerging from 
interviewees' accounts. The interview covered the processes of selection, procurement, 
distribution and use of medicines in the public sectors and the comparison of differences 
and similarities of the medicines supply system before, after and during the UCS 
implementation. In addition, interview subjects also included the roles of pharmacists in 
medicines provision and in enhancing the equity of access to a supply of medicines in the 
public health care system. The final versions of the semi-structured interview topic lists 
(both English and Thai versions) are attached in Appendix C. 
5.5.4 Qualitative Analysis 
All interviews were tape-recorded and transcribed for coding and analysis using the 
Content Analysis Method. This method was more suitable for this study because the data 
were predetermined by their categories as displayed in the DMC processes (selection, 
procurement, distribution and use) and were also categorised according to the levels of 
health care providers, including the provincial, district and community levels (Bryman 
2001). Although, I was aware that Grounded Theory could have been used for analysing 
the data, the method itself may not be useful to recreate the DMC categories from the data 
which could not be matched with the actual processes of the DMC. Therefore, using 
content analysis was considered more efficiently and suitably for a small scale analysis of 
data comprising only 22 respondents. 
The classification of qualitative data was operated at three levels. 
0 First of all, each transcript was categorised in relation to the levels of health care in 
Pathumthani Province, the provincial, district and community levels. Each level of 
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health care was retained as an individual data case and was coded in respect of the 
processes of the DMC performed in such a level. 
0 Second level codes were descriptive categories used to label themes identified in each 
health care level according to the processes of the DMC. For example, practice in the 
selection process at the provincial level and comparisons between the current practice 
and previous experiences of medicines management in Pathumthani Province. 
" Third level codes were descriptive sub-categories of level two codes or emergent 
themes identified through the analysis, such as an explanation of good practice in the 
medicines selection process at the provincial level or recommendations for improving 
the DMC from respondents. The third level codes are described in the findings 
(Chapter 6). 
The content analysis of the semi-structured interview with health care stakeholders had 
the following objectives: 
" to describe the processes of the DMC implemented under the UCS in public health 
care providers from the three levels of health care, the province, district and 
community or PCU; 
" to identify differences and similarities in the DMC among the three health care levels 
and; 
" to identify obstacles, from the supply side's perspectives, which prevent health care 
providers from performing efficient medicines management. 
In all cases of respondents, negative and positive answers were only considered when 
data showed corroboration from two or more sources (i. e. two or more policy 
administrators, or health care staff from Pathumthani Hospital). This criterion was set to 
ensure the significance of qualitative data with the confirmation from two or more 
respondents under the same question from the semi-structured interview. In this way, the 
responses from the health care stakeholders were summarised and linked to each process 
of the drug management system in public health care facilities. 
5.6 QUANTITATIVE INVESTIGATION 
The quantitative component of the study was designed to reflect health care situations 
among patients, including their attitudes towards medicines supply and the overall health 
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care system in the public sector. The investigation involved data collection through the 
questionnaire and analysis in relation to five main areas: 
" The Characteristics of Respondents refer to demographic data such as age, gender, 
educational background, income and districts of residency. 
" Data on Coverage of the UCS comprises data about coverage of the UCS sub- 
schemes (CSMBS, SSS and TBS), data about TBS subcategories, the levels of care in 
the health care system and household's coverage under the UCS. 
" Data of Incurred Cost from Using Health Care Services is based on the out-of-pocket 
expenses that respondents paid out when accessing health care services from public 
health care providers. These costs refer to transportation costs, possible health care 
costs and other costs. 
" Respondents' Clinical Data focuses on illness caused by hypertension or diabetes or 
both of these diseases with other chronic diseases and the use of medicines, such as 
the number of medicines per prescription per visit and the number of hospital visits 
per year. This topic also included patient's experiences of using other health care 
providers that were not their main contractors or sub-contractors. 
" Respondent's Attitudes towards Medicines Supply and the Health Care System refer 
to the evaluation of opinions of respondents towards both medicines provision which 
included drug quality, pharmacy services and the overall health care services given by 
public health care providers in Pathumthani Province. 
5.6.1 Purposes 
As mentioned in Chapter 3, access to medicines provision should be considered from the 
supply side. Hence, the DMC is considered to be one approach, which has been 
implemented in many countries (described in Chapter 4), that helps to enhance the 
efficiency of managing the supply of medicines in the health care system. Qualitative 
findings from Chapter 6 will explain the situation of medicines management in 
Pathumthani Province after the implementation of the DMC under the UCS. 
Nevertheless, respondents' opinions towards the medicines supply system, which 
includes the quality of medicines, services obtained from the pharmacy department and 
the overall health care services, were required to be assessed by health care users. Thus, 
the primary purpose of the quantitative survey is to assess medicines provision through 
the performance of the pharmacy department in public health care providers from health 
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care users' perspectives. Another purpose is to evaluate the overall health care system 
under the UCS after its first implementation in April 2001. 
5.6.2 Sample 
400 OPD patients were randomly selected from all public health care providers in 
Pathumthani Province. In addition, all eligible respondents must have diabetes (DM), 
hypertension (HT) or DM and HT or either DM or HT with other chronic diseases such as 
heart disease, cancer, gout, stroke and so on. All respondents were patients who had 
regular appointments with doctors to follow-up their treatment at the DM and HT clinics 
in each public health care provider. 
The number of respondents selected from each health care provider was calculated 
using the proportion of HT or DM patients from each health care provider to the total HT 
or DM patients in Pathumthani Province as displayed in Table 5.1: 
Table 5.1: Estimated Number of Diabetes (DM) or Hypertension (HT) Respondents Selected from each 
Public Health Care Provider in Pathumthani Province 
Health Care Number of DM or HT 
Number of DM or Estimated number of 
Providers HT patients for one patients selected from 
Mcpl 
Patients from each HCP* week each HCP 
Pathumthani 3,366 842 87 
Lumlukka 3,022 756 78 
Prachathippat 2,648 662 69 
Thunyaburi 1,748 437 45 
Samkok 1,433 359 37 
Latlun kaew 1,328 332 35 
Nongsua 896 224 23 
Klongluang 599 150 15 
PCU 1 233 59 6 
PCU 2 197 50 5 
Total 15,470 3,871 400 
* Data obtained from Pathumthani Provincial Health Office (2005) 
In the field survey, data collection for one health care provider was completed within one 
day of the DM or HT clinic. Therefore, only one quarter of the total DM or HT patients 
met GPs for repeating their medication in that week (the DM or HT clinic was scheduled 
every week). From Table 5.1, the third column shows the number of patients assigned to 
attend the DM or HT clinic in each health care provider for each week. In addition, the 
number of respondents displayed in the last column is an approximation of the DM or HT 
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patients expected to be randomly selected from the OPD of each health care provider. The 
simple random method was employed for the data collection by selecting one from every 
ten DM or HT patients from the clinic. This figure was computed from the proportion of 
the estimated number to the weekly number of patients (1: 10). All respondents were pre- 
assigned and enquired by an OPD nurse about their consent to participate in the survey. 
The selection method allowed a respondent to have approximately 10 to 15 minutes to 
complete the questionnaire and provided the author enough time to clarify any queries 
from respondents. Although the response rate for this quantitative survey was 100%, 
approximately 20% of respondents needed assistance from the author in clarifying the 
questions or helping them with the problem of reading difficulties. 
Reasons for focusing on DM or HT patients related to the provincial morbidity and 
drug consumption statistics. The former showed that DM and HT were among one of the 
top five diseases due to the number of cases reported to the provincial health office (DM 
and HT were only after cancer and accidents), while the latter proved DM and HT to be 
important because they had the second highest proportion of the total drug consumption 
in 2004 (Department of Health Care Projects 2004). Both antidiabetes and 
antihypertensive drugs had one of the highest drug values in the drug budget after only 
antibiotics as mentioned in Chapter 2. In addition, DM or HT patients are regular health 
care users of health care providers as they need follow-up and to repeat their medication 
every month. Therefore, they are expected to be key people in noticing any changes that 
may have happened to the health care system in Pathumthani Province after the 
implementation of the UCS. 
5.6.3 Data Collection 
The questionnaire was prepared originally in English and was translated into Thai by the 
author. This translated version was then passed on to a linguistic expert in Thailand to 
validate identical meaning and preciseness of the translation with the English. After 
approval from a linguistic expert, the questionnaire was pre-tested with 20 DM or HT 
patients from the OPD at BMA and Vajira Hospital in Bangkok. 
The pre-testing of the questionnaire aimed to ensure whether both the informed 
consent leaflet and the questionnaire were understandable to respondents. In addition, it 
also intended to check the approximate time spent on the completion for each 
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questionnaire. Changes in wording for both the informed consent leaflet and the 
questionnaire were implemented after pre-testing. The major changes made in the 
informed consent leaflet were to clarify the terms `anonymity' and `confidentiality'. 
Minor adjustments of wording in the clinical and UCS sections of the questionnaire were 
also implemented to improve clarification and help in speeding up the completion of the 
questionnaire. 
The questionnaire was then given to all respondents from public health care providers 
in Pathumthani Province, commencing on l0"' January and ending on 19t" February 2006. 
During the five-week data collection, each respondent was required to complete five parts 
of the questionnaire (as described in Section 5.6), which were: 
" the characteristics of respondents; 
" data on the UCS coverage; 
" respondents' clinical data; 
" data of incurred cost from using health care services and; 
" respondents' opinions towards medicines provision and overall health care services 
from public health care providers. 
Respondents were required to answer all questions in the first four parts of the 
questionnaire (parts 1 to 4), which were multiple choices. However, in part 5 which was 
related to respondent's attitudes towards the medicines supply system and health care 
services, the three Likert Scale ranging between 1 and 3 was applied (1 refers to disagree, 
2 represents no opinions and 3 means that a respondent agrees with the proposed opinions 
in the questionnaire). I was aware that using a wider spread Likert Scale (e. g. five or 
more) may convey a greater distribution in respondents' attitudes. However, the wider 
scale can sometimes cause confusion in respondents, particularly the elderly. For 
instance, some respondents may find that there is no difference between `totally agree' 
and `agree' or `totally disagree' and `disagree' in the five point Likert Scale because they 
all do mean agree or disagree. To help respondents who were mostly elderly, the three 
point Likert Scale was therefore used to reduce possible confusion and help in speeding 
up the response to the questionnaire. The three point Likert Scale applied in Part 5 of the 
questionnaire was divided into three sections. These comprise respondent's opinions 
towards, drug quality, services received from the pharmacy department and overall health 
care services from public health care providers in Pathumthani Province. 
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5.6.4 Quantitative Analysis 
The aims of quantitative analysis are to provide results from the questionnaire which are 
used to describe characteristics of respondents and measure attitudes of respondents 
towards public health care services. All questions in the questionnaires were analysed 
using the SPSS statistics programme and were separated in five sections. Sections 1 to 4 
were computed based on descriptive statistics to find out the frequency in characteristics 
of respondents. Part 1 represents demographic data as percent of gender, age group, 
educational background, income and district of residency. Part 2 relates to the UCS 
coverage which was classified by using percent of respondents in each Universal 
Coverage sub-scheme. Part 3 displays the percent of respondents who had DM or HT and 
their medications. Part 4 relates to the incurred costs for respondents per episode of 
access to health care, which were calculated using percentages of the categories, 
transportation costs, health care costs and other costs. Part 5 is where the mean scores for 
quality of drugs, pharmacy services and overall health care services from public health 
care providers are ranked from the highest to the lowest in each category. 
5.7 CONCLUSION 
The goal of the study is to evaluate the DMC implemented in all public health care 
providers in Pathumthani Province in respect of improving access to medicines supply 
among patients. The study employed both qualitative and quantitative approaches. The 
former aims to describe health care stakeholders' opinions towards an application of the 
DMC for medicines management in public health care providers and the data obtained at 
this stage was analysed using content analysis. The latter reflects health care users' 
attitudes toward medicines management and health care services provided by the public 
sector. DM or HT patients from OPD were randomly selected for different public health 
care providers and the data obtained was analysed using descriptive statistics computed 
by a statistic programme. 
Findings from both qualitative and quantitative research are then presented in Chapter 
6 and Chapter 7 respectively. 
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CHAPTER 6 
Qualitative Findings: 
Medicines Management in Public Health Care Providers 
6.1 INTRODUCTION 
The evolution of health care reforms in Thailand includes two common assumptions 
about the availability of medicines. The first is that rational management of medicines 
will ensure the availability of them through the health care system. Thereby suggesting 
that, if medicines are supplied and managed effectively and they are prescribed in 
accordance with professional standards, then medicines will be available. The second 
assumption is that quality of care, especially in relation to medicines provision, will be 
satisfactory for the majority of both prescribers themselves and patients. 
In this chapter, the investigation of availability of medicines is focused on the Drug 
Management Cycle (DMC) which if followed effectively, ensures that medicines 
management is regulated. This cycle involves four basic processes: selection, 
procurement, distribution and use of medicines. Findings from each of these study 
components are presented in three categories, which are determined by the hierarchy of 
the health care system, comprising the provincial, district, and community or primary care 
unit (PCU) levels. 
6.2 THE RATIONALE OF MEDICINES MANAGEMENT 
The question of whether medicines management was rational was investigated through 
semi-structured interviews with 22 health care stakeholders. The stakeholders comprised 
three policy administrators from Pathumthani Provincial Health Office, three health care 
staff from Pathumthani Hospital, seven hospital directors, seven heads of the community 
pharmacy departments from district hospitals and two heads of the PCUs. The interviews 
were conducted between January and February 2006. This section presents the data from 
these interviews that were analysed in order to: 
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" describe the process of drug management in Pathumthani by the level of the health 
care system, i. e. either the provincial, district, or PCU levels; 
" identify differences and similarities in medicines management before and after the 
implementation of the UCS in 2001 and; 
" describe the role of a pharmacist in medicines management after the initiation of the 
UCS in 2001. 
6.3 THE PROCESS OF MEDICINES MANAGEMENT IN PATHUMTHANI 
PROVINCE 
This section presents the findings from the semi-structured interviews with 22 health care 
stakeholders from all levels of the health care system in Pathumthani Province. 
6.3.1 The Process of Medicines Management in Pathumthani at the Provincial Level: 
How did Policy Administrators Steer the Drug Management Cycle? 
The findings in this section relate to the opinions of three policy administrators from the 
provincial health office and three health care staff from Pathumthani Hospital (a 336- 
bedded hospital) at the provincial level on the DMC. Results from the semi-structured 
interview are summarised in Figure 6.1 which also explains the main findings of this 
section. 
6.3.1.1 Selection 
Qualitative data demonstrate that there are two key components affecting the drug 
selection process: the Provincial Drug List and Needs Assessment. 
- The Provincial Drug List 
In Pathumthani Province, the provincial health office had no direct responsibility for 
choosing drugs on behalf of public health care providers but could encourage the 
Provincial Pharmacy and Therapeutic Committee (PPTC) to draft a guideline for drug 
selection and the provincial essential drug list. The provincial drug list was determined by 
the National Essential Drug List (NEDL) from the MOPH and was implemented in all 
public health care providers in the province. 
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Figure 6.1: Drug Management Processes at the Provincial Level and Main Findings from the Semi- 
structured Interviews with Policy Administrators at the Provincial Health Office and 
Members of Health Care Staff from Pathumthani Hospital 
Summary of the main findings from `Selection' 
SELECTION There were 2 major components in the selection process: 
a) The Provincial Drug List: A protocol for drug 
selection that was expected to ensure a better supply, 
more reasonable use and a low cost of drugs. 
b) Needs Assessment: Being made responsible by the 
PTC for the estimation of demands in drug use from 
all units in Pathumthani Hospital. Assessment of 
drug prioritisation was performed through the VEN 
system. The problem was that the data of drug use 
per fiscal year was not up-to-date. 
Summary of the main findings from `Procurement' 
In this process, there are 3 major components: 
a) Purchase Methods: Pooled Purchase was proper at 
the provincial level but larger hospitals could gain 
PROCUREMENT more benefit than the smaller ones. 
b) Dru Bud et - Fair distribution of bud et on dru g g g g . 
purchases but the delay in budget allocation posed 
considerable problems for drug purchase. 
c) Quality of Drugs: Drugs must be purchased from the 
GMP & QA approved drug companies. However, 
C some respondents were dubious about drugs quality 
from the Government Pharmaceutical Organisation 
(GPO). 
z 
Summary of the main findings from `Distribution' 
Distribution comprises 4 major components: 
C7 a) Distribution Systems: The Pull System was used in 
the distribution of drugs from the pharmacy 
department to other units in Pathumthani Hospital. 
There was no distribution of dru s from the g 
DISTRIBUTION provincial health office to local health care 
providers. 
b) Drug Storage: Using both central stock and the sub- 
stock systems. 
c) Delivery System: Drugs were double checked by 
both a pharmacist and a member of staff from each 
it th df d Th tit dt t requeste or rugs. e quan y an ypes un a 
of drugs were also verified before delivery. 
d) Pre-prescription Arrangement: The last process of 
drug distribution before prescription. This process 
related to pre-packing or pre-arranging drugs into a 
sub-stock. 
Summary of the main findings from `Use' 
There are 4 components for rational drug use: 
a) Correct Drugs: This related to monitoring and 
USE 
double checking the prescription. 
b) Appropriate Indication: Pharmacists monitoring and 
providing drug counselling services to prescribers. 
c) Proper Drugs and Suitable Dosage: This was 
controlled by a hospital drug use guideline and 
monitored by pharmacists. 
d) Patient Adherence to Treatment: This is not 
satisfactory in the hospital yet. More health 
education and community work must be 
implemented. 
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"... The PPTC will determine and draft the provincial drug list which is the protocol to ensure 
drug availability in the province. In addition, drug lists from other health care providers must 
comply with this protocol. " (Health policy administrator 1) 
The drug selection guideline states that all public health care providers must choose drugs 
items from the essential drug list as their first priority. Nonetheless, such a guideline 
provides flexibility for the hospital to purchase non-essential drugs (NEDs) if they are 
included in the hospital drug list. Therefore, the NEDs could be added to a hospital drug 
list if their total value does not exceed 20% of the hospital's total drug budget (Table 6.1). 
Table 6.1: Recommended Proportions of Essential Drugs (ED) to Non-essential Drugs (NED) 
(by Percent of Drug Purchase Value) 
Percent of recommended ED to NED 
by drug budget Maximum drug 
Levels of public health items allowed 
care providers 
ED NED 
Provincial Health Office N/A N/A N/A 
Pathumthani Hospital 80 20 600 
District Hospital 90 10 395 
Primary Care Unit 100 0 95 
Remark: - N/A denotes that Pathumthani Provincial Health Office does not provide curative care 
services for patients and thus no drug is available there. 
Source: Pathumthani Provincial Health Office Report 2004 
"... Although drug items are carefully selected in accordance with the provincial drug list and a 
selection guideline, massive requests for new drugs (both EDs and NEDs) from prescribers are 
increasing everyday. This is partly due to the out-of-date hospital drug list. " (Member of health 
care staff 1, Pathumthani Hospital) 
"... It is impossible for the hospital drug list to include only drugs in the provincial guideline. 
Prescribers tend to prefer high-end drugs to generic ones; therefore, they don't even know what is 
in the national drug list. " (Member of health care staff 3, Pathumthani Hospital) 
As the largest and most important hospital in the province, Pathumthani Hospital has 
numerous specialists in different fields of treatment. Although up to 20% of the total 
drugs budget could be spent on non-essential drugs, some prescribers still requested to 
use drugs that were not included in the hospital drug list. As a result, demands to use 
drugs which are excluded from the essential drug list can occasionally cause some 
problems in the drug selection process. 
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"... It may be true that the newest generations of drug items are often more effective but sometimes 
are more expensive than the older generations. However, the problem is that they are not usually 
included in the hospital drug list. The limit of the drug budget and the increase in numbers of 
patients still worry me about how to decide on such a selection. " (Member of health care staff 1, 
Pathumthani Hospital) 
- Needs Assessment 
Due to the various requirements of drugs used in the hospital, needs assessment is done to 
evaluate demand and necessity of drug items that are used in the hospitals for a particular 
period of time. Needs assessment is operated through the Pharmaceutical and Therapeutic 
Committee (PTC) which comprises doctors, dentists, pharmacists, nurses and other 
related health care staff. All committee members are officially appointed from the 
hospital and endorsed by the provincial health office. The committee's responsibilities are 
to determine and revise the hospital drug list. This process is performed through the drug 
prioritisation system or `VEN'. 
VEN is a system of setting priorities for selecting drugs and keeping stock, in which 
drugs are divided according to their health impacts. The abbreviation of VEN comprises 
three drug categories, V for `vital', E for `essential' and N for `non-essential' drugs. Vital 
drugs (V) are those that are occasionally prescribed but are regarded as life saving, such 
as snakes' serum or dopamine. Nonetheless, these drugs are required to be in stock all the 
time due to their unique efficacy of treatment. Essential drugs (E) refer to 
pharmaceuticals that are specified in the National Essential Drug List (NEDL) and 
commonly used in the health care services, such as Paracetamol, HCTZ and Amoxicillin. 
Non-essential drugs (N) are those that are rarely used and are not categorised in the 
NEDL, such as some orphan drugs; and combination formulae of muscle relaxants or cold 
remedies (WHO 1997d). 
"... Needs assessment is conducted through the PTC which helps facilitate the process of' drug 
selection. " (Health Policy Administrator 2) 
"... Information regarding the demand for drugs from each department is useful for needs 
assessment. " (Member of health care staff 2, Pathumthani Hospital) 
The drug selection process at the provincial level comprised two key elements: the 
essential drug list and needs assessment. The concept of the essential drug list was 
centred on the essential drug policy which was originally determined by the National 
Essential Drug List Committee from the MOPH. The provincial health office was 
responsible for determining a guideline for drug selection but did not directly involve 
itself in such a process. Conversely, Pathumthani Hospital was regarded as a health care 
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provider that adopted the provincial drug list in its practice. The hospital's proportion of 
ED: NED, by percent of drug budget was approximately 83: 17, which complied with the 
provincial criteria of 80: 20 (Pathumthani Province 2004). 
Needs assessment was performed by the PTC in each health care provider and the 
committee comprised health care professionals such as doctors, dentists, pharmacists and 
other drug-related health care staff. One of the reasons that some health care professionals 
were invited to participate in the PTC was to brainstorm on proper drug selection. 
Another purpose was to prevent further arguments from other health care professionals 
who would have requested to use NEDs or drugs that were not included in the hospital 
drug list. Nonetheless, the up-to-date hospital drug list needs to be adjusted regularly by 
the PTC to ensure that the selection process corresponds with the demand from both 
prescribers and patients. 
6.3.1.2 Procurement 
Data from the semi-structured interview show that there are three major components 
influencing the drug procurement process at the provincial level: Purchase Methods, Drug 
Budget and Drug Quality. 
- Procurement Methods 
Since the provincial health office had no responsibility to purchase drugs for health care 
providers, it set up the `Pooled Purchase' method which is used as a central tool to 
maintain the effective procurement process. Health policy administrators believe that 
Pooled Purchase is the best way to negotiate with drug suppliers to obtain low price, good 
quality drugs. Therefore, health care providers are able to save money on the part of their 
budget that would be spent on other drug purchases: 
"... Pooled Purchase, although not the best solution for drug procurement, can guarantee that less 
money will be spent on drug purchases. " (Health Policy Administrator 3) 
"... Comparing the current systems of drug purchase with the one three years ago, I am quite 
satisfied with the result. With massive orders, the price will be lower than it is for individual 
purchases. " (Health Policy Administrator 1) 
In addition, some member of health care staff suggested that the pooled purchase 
system be an appropriate method for drug procurement and should be implemented in a 
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drug management system without any pressure or force from the provincial health office. 
This resulted in the improvement of transparency in drug purchases: 
"... The Pooled Purchase Method itself is compatible with the current situation in the province. In 
addition, it is more transparent than it was ten years ago. " (Member of health care staff 1, 
Pathumthani Hospital) 
"... Pooled Purchase is the best solution so far but must not be interfered by the provincial health 
office like it was in the past. " (Member of health care staff 2, Pathumthani Hospital) 
Alternatively, other drug items, which were not included in the Pooled Purchase's list, 
were bought separately by individual health care providers. Generally, the drugs were 
supplied by the Government Pharmaceutical Organisation (GPO) and private drug 
suppliers. Health policy administrators agreed that the cost of drug purchases could be 
reduced by 20% to 30% if public health care providers bought most drugs from the GPO 
and used Pooled Purchase for buying in bulk (PPHO 2004). Members of health care staff 
in Pathumthani Hospital argued that drugs from the GPO were somewhat more expensive 
than those from private drug suppliers. This would cause an increase in the total budget 
for drug purchases since the hospital needs to maintain the ratio of drug purchases at 80 to 
20 (EDs to NEDs). 
"... There is a wide range of good quality essential drugs manufactured by the GPO and their costs 
are generally much cheaper than private suppliers. " (Health Policy Administrator 2) 
"... All public health care providers are forced to buy essential drugs from the GPO if such items 
are manufactured by the GPO. Several drug items manufactured by the GPO are more expensive 
than other private drug suppliers. " (Member of health care staff 3, Pathumthani Hospital) 
However, members of health care staff agreed that the GPO had a crucial 
responsibility to produce orphan drugs, such as antimalarial medication (e. g. Quinine and 
Chloroquine) since no other drug suppliers manufactured them. In addition, these drugs 
are rarely used in Pathumthani Province, but are generally considered to be life saving 
drugs or in the V category. The opinions from some health care staff towards the GPO's 
role in this respect were positive: 
"... The GPO impresses us by its goal to provide drugs to solve health care problems for Thais. 
Although it is known that the cost for manufacturing some orphan drugs, such as Quinine, is 
rather high and the use of such a drug is rare, the GPO still manufactures this drug. " (Member of 
health care staff 3, Pathumthani Hospital) 
- Drug Budget 
Regarding the provincial budget allocated to Pathumthani Hospital, health care staff felt 
that although the drug budget was adequate, it may not be sufficient for any possible 
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emergency situations, such as an outbreak of infectious diseases (e. g. dengue fever or bird 
flu). In addition, the delay of annual budget allocation caused the hospital to be in debt 
with drug companies. 
"... The drug budget is adequate but not for any unexpected emergency situations or unplanned 
activities. " (Member of health care staff 1, Pathumthani Hospital) 
"... Although the budget is available for drug purchase, the hospital needs to use its credit to order 
drugs from suppliers due to the delay of the budget allocation from the provincial health office. 
Thus, when the money arrives, the hospital is already in debt. " (Member of health care staff 2, 
Pathumthani Hospital) 
This was argued by policy administrators that the fiscal budget allocated to public 
health care providers did not relate to the emergency outbreaks of diseases which in fact 
had another separate fund. In addition, the delay of budget allocation was due to the 
governmental regulations at the MOPH which consumed more time than expected to 
check the amount of budget. 
"... The fiscal budget is not intended to be used for the emergency outbreak of diseases which has 
its separated budget already. " (Health Policy Administrator 2) 
"... We have strived to chase up the MOPH regarding budget allocation. However, the delay is due 
to those bureaucratic rules and regulations before the budget is transferred from the MOPH. " 
(Health Policy Administrator 3) 
- Drug Quality 
Regarding the quality of drugs from both the GPO and the Pooled Purchase system, 
health policy administrators believed that drug quality from the GPO and private drug 
companies was similar. This was because drug companies, including the GPO, were 
required to submit the GMP and QA certificates on any drug items purchased from them 
to either the PPTC (for Pooled Purchase) or the public health care providers (for normal 
or open tender purchase) before their bids. Conversely, members of health care staff from 
Pathumthani Hospital were unconvinced about drug quality, especially drugs 
manufactured by the GPO. The reason was that the QA process was an in-house 
inspection performed by each drug supplier separately. Therefore, negative results 
regarding drug quality could be adjusted or distorted to meet the minimal standard for 
each drug. Members of health care staff proposed that the provincial health office should 
be the centre for QA monitoring. This could be done by setting up a provincial drug 
sampling plan, which aimed to inspect drugs produced by both private suppliers and the 
GPO, and then sending them to the central lab at the MOPH for inspection to ensure that 
good quality drugs are received. 
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"... There are QA certificates for all drug items purchased from either Pooled Purchase or Direct 
Purchase from the GPO. In addition, drug suppliers and the GPO can guarantee the quality of 
their drugs by having their GMP certificates, which are obtained from the MOPH. " (Health Policy 
Administrator 3) 
"... 1 do agree that GMP and QA certificates can fundamentally guarantee drug quality. However, 
1 am a bit dubious about the self-audit process that drug companies or the GPO use, which 
involves them using their in-house lab to examine their drugs. " (Member of health care staff 2, 
Pathumthani Hospital) 
"... The provincial health office must be the centre of QA monitoring for drugs that we purchased 
through either Pooled Purchase or the GPO. Some drug items will occasionally be randomly 
selected and sent to the central lab at MOPH for assurance of their quality. " (Member of health 
care staff 3, Pathumthani Hospital) 
The qualitative data showed that the drug procurement process consists of three major 
components, which help to ensure the availability of drugs in a health care system. 
Firstly, Procurement Methods used in Pathumthani Provinces comprised three methods: 
Open Tender, Direct Purchase and Pooled Purchase. Open Tender was the key method for 
drug procurement in all public health care providers, whereas Direct Purchase was the 
method used for buying drugs from the GPO and Pooled Purchase was applied to those 
drug items determined by the PPTC to be purchased in bulk. Secondly, Drug Budget was 
allocated by the provincial health office in terms of annual fiscal budget which comes 
totally from taxation. However, health care stakeholders complained that the fiscal budget 
was limited, and may not be sufficient if there were any emergency situations. Lastly, for 
Drug Quality, this was guaranteed by the GMP and QA certificates from both drug 
companies and the GPO. However, some members of health care staff were not 
convinced of the self-audit quality assurance and thus they proposed that the provincial 
health office should set up a plan to clarify the drug quality issues. 
6.3.1.3 Distribution 
After drugs are carefully chosen in the selection process and are purchased by using the 
procurement system, they are delivered to operational units in the hospital. The results 
from the semi-structured interviews were mainly centred on members of health care staff 
in Pathumthani Hospital. According to the qualitative data, drug distribution in 
Pathumthani Hospital required four major components: Distribution Systems, Storage, 
Delivery Methods and Pre-prescription Arrangement. 
- Distribution Systems 
The distribution system starts with the system design which comprises two key methods, 
the Pull and the Push Systems. Both systems are generally used in the public health care 
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system as described in Chapter 3. Members of health care staff from Pathumthani 
Hospital agreed that the most suitable distribution system for them was the Pull System. 
The pharmacy department acted as a drug supply source and received orders from 
individual departments in the hospital. Each department determined the types and 
quantities of drugs required and submitted their requisites to the pharmacy department. 
"... Any operational units that need drugs must submit a form specifying types and quantities of 
drugs to the pharmacy department. (Member of health care staff 1, Pathumthani Hospital) 
The Pull System was suitable for Pathumthani Hospital because it is a large hospital 
with many operational units requested for drugs. As a result, the pharmacy department 
could not handle the estimation of need for each operational unit. The Pull System 
provides flexibility for operational units to manage and adjust their demand of drug use in 
relation to the situation of diseases and patients' need. However, the pharmacy 
department, in fact, still control demands of drugs from every department. This is because 
it is the pharmacist's responsibility to check drug inventory from a sub-stock15 in all 
operational units every month. The amounts of drugs that were used in the past month 
should be equal to the requested quantities on the order form for the current month. In 
addition, re-checking was also performed when there were abnormalities in the orders, 
such as the quantity of drugs being too large or orders of drugs that were not listed in the 
hospital's drug list. 
"... Although all operational units are self-managed to use drugs, the pharmacy department still 
control them by sending a pharmacist to check the balance of inventory regularly. " (Member of 
health care staff 2, Pathumthani Hospital) 
"... I experienced the huge amount of drugs in the drug order form submitted by one operational 
unit. Later, it appears that this was a mistake due to mistyping. (Member of health care staff 3, 
Pathumthani Hospital) 
The staff from the pharmacy department proposed that regular checks of inventories of 
the sub-stocks from other departments should be performed. One member of staff from 
the pharmacy department also commented that the double check process from both a 
pharmacist and a staff member who works in the department involved may help alleviate 
errors and mistakes. 
'5A sub-stock is a place in an operational unit reserved for stocking drugs and medical equipment that are 
regularly used for health care services. A sub-stock is there to provide drugs to either patients or health care 
staff when the pharmacy department is closed. The sub-stock is usually available at A&E, IPD, OPD, the 
Labour Room (LR), the Operation Room (OR) and the dental department (WHO 1997e). 
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"... Errors or misunderstandings between a pharmacist and members of staff in operational units 
could be reduced if there is a double checking process whereby a pharmacist and a member of' 
staff from a particular department confirm whether a sub-stock is available. (Member of health 
care staff 1, Pathumthani Hospital) 
- Drug Storage 
Health care staff pointed out that storage depends on the type and nature of a drug which 
are specified in the instructions supplied when a drug is delivered to the pharmacy 
department. In addition, the provincial health office provides a guideline for the storage 
of drugs which are in the provincial drug list. This guideline is adopted from the NEDL. 
In addition, drugs distributed to all departments in the hospital that have sub-stocks must 
comply with the guidelines of storage. Nonetheless, some vital drugs such as snakebite 
serums, rabies vaccine and insulin must be stored at low temperatures. A pharmacist is 
responsible for providing further instruction and advice about this to the staff in each 
operational unit. 
"... The instructions regarding drug storage come from both drug companies and the provincial 
health office guideline. In addition, a pharmacist will help to control the storage process and make 
sure that drug quality remains the same as when it was originally produced. " (Member of health 
care staff 2, Pathumthani Hospital) 
- Delivery Methods 
Drug delivery refers to the process where drugs are distributed to operational units in the 
hospital that require them. After all departments send an order form to the pharmacy 
department, a member of staff from each department will collect and check both the 
quantities and types of drugs before they are released. 
"... Before drugs are delivered to an operational unit, a pharmacist and a member of staff from 
that particular department will check them together. In addition, after drugs are delivered to the 
target departments, double checking will also be carried out by a pharmacist and each 
department's representative. This is to re-check quantities and types of drugs as well as the 
condition of storage. " (Member of health care staff 1, Pathumthani Hospital) 
- Pre prescription Arrangement 
After drugs are distributed to all departments, they are ready for prescribing. However, in 
Pathumthani Hospital, there is another step in between the process of drug delivery to 
patients and the use of drugs. A member of health care staff in the pharmacy department 
pointed out that this process is called `Pre prescription Arrangement' which refers to any 
preparation that helps facilitate the process of drug dispensing, aiming to improve 
efficiency of the pharmacy services. 
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"... 1 think the pre-prescription process is a stage where members of health care staff strive to 
create a certain readiness for their health care service before delivering drugs to patients. Drug 
preparation such as pre-packing, arranging drugs on shelves and releasing drugs from a stock to 
a sub-stock are carried out by members of health care staff in operational units to ensure that the 
drugs are ready to be prescribed and given to patients. " (Member of health care staff 2. 
Pathumthani Hospital) 
The drug distribution process at the provincial level revolves around its four 
components which are distribution systems, drug storage, delivery methods and pre- 
prescription arrangement. Pathumthani Hospital managed the distribution system using 
the Pull System by allowing operational units to determine their drug demand and 
participate in the check and balance system. In addition, drug storage is centred on the 
process of keeping or storing drugs in accordance with both the provincial and drug 
companies' guidelines. Drugs were delivered to operational units by a member of health 
care staff who collects drugs directly from the pharmacy department. However, pre- 
prescription arrangement was performed to improve efficiency of pharmacy services 
before drugs were dispensed to patients. 
6.3.1.4 Use 
Health care stakeholders defined the term `use' as rational drug use which states that a 
prescriber must: select correct drugs, prescribe drugs with appropriate indication, use 
drug with suitable dosage, encourage patients' adherence to treatment and use generic 
drugs. 
- Selecting Correct Drugs 
Health care stakeholders stated that a prescriber should consider the promotion of correct 
drug use in their health care facilities. To do this, the pharmacy department set up a team 
which only consisted of pharmacists who double checked prescriptions and asked patients 
about their symptoms or diseases. If it appears that the drugs prescribed do not 
correspond with the clinical manifestation, a pharmacist will consult a prescriber to 
confirm whether the prescription was correct. 
"... The key factor for rational drug use is when a prescriber orders correct drugs. " (Member of 
health care staff 2, Pathumthani Hospital) 
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- Prescribing Drugs with Appropriate Indication 
Health care staff from the pharmacy department defined the terms `appropriate 
indication' as the reason to prescribe drugs based on medical considerations. 
Furthermore, it is difficult for a pharmacist to measure this directly since a prescriber has 
their own judgement on selecting proper drugs for either a disease or a patient. However, 
at this stage, the pharmacy department provides suggestions for alternative drugs when 
there is an inappropriate indication of drug use that appears in a prescription. 
"... We cannot do much to interfere with a doctor's order. To date, what we do is consult a doctor 
and recommend him for alternative drugs with more proper indications. " (Member of health care 
staff 3, Pathumthani Hospital) 
- Using Drugs with Suitable Dosage 
To encourage prescribers to use proper drugs with suitable dosage in health care facilities, 
Pathumthani Hospital has drafted a proper drug use guideline for prescribers to be used as 
a reference for treatment. The guideline is drafted by the PTC and is revised twice a year. 
It is distributed to all operational units in the hospital as a medical reference. Prescribers 
are required to comply with the practice in the guideline to ensure maximum benefits for 
both the hospital and patients in terms of safety and cost-effectiveness in drug use. This 
guideline is a brief summary of instruction in terms of the drugs that are considered the 
first and the second choice treatments for patients with particular diseases. In addition, the 
guideline encourages prescribers to diminish polypharmacy in a prescription. This also 
helps to avoid any consequences of overprescribing, such as an increase in adverse drug 
reactions and the overdose of drugs. 
However, some members of health care staff disagreed with the guideline. The reason 
is that treatment is the combination of both medical knowledge and art; to diagnose and 
treat patients. Moreover, they believe that drugs in the prescription are the most proper 
with correct dosage and thus they may ignore the guideline. Nonetheless, most health care 
staff realised that to make drugs more rational, they needed to consider the 
appropriateness of the medication and its dosage before prescribing any drugs. 
".... I disagree that having a guideline is the answer for rational drug use. Conversely, it may 
restrain a prescriber from performing their responsibility towards patients. " (Member of health 
care staff member 2, Pathumthani Hospital) 
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- Encouraging Patients 'Adherence to 
Treatment 
Members of health care staff emphasised that patient's adherence to medication was key 
success and an ultimate goal in health care services. However, a member of health care 
staff commented that although patients understand how to use drugs appropriately and 
have a basic knowledge of disease prevention, their lifestyles and community may also 
influence their behaviour not to comply with the medication regimen. 
"... Although instructions and community-based tasks (such as home health care) have been 
provided for patients, more than a half of them who regularly visit this hospital, particularly the 
elderly, still do not adhere to treatment. There must be some factors, such as the community itself 
or their lifestyles that affect drug compliance. " (Member of health care staff 3, Pathumthani 
Hospital) 
The drug use process at the provincial level referred to rational use of drugs in 
Pathumthani Hospital. However, the effective drug use requires collaboration between 
prescribers and patients. In addition, factors influencing rational drug use comprise: 
selecting correct drugs, understanding appropriate indication, choosing proper drugs and 
suitable dosage, and encouraging patient to comply with treatment, which health care 
stakeholders believed to improve the rational use of drugs in the province. 
6.3.2 The Process of Medicines Management in Pathumthani at the District Level: 
How did Hospital Directors and Heads of the Community Pharmacy Departments 
Steer the Drug Management Cycle? 
The findings in this section describe 14 health care stakeholders' opinions towards the 
DMC. These views were specifically obtained from seven hospital directors and seven 
heads of the community pharmacy department from seven district hospitals in six 
districts. The size of health care providers in terms of the number of beds available varies 
from 10 to 120. Results from the semi-structured interview are summarised in Figure 6.2 
which also explains the main findings of this section. 
6.3.2.1 Selection 
Qualitative data obtained from stakeholders at the district level show that factors affecting 
the drug selection process consist of the Provincial Drug List and Needs Assessment. 
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- The Provincial Drug List 
Hospital directors and heads of the community pharmacy department agreed that the 
provincial drug list was important in shaping the drug list in district hospitals. However, 
some hospital directors suggested that the provincial drug list should be updated regularly 
since new drugs are launched in the market everyday and the demands from prescribers 
for new essential drugs are continually increasing. 
"... It would be better if the PPTC updates the provincial drug list regularly. Thus, a district 
hospital can provide the most up-to-date and high potency drugs for prescribing to patients. " (A 
Hospital Director, District Hospital 1) 
"... Obviously, the drug selection process at the district level is a subset of the provincial drug list. 
Without the provincial drug protocol, drugs in this province might vary from one hospital to 
another, depending on the demands of the prescribers and the richness of a health care provider. 
(A Head of the Community Pharmacy Department, District Hospital 2) 
- Needs assessment 
Health care stakeholders at the district level emphasised that the terms `needs assessment' 
should refer to a process of evaluating the demand for drugs used in the operational units 
of a district hospital. All operational units could suggest certain drug items that could be 
included in the hospital drug list through the PTC. 
"... Needs assessment is the first and very important stage in drug selection. Annual demands for 
drugs from every operational unit in the hospital will be discussed through the PTC regarding 
necessity and cost-effectiveness for each drug. " (A Head of the Community Pharmacy 
Department, District Hospital 6) 
"... When talking about needs assessment, the PTC is also key in the success of the drug selection 
process. This committee is very important in shaping the hospital drug list which combines all the 
needs for drugs from every operational unit in the hospital. " (A Hospital Director, District 
Hospital 4) 
Interestingly, although the PTC expected to obtain as much information as possible 
from operational units, the decision to include any drug items in a hospital drug list relied 
mainly on prescribers' preferences and was not based on the existing data. Some hospital 
directors argued that those drugs which could certainly be added to the hospital drug list 
needed no consideration. Therefore, this process can be skipped to save time. However, 
for new drugs, which have never appeared in the drug list before, the PTC must carefully 
consider them and use the clinical drug data for determination before approval. 
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Figure 6.2: Drug Management Processes at the District Level and Main Findings from the Semi- 
structured Interviews with Hospital Directors and Heads of the Community Pharmacy 
Departments from Seven District Hospitals 
Summary of the main findings from `Selection' 
SELECTION There are 2 factor affecting drug selection: 
a) Provincial Drug List: Each hospital had its own drug 
list and used it as a protocol for drug selection. 
b) Needs Assessment: The hospital's PTC determined 
drug requirements. However, the major problem 
regarding the PTC's authority was that drugs were 
chosen regarding GPs' preferences rather than the 
real demand of drug consumption in a hospital. 
Summary of the main findings from `Procurement' 
There are 3 major factors affecting drug procurement: 
a) Purchase Systems: The Pooled Purchase System was 
used for drug purchases. Each hospital ordered drugs 
directly from suppliers. Larger hospitals tended to 
PROCUREMENT gain more benefit from this method than smaller 
id h h l care prov ers. ea t 
b) Drug Budget: Fair distribution but most interviewees 
worried about the delay in budget allocation from 
the provincial health office. 
C4 C) Drug Quality: The quality of drugs depended on 
0. 
GMP approval from the MOPH and the provision of 
C . a QA certificate from drug companies. 
However, the 
quality of drugs from the GPO was reliable and 
complied with the standards. 
z 
Summary of the main findings from `Distribution' 
There are 3 major factors affecting drug distribution: 
Z a) System of Distribution: The distribution of drugs 
from the community pharmacy department to the 
DISTRIBUTION operational units 
in the hospital was classed as the 
stem Pull S 4 10 4 . y 
b) Drug Storage: The major problem was the 
inappropriateness of storage areas in terms of space, 
temperature and equipment. However, this was 
being improved in each hospital. 
c) Drug Delivery: There was double checking of the 
drugs carried out by a pharmacist and a staff member 
from other operational units to prevent errors or 
mistakes in quantities or types of drugs. 
Summary of the main findings from `Use' 
There are 4 major factors relating to use of drugs: 
a) The Meaning of 'Use': This referred to rational drug 
use. 
b) Enhancing Rational Drug Use in District hospitals: 
This required 3 key components, prescribers, 
USE dispensers and patients. 
c) Achieving the Rational Drug Use Concept: Patients' 
adherence to treatment must be encouraged to 
expand to more patients. The results from the district 
hospital were not yet satisfactory. More health 
education and community work in relation to 
community participation needed to be done by 
patients. 
d) Generic Drugs Policy: The increase in generic drug 
items in the hospital drug list resulted in saving drug 
budget and diminishing the difference in drug items 
used between patients under each UCS sub-scheme. 
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"... Needs assessment might be influenced by a hospital director and some prescribers by adding 
drugs that they want to use to the list. " (A Head of the Community Pharmacy Department, District 
Hospital 5) 
"... Since there are more than 300 drug items to consider, we have to save time by moving on to 
some new drugs or drugs that are proposed to be withdrawn from the hospital drug list. However, 
such a process needs to be approved by the PTC. " (A Hospital Director, District Hospital 4) 
Both hospital directors and heads of the community pharmacy department also pointed 
out that due to the high turnover rate of GPs among district hospitals, some drugs that 
were previously used by one GP, but had not been prescribed since they left to work 
somewhere else, became orphan drugs. Therefore, the PTC needed to pay more attention 
to such drugs and update the hospital drug list regularly. 
At the district level, health care stakeholders stated that the drug selection process was 
crucial as the first stage of the DMC. Factors affecting drug selection comprised the 
hospital drug list and needs assessment. The former was influenced by the provincial drug 
list which was employed by all public health care providers in the province as a protocol 
for drafting a drug list. The latter involved a local PTC who was responsible for 
determining the requirement of and considering drugs requested from all related 
departments in a district hospital. However, the `needs assessment' term that health care 
stakeholders articulated is likely to refer to the data of drug consumption in a district 
hospital which were used for estimating drug volume and selecting drug items to the 
hospital drug list. 
6.3.2.2 Procurement 
At the district level, health care stakeholders considered three major factors influencing 
drug procurement: Procurement Methods, Drug Budget and Drug Quality. 
- Procurement Methods 
The methods for drug procurement applied to district hospitals comprised: Pooled 
Purchase, Direct Purchase and Open Tender. Pooled Purchase was used to procure drugs 
in bulk and believed to improve bargaining power against drug suppliers. In addition, 
small district hospitals could afford more brand name drugs which were necessary but 
usually expensive. As a result, patients benefit from such purchases because they have 
more opportunities to use better drugs. 
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"... Pooled Purchase is a good method for drug procurement in all health care levels. For us, it 
increases both our bargaining and purchasing power. Some trade names drugs are more 
affordable for the hospital and, of course, for patients too. " (A Head of the Community Pharmacy 
Department, District Hospital 3) 
"... Pooled Purchase is one part of medicines management that helps alleviate the problem of drug 
unavailability in district hospitals or small health care providers. " (A Hospital Director, District 
Hospital 6) 
Some hospital directors expressed their concerns over the weakness of Pooled 
Purchase. Although it is a proper method for drug procurement in bulk, both drug value 
and volume of purchase were determined and enormously influenced by larger hospitals. 
Some of the drug items in the Pooled Purchase list that appeared in larger hospitals' drug 
lists were not included in some of the district hospitals' or PCUs' drug lists. This was 
because the PPTC only used drug volume and purchase value to prioritise drugs for 
Pooled Purchase. In fact, some criteria such as necessity of drugs as the provincial overall 
picture or cost-effectiveness should have added to the PPTC consideration. 
"... If look carefully, several drug items are missing from the Pooled Purchase list. Such drugs are 
also necessary for all health care providers but do not denote high volume or value of purchase. In 
addition, all hospitals need to use these drugs but drug companies usually refuse to sell them due 
to very low demand in the order. Pooled Purchase could solve this problem, but so far I have not 
seen anything done about it. (A Hospital Director, District Hospital 7) 
For Direct Purchase, it was the method that district hospitals used to procure most of 
their generic drugs from the GPO. Health care stakeholders pointed out that this process 
was compulsory for all public health care facilities and the process of drug purchase was 
also bureaucratic. Such a process took more time and required more paperwork than 
purchasing drugs from private suppliers. 
"... Direct Purchase is a compulsory method for public health care providers, used for buying 
drugs from the GPO. The purchasing process is much delayed by some unduly governmental 
requirements. " (A Head of the Community Pharmacy Department, District Hospital 2) 
"... Nothing wrong with the Direct Purchase method but the problem regarding drug procurement 
emerges from the governmental system itself. " (A Head of the Community Pharmacy Department, 
District Hospital 5) 
Open Tender was used for drug purchase from private drug suppliers. However, it was 
more flexible than Direct Purchase from the GPO but was yet controlled by the 
governmental rules and regulations. In addition, drug price is more competitive and more 
negotiable than the GPO's. 
"... Although drug purchase from private suppliers is more negotiable than the GPO, it is still 
restrained by the strict regulations, particularly on the use of drug budget. " (A Head of the 
Community Pharmacy Department, District Hospital 7) 
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- Drug Budget 
The second factor affecting the drug procurement process is drug budget. All district 
hospitals receive the fiscal budget or the UCS budget through the provincial health office. 
Stakeholders at district hospitals were satisfied that the budget allocation was fair since 
the proportion of budget distributed was computed based on capitation and workload 
performed by each health care provider within one fiscal year. However, health care 
stakeholders also pointed out that using such indicators for the estimation of drug budget 
may leave severe problems to some small district hospitals. For instance, district hospitals 
may compete for increasing their capitation and workload by using their budget to 
provide more branded-name drugs to attract patients. Consequently, smaller district 
hospitals could be left idle because patients tend to register with the larger health care 
providers. The situation could to some extent hinder the principal aim of the UCS in 
creating health care network and using health care providers at each level as a gatekeeper. 
In addition, the quality of health care services in larger hospitals would be affected if the 
number of registered patients increases. 
"... 1 agree that budget allocation should be assessed on the basis of health care performances, 
using workload and capitation. Success in managing drug budget depends totally on the capability 
of each health care provider. " (A Hospital Director, District Hospital 1) 
"... The situation is that every hospital strives to increase their capitation and workload. I am 
afraid that if patients registered more with larger hospitals, nobody will visit the 10 or 30 bedded 
hospitals. They will be left idle and the provincial health care system will inevitably be affected. 
(A Hospital Director, District Hospital 5) 
- Drug Quality 
The quality of drugs is determined by their GMP and QA certificates issued by drug 
companies. In addition, the certificates are compulsory for the drug procurement process 
since they must be submitted to health care providers at the same time when drugs are 
delivered to health care facilities. This is to ensure that the drugs comply with both the 
governmental regulations and pharmacological criteria. Nevertheless, health care 
stakeholders were sceptical about the quality of drugs manufactured by the GPO. Many 
complaints regarding physical problems, such as coating and colour inconsistency for 
tablets, were reported by both prescribers and patients. 
"... In general, drug companies will submit copies of both GMP and QA certificates with the drugs 
to the hospitals. Drugs will be rejected and returned to the companies if such certificates are not 
delivered with drugs, or do not match with their batch numbers. " (A Head of the Community 
Pharmacy Department, District Hospital 2) 
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"... 1 am dubious about drug quality from the GPO. Of course, they provide us with all required 
certificates which fulfil the hospital's minimal requirements. However, when I carefully check 
some physical properties of the drugs such as the consistency of coating or colour, I feel unsure 
whether to use the drugs from the GPO. " (A Head of the Community Pharmacy Department, 
District Hospital 6) 
The Drug Procurement Process at the district level relates to three major components. 
First, there is the purchase system which includes three methods: Pooled Purchase, Direct 
Purchase and Open Tender. Health care stakeholders tended to be satisfied with the 
procurement system in their hospitals but disagreed with bureaucratic regulations which 
caused considerable delays in drug purchasing from either the GPO or private suppliers. 
The second part is the UCS budget which is allocated by the provincial health office in 
relation to the performances of each health care provider in respect of capitation and 
workload data. The method was satisfactory but concerns regarding some small hospitals 
being left useless were widely criticised among health care stakeholders. Lastly, to ensure 
that all drugs purchased meet the provincial standard, the GMP and QA certificates issued 
by drug companies were the basic criteria that the district hospitals require from drug 
suppliers. 
6.3.2.3 Distribution 
Referring to the qualitative data, the drug distribution process in district hospitals 
comprises three components: Distribution Systems, Drug Storage and Drug Delivery. 
- Distribution Systems 
In general, there are two systems used for distributing drugs to other operational units, the 
Pull and the Push Systems. However, health care stakeholders proposed that the Pull 
System was appropriate for transferring drugs to all operational units in the district 
hospitals. Similarly to Pathumthani Hospital, the community pharmacy department acted 
as a drug supply source and received order forms from operational units. These units 
determine types and quantities of drugs, and then submit their requisites to the community 
pharmacy department. 
"... The Pull System is applied for drug distribution in most district hospitals by having the 
community pharmacy department as a drug supply source. " (A Head of the Community Pharmacy 
Department, District Hospital 2) 
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In the Pull System, other departments estimate their drugs demand and submit the order form to 
me. My department will double check the quantities and types with inventories at a sub-stock 
located in each operational unit. (A Head of the Community Pharmacy Department, District 
Hospital 5) 
- Drug Storage 
Health care stakeholders proposed that drugs would remain their original quality and 
potency depending on appropriate storage conditions. However, most district hospitals 
reported that drug storage conditions were satisfactory. For example, a storage room was 
equipped with air-conditioning. Although it is perceived that storage condition is 
important, some district hospitals had ignored the proposal to provide proper conditions 
for drug storage either in the central stock or the sub-stock. Conversely, some hospital 
directors argued that this was due to inefficient management of storage space in the 
community pharmacy department. 
"... Storage is the major concern with respect to prolonging drug quality before they are 
distributed to operational units. (A Head of the Community Pharmacy Department, District 
Hospital 1) 
"... I totally agree that quality of drugs is key in the success of medicines provision for health care 
services. Furthermore, storage is also one process to ensure that we have good drugs to serve 
patients. However, I want to see proper management of space in the hospital's stock first before 
deciding to do something towards the request to expand the central stock for drugs. " (A Hospital 
Director, District Hospital 3) 
- Drug Delivery 
To ensure that drugs are delivered to all departments correctly and efficiently, some 
district hospitals established the double-checking system between the community 
pharmacy department and the operational units that the drugs were delivered to. This 
system was conducted in hospitals where the sub-stocks were separate from the 
community pharmacy departments. The aim of setting up the double-checking system 
was to prevent errors or mistakes that might happen during the arrangement of drugs 
before delivery. Double checking is performed by a pharmacist and a staff member in 
each operational unit altogether. 
"... 1 would prefer the distribution system that includes a sub-stock as a drug storage source to the 
method without a sub-stock one. At least a pharmacist can track how drugs are used as well as 
other specific details, such as drug expiry date and inventory. " (A Hospital Director, District 
Hospital 6) 
For those hospitals with no sub-stocks available in other operational units, a 
pharmacist and a member of staff from another department undertake an inspection for 
mistakes and errors regarding quantities and types of drugs on the order forms. Drugs 
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with types and quantities as indicated on such forms will be released from the community 
pharmacy department once the form has been approved by the pharmacist and the 
member of staff from the particular department involved. 
"... After the drugs are delivered to each department, a member of staff there will check this again 
and then report to the community pharmacy department. " (A Head of the Community Pharmacy 
Department, District Hospital 2) 
"... We do not have a sub-stock here but the inspection system can be performed by both a 
pharmacist and a member of staff from each department. The checking of quantities and types of 
drugs is performed at the community pharmacy department only. " (A Head of the Community 
Pharmacy Department, District Hospital 4) 
The Drug Distribution System comprises three major components: distribution 
systems, drug storage and drug delivery systems. The Pull System was used as the 
method for distributing drugs from the pharmacy department to operational units by 
allowing them to decide their demand and collect drugs from the pharmacy department. 
Drug Storage relies mainly on appropriate conditions and proper management of the 
central drug stock and a sub-stock. These are vital in the success of maintaining the 
quality and availability of drugs. A central drug stock (under the community pharmacy 
department's supervision) is the centre for storing all drug items. In some hospitals, there 
is a small place in other departments to store drugs called a `sub-stock', which aims to 
provide additional space for those common and necessary drugs. A few hospitals did not 
have a sub-stock because they were too small (between 10 and 30 beds) for it to be 
necessary. In terms of drug delivery, the double-checking system is considered important 
because it helps to prevent errors and mistakes in quantities and types of drugs before 
they are distributed to other departments. 
6.3.2.4 Use 
Similar to Pathumthani Hospital, health care stakeholders at the district level stated that 
`drug use' referred to `rational drug use'. They proposed that proper management of 
rational drug use must be based on five concerns: correct drugs, appropriate indication, 
proper drugs and suitable dosage, proper patients, patient adherence to treatment and 
equity of drug use in patients. In addition, the success of rational drug use is partly based 
on compliance from patients with medical regimens. 
"... Rational drug use is the collaborative work between prescribers, dispensers, other health care 
related staff and patients. " (A Hospital Director, District Hospital 3) 
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To conform to the concept of rational drug use, health care stakeholders proposed that 
prescribers should follow a standard process of prescribing, which starts with diagnosing 
patients' illnesses to identify the problem. Then the therapeutic goal should be defined 
and a prescriber must decide which treatment is required. The decision to use drugs is 
based on the district hospital's guideline regarding therapeutic information and a 
prescriber's own judgement. When the decision was made to treat a patient with a 
particular drug, the best drug for patient was selected based on efficacy, safety, suitability 
and cost. The dose, route of administration and duration of treatment must be correctly 
determined by a prescriber. In addition, when prescribing drugs, a prescriber should 
provide proper and sufficient information to a patient regarding both the drugs and the 
patient's condition. 
"... Drugs in a prescription should be derived from the most scrutinised process by a prescriber 
regarding the nature of the patient's problem and the disease. Therefore, drugs are expected to be 
correct, efficient, suitable and just to patients. However, drugs in the prescription are re-checked 
by a pharmacist to prevent any mistakes before they are dispensed to patients. " (A Head of the 
Community Pharmacy Department, District Hospital 5) 
"... Both prescribing and dispensing processes are very important in the delivery of drugs to 
patients. In addition, the attitude of patient towards treatment and medications is also crucial in 
achieving rational drug use. " (A Hospital Director, District Hospital 7) 
The ultimate goal of rational drug use is patients' adherence to treatment. Health care 
stakeholders emphasised that both health promotion and prevention must be implemented 
in either the community or the hospital to provide self-care knowledge to patients. Several 
district hospitals offered home health care projects so that they could reach more people, 
while drug counselling services were also available at the pharmacy department. 
However, the report from Pathumthani Provincial Health Office (2004) indicated that 
more than 50% of OPD patients in district hospitals did not adhere to treatment or 
medical regimens. This was particularly the case with elderly people who suffered from 
chronic diseases such as hypertension and diabetes (Department of Health Care Projects 
2004). 
"... We hope that patients will be aware of their individual health status soon. Hence, it is the 
ultimate goal that they are able to take care themselves and comply with the medication. " (A 
Hospital Director, District Hospital 3) 
"... At the moment, rational drug use in at the district level is still unsatisfactory. Some prescribers 
are not aware of the cost-effectiveness of drugs, while patients are not yet adhered to treatment. 
(A Hospital Director, District Hospital 6) 
Similar to Pathumthani Hospital, an increase in the use of generic medicines under 
Generic Drugs Policy resulted in saving drug budget and diminishing the difference in 
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drug items used between patients insured with the UCS sub-scheme. However, some 
hospital directors proposed that `equity in drug use' should not only refer to the fact that 
everyone uses the same drug items but must also include the processes of prescribing 
drugs and the patient's opportunity to receive drugs regardless of their residency, income 
or social status. 
"... I agree that Generic Drug Policy could help narrowing the gap between patients from each 
UCS sub-scheme in terms of drug use. However, the quality of treatment and the reasonable drug 
order from prescribers must be based on the same standard too. (A Hospital Director, District 
Hospital 4) 
"... It may be a just process that a hospital has only one drug list to be used for all patients under 
the UCS and those who are not insured. (A Hospital Director, District Hospital 7) 
Concerns regarding the provision of rational drug use in district hospitals were related 
to: appropriate indication, proper drugs and suitable dosage, patient adherence to 
treatment and generic drug policy. Such concerns are based on collaborations between 
health care professionals and patients to ensure that drugs are used effectively. In 
addition, to achieve patient adherence to treatment, basic knowledge of self care must be 
implemented in the community. Furthermore, the most practical policy was to encourage 
district hospitals to use more generic drugs which help saving drug budget and increase 
an opportunity for the disadvantaged and the poor groups in access to medicines. 
6.3.3 The Process of Medicines Management in Pathumthani at the Primary Care 
Unit or Community Level: How did Heads of the Primary Care Units Steer the Drug 
Management Cycle? 
At the primary care unit or community level, a primary care unit (PCU) is regarded as the 
smallest health care provider in the provincial health care system. The PCU administrative 
system is simple but its tasks include many health care responsibilities that are delegated 
from both the district and provincial levels. Key findings from the qualitative data are 
summarised in Figure 6.3. 
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Figure 6.3: Drug Management Processes at the PCU Level and Main Findings from the Semi-structured 
Interviews with Heads of the PCUs 
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Summary of the main findings from `Selection' 
SELECTION Factors affecting drug selection comprise: 
a) Essential Drug List: Each PCU had a drug list 
guideline and all drug items were a subset of' the 
district hospital. The number of drug items at the 
PCU must not exceed 95 and all must be essential 
drugs. 
b) Needs Assessment: Needs assessment was performed 
and estimated by the PTC at the district hospital, 
using data from previous fiscal years. 
Summary of the main findings from `Procurement' 
Factors affecting drug procurement consisted of: 
a) Drug Purchase Systems: Pooled Purchase and Direct 
Purchase were mostly used and drugs were ordered 
PROCUREMENT by the district hospital on behalf of the PCU. 
b) Drug Budget: The budget was totally managed by 
the district hospital. 
c) Drug Quality: Most of the drugs purchased for a 
PCU were ordered from the GPO. Thus, drug quality 
was acceptable and complied with the GPO 
standards. 
Summary of the main findings from `Distribution' 
Factors affecting drug distribution consisted of 
a) Distribution Systems: The Pull System was used as 
the major drug distribution system and the district 
hospital was the only drug supply source for the 
DISTRIBUTION 
PCU. 
b) Drug Storage: The major problem was the limit of 
storage spaces due to many PCUs having 
inappropriate storage conditions for keeping drugs. 
c) Drug Delivery: Staff from a PCU collected drugs 
from a district hospital. When drug arrived at the 
PCU, there was no double checking system since the 
service at the PCU level was a one-stop service. 
Drugs were prescribed and dispensed by one set 
health care staff. Inventories and a report on drug 
use were recorded in an order form and submitted to 
the district hospital. 
Summary of the main findings from `Use' 
a) Rational Drug Use: This was stated by a member of 
health care staff to mean the reasonable use of drugs 
USE as determined by centring on patients needs and 
satisfaction but was in fact based on the provincial 
guideline for clinical practice. 
b) Achieving the Concept of Rational Drug Use: 
Patients must have basic knowledge in self-care and 
health care providers are required to have a more 
community-based approach. 
c) Generic Drug Policy: Such policy was effective and 
was key policy at a PCU to promote rational drug 
use. 
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6.3.3.1 Selection 
Opinions towards the drug selection process at the PCU level were not much different 
from both the provincial and district levels. The concept of an essential drug list also 
applied to the PCU. In addition, it is compulsory that the drug list of each PCU must not 
exceed 95 items and all of these must be essential drugs. However, members of staff at 
the PCUs stated that 95 essential drug items did not cover and solve the real problems 
emerging in the community. In addition, the PCU did not have much involvement in the 
selection process as the drugs were chosen from the district hospital by the PTC. 
"... The provincial or the district hospital drug list is used to determined drug items that are 
allowed to be used in the PCU. I disagree with only 95 drug items being permitted to be 
prescribed in the PCU. In the remote PCUs, there should be more drug items to cover any 
emergency cases. " (Head of PCU 1) 
"... We do not know much about drug items until the PTC at the district hospital informs us. What 
we do is just submit our annual requisite for drugs to the committee and wait for such drugs to be 
delivered to us. (Head of PCU 2) 
Needs assessment at the PCU was not so well-managed that it was mainly performed 
by the district PTC. In addition, such assessment commenced when the members of staff 
checked inventories and submitted their requisite to the district hospital. The estimation 
of drug requirement at a PCU was based on the volume of drugs used from past fiscal 
years and was performed by the PTC at the district hospital. Therefore, drug selection for 
a PCU was also done at a district hospital which resulted in the emergence of many 
problems, such as a shortage of drugs, drug expiry, drug overstock or dead stock drugs. 
"... We have used our experiences to estimate and select drugs. So, the normal problems in the 
PCUs are the shortage or overstock of drugs and drug expiry. I think the district hospital should 
be more helpful in terms of guiding us with regards to needs assessment. " (Head of PCU 1) 
"... The judgement from the PTC at the district hospital does not reflect the PCU's real need. It is 
strange that we, who use the drugs, submit the form to somebody who does not know the exact 
situation of drug use at the PCU. Then, they approve what we should buy and what we shouldn't. 
(Head of PCU 2) 
The drug selection process at the PCU mainly relied on the decision of a district hospital. 
Members of staff at a PCU were involved in needs assessment process but not the 
decision making with regards to drug selection as this was performed by the PTC at the 
district hospital. Hence, drug selection at the PCU tended to be under close supervision 
from the district hospital. 
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6.3.3.2 Procurement 
The Drug Procurement Process at the PCU comprised three components, Purchasing 
Systems, Drug Budget, and Drug Quality. At the time of data collection in 2006, the PCU 
was not fully functioning; therefore, all major work regarding the procurement process 
was carried out by the district hospital instead. 
- Purchase Systems 
Drug purchases were performed in bulk through the district hospital using Pooled 
Purchase. Non-essential drugs were not allowed to be purchased and used at the PCU. In 
addition, members of staff at the PCUs strongly agreed with the use of Pooled Purchase 
and supported the district hospital in its central role in purchasing drugs for them. 
"... 1 strongly agree that the Pooled Purchase system provides the PCU with good quality drugs. 
What we do is check the stock and submit the order form to the district hospital. " (Head of PCU 1) 
"... We have a shortage of experienced members of staff who can deal with drug purchase. Passing 
this process on to the district hospital is the best solution since the PTC is there and it will ensure 
that both the quality and availability of drugs remain high. " (Head of PCU 2) 
Conversely, one member of staff argued that although the drug purchases by the 
district hospital could partially ensure the quality of drugs that were used for health care 
services, the actual drug items themselves only corresponded to the district hospital's 
demand rather than what the PCU really needed. 
"... Sometimes drugs that the district hospital purchases for us have never been prescribed. The 
worst case is we do not even know the indication of how to prescribe such drugs to patients. In 
addition, I wonder how these drugs came to the PCU since I am sure that I have not written such 
things in the order form. " (Head of PCU 2) 
- Drug Budget 
Heads of the PCUs disagreed that drug budget was transferred appropriately to the district 
hospital. In addition, they proposed that the Provincial Health Office should allow health 
care providers to manage their budget themselves. In addition, many PCUs experienced a 
shortage of funds for drug purchases since the estimation of their budgets were not based 
on the real data available at the PCU, such as prevalence of diseases or demand of drugs 
by communities. 
"... We have the data of drug consumption or community health status which could be useful as a 
key consideration for budget allocation. However, nobody asks for such data but they can estimate 
how much budget we need. (Head of PCU 1) 
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"... 1 am very dubious of what the Provincial Health Office considers for budget allocation. Every 
year, / experience a shortage of drug budget and need to ask for support from other PCUs or 
district hospitals. " (Head of PCU 2) 
- Drug Quality 
All drugs used at the PCU were essential medicines and were purchased mainly from the 
GPO. Heads of the PCUs agreed that drug quality was acceptable regarding the GMP or 
QA certificates. 
"... At the PCU, we only have essential drugs and almost all drugs are GPO brands. I think drug 
quality is acceptable so far. " (Head of PCU 1) 
"... Drugs are guaranteed by their GMP and QA certificates and thus we are not worried about 
their quality. " (Head of PCU 2) 
The PCU did not play much of a role in the procurement process due to governmental 
regulations and a lack of members of staff. The Pooled Purchase system was also applied 
for drug procurement at the PCU level but did not play an important role in drug 
purchases. Nonetheless, the quality of drugs at both the PCU and the district hospital were 
of the same quality since they were procured from the same source. 
6.3.3.3 Distribution 
The distribution process at the PCU comprises three major components: Distribution 
Systems, Drug Storage and the Drug Delivery. 
- Distribution Systems 
As with the provincial and district levels, the Pull System was also applied to drug 
distribution at the PCU level. The pharmacy department at the district hospital is the 
major drug supply source of the PCU. In addition the PCU is likely to be compared to one 
operational in the district hospital and the only difference is that the PCU is located 
outside the district hospital. Regarding the Pull System, heads of the PCU described that 
they could submit a requisite form to the district hospital at anytime. However, both heads 
of the PCUs requested that there should be a fixed schedule between the hospital and 
themselves concerning the time that drugs are available to be collected from the district 
hospital. 
°... The Pull System is proper but we are not a department inside the district hospital. The 
community pharmacy department has not yet arranged any fixed schedules for PCUs to pick up 
drugs. (Head of PCU 1) 
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"... I am not satisfied with the drug distribution system firom the district hospital to the PCU. I have 
to track my order whether any drugs are available for collection. The hospital should organise the 
drug distribution system because this does really waste time and other resources, particularly for 
those PCUs located in the remote areas. " (Head of PCU 2) 
- Drug Storage 
Drug Storage is the only process that is obviously managed by the PCU. When drugs 
arrive in the PCU stock, drug registration regarding the details such as names, quantities 
and expiry dates will be recorded. However, heads of the PCU reported that there were 
some problems such as inappropriate places and conditions for drug storage which could 
affect the quality of the drugs. 
"... We only have 95 drugs items but it is not easy to store them properly. I have to keep drugs at 
an ambient temperature which is over 30 degrees Celsius (or 35 degrees Celsius in the summer) 
without air conditioning. I am not sure that drug quality still remains the same as the labelled 
amount or not. " (Head of PCU 1) 
- Drug Delivery 
The drug delivery system at the PCU was performed through district hospitals. Similar to 
operational units in the district hospital, the PCU collected drugs from the pharmacy 
department and brought back them to the PCU. When the drugs arrived at the PCU, there 
was no double checking system at all. In addition, heads of the PCU explained that drugs 
at their unit were prescribed and dispensed by only one or two members of health care 
staff. Thus, with limited health care staff, the process was shorten and incomplete. 
"... There is no drug delivery from the hospital but we do that by ourselves. The proper system 
should be that drugs are delivered directly from the GPO or private drug companies to the PCU 
with the pre-arranged schedules (i. e. every three months or whatever), even though the hospital 
may continue to order drugs for the PCU" (Head of PCU 1) 
"... After the drugs are delivered to the PCU we keep them in the PCU stock. However, we do not 
perform the double checking since most PCUs only have the maximum of three to five members of 
staff. " (Head of PCU 2) 
Drug distribution at the PCU level was performed by using the Pull System. The PCU 
which is located in the community can be compared with one department of the district 
hospital. Each PCU was required to collect drugs from the district hospital but needed to 
set up an arrangement with the community pharmacy department before collecting the 
drugs. After the drugs arrived at the PCU, storage was the next major issue because of 
inappropriate storage conditions and lack of space, which can both have an affect on the 
quality of drugs. 
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6.3.3.4 Use 
The use of drugs at the PCU is centred on the concept of rational drugs use. Heads of the 
PCU defined the meaning of rational drug use to be based on cost-effectiveness and the 
use of drugs by a prescriber to satisfy and benefit patients. However, heads of the PCUs 
stated that such rational drug use referred to: correct drugs, appropriate indication, 
suitable dosage, proper patients, patient's adherence to treatment, and use of generic 
drugs. 
"... I have been working in the community for several years and my idea of rational drug use is 
also the community-based one. So, rational drug use refers to both appropriate treatment and 
satisfaction towards such drugs from the patients who receive them. Moreover, this also refers to 
both the efficacy of drugs and patients' compliance to the medications. " (Head of PCU 1) 
To achieve the rational drug use concept, heads of the PCUs proposed that patients 
must have basic knowledge in terms of caring for themselves when they have a particular 
disease. Furthermore, health care services need to be more community-oriented and 
encourage more community participation to cover all groups of patients. In addition, the 
implementation of Generic Drug Policy was effective at the PCU level since all items in 
the PCU's drug list are generic drugs. 
"The PCU is regarded as a gatekeeper in the health system. This means that if the community is 
healthy and knowledgeable, few drugs will be used in the future to treat some trivial diseases. " 
(Head of PCU 1) 
"... I think the community has its power but the health care workers may not have entered the 
community in the right channel. As a result, we have experienced the health situation so far when 
drugs are irrationally used by both prescribers and patients. " (Head of the PCU 2) 
The use of drugs at the PCU level was similar to the provincial and district levels, 
which were based on the rational drug use concept. To achieve this, a collaboration 
between patients and health care providers needs to be established. Patients should have 
basic knowledge concerning self-care, while prescribers are required to emphasise the 
importance of community-based work. In addition, the PCU needs to create more 
community participation in health care activities, which will in turn help to achieve 
rational drug use and other health care goals. 
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6.4 DIFFERENCES AND SIMILARITIES OF MEDICINES MANAGEMENT 
BEFORE AND AFTER THE IMPLEMENTATION OF THE UNIVERSAL 
COVERAGE SCHEME IN APRIL 2001 
Referring to the data from the semi-structured interviews with health care stakeholders in 
Pathumthani Province, there are differences and similarities in the DMC before and after 
the implementation of the UCS in 200116. The period before the reform in this study was 
between the fiscal year 1999 and 2001 (1st October 1998 to 30th March 2001), while the 
period after the UCS implementation was between 2001 and 2005 (1st April 2001 to 30 
September 2005)'7. The differences and similarities are explained in four categories 
regarding the processes of the DMC. 
Table 6.2: Comparison between Differences and Similarities of the Drug Management Cycle (DMC) 
before and after the Implementation of the Universal Coverage Scheme (UCS) in 
Pathumthani Province 
Criteria of 
Before the implementation of 
DMC Processes Comparison the 
UCS 
(1999 to 2001) 
After the implementation of 
the UCS 
(2001 to 2005) 
1. Selection - Essential Drug List There was a provincial " There was a provincial 
essential drug list but did drug list and all necessary 
not include some drugs drugs were added to the 
that were used in health list. 
care providers. " There were more essential 
" Drugs in the list did not medicines on the 
cover all diseases in each provincial drug list which 
health care provider. covered all common 
" There was more than one diseases for each health 
hospital drug lists in some care provider in different 
health care providers. levels. 
" There was only one 
hospital drug list in each 
health care provider. 
- Needs Assessment " Undertaken by the 
pharmacy department 
" Steered by the Pharmacy 
and Therapeutic 
Committee (PTC) at both 
the provincial and district 
levels. 
''The Universal Coverage Scheme (UCS) was first implemented in the five provinces of Thailand, 
including Pathumthani Province, on 1s` April 2001. 
'7According to the Thai Government's regulations, the first day of each fiscal year is on 1s` October and the 
last day is 30`h September of the following year. For instance, the first day of the fiscal year 2005 was 
between 1 s` October 2004 and 30`x' September 2005. 
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Table 6.2: Comparison between Differences and Similarities of the Drug Management Cycle (DMC) 
before and after the Implementation of the Universal Coverage Scheme (UCS) in 
Pathumthani Province (continued) 
Criteria of 
Before the implementation of 
DMC Processes Comparison the 
UCS 
(1999 to 2001) 
After the implementation of 
the UCS 
(2001 to 2005) 
2. Procurement - Purchase Methods " Individual purchases " Individual purchases but 
under the provincial drug using Pooled Purchase to 
list. buy drug in bulk in 
" Drugs were purchased combination with Direct 
mainly from both the Purchase and Open 
GPO and private drug Tender. 
comnanies. 
- Drug Budget Drug budget allocation " Drug budget allocation 
used an estimation based was based on work 
on the budgets from performance (capitation 
previous fiscal years. and workload) from 
previous fiscal years. 
- Quality of Drugs " Both GMP and QA " Both GMP and QA 
certificates were required certificates were required 
to ensure the quality of to ensure the quality of 
drugs. drugs. 
3. Distribution - Distribution " Both Push and Pull " Pull System 
Systems Systems depending on 
health care providers' 
preference 
- Storage " Using a stock and a sub- " 
stock system 
" Inappropriate storage " 
conditions of the stocks or 
sub-stocks 
Using a stock and a sub- 
stock system 
Inappropriate storage 
conditions of stocks or 
sub-stocks (4 out of 10 
health care providers) 
- Delivery Double checking by both " Double checking by both 
a pharmacist and a a pharmacist and a 
member of health care member of health care 
staff in an operational unit staff in an operational unit 
4. Use - Drug Use Concept " Based on the concept of " Based on the concept of 
rational drug use rational drug use 
" Less community-based " Focusing more on 
health care tasks. community-based 
" Emphasising curative care approach 
in health care facilities " Focusing on the 
and providing patients combination of treatment, 
with medicines prevention and health 
promotion 
" Striving to improve 
patient adherence to 
treatment 
6.4.1 Selection 
For drug selection, there are two comparison criteria, the essential drug list and needs 
assessment. During 1999 to 2001 or before the first launch of the UCS, the notion of the 
essential drug list was not effectively implemented in Pathumthani Province. In addition, 
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some drugs that were required for the treatment of common diseases were not included in 
the provincial drug list. The most severe situation was that some hospitals drafted two or 
more hospital drug lists to be prescribed for patients registered with different health care 
sub-schemes. 
"... Some hospitals had more than two or even five drug lists. Of course, these were for patients 
with different health care insurance schemes. For example, if you were entitled to health care 
services free of charge; the most likely drugs that would be prescribed to you were those local 
made or GPO brands. Conversely, if you paid in full, the hospital would prescribe you the original 
brands of drugs. " (A Head of the Community Pharmacy Department, District Hospital 7) 
After the implementation of the UCS between 2001 and 2005, the essential drug list 
covered more drug items than regularly used in health care providers at all levels. In 
addition, the most important event to enhance the equity of drug use was the launch of the 
Generic Drug Policy. Hence, in the drug selection process, one generic drug was chosen 
with only one brand and such selection also appeared in both the provincial and the 
hospital drug lists. 
"... The changing point of the provincial drug list was after the implementation of the UCS in 
2001. The Generic Drug Policy influences the drug selection process and; therefore, inspires 
every hospital to substitute branded-name drugs with generic ones" (A Hospital Director, District 
Hospital 4) 
Before 2001, the pharmacy department was only responsible for needs assessment in 
terms of drug use in a health care provider. However, after the implementation of the 
UCS in 2001, the PTC which comprises representatives from all departments in a health 
care provider was in charge of needs assessment. The major task of the PTC in needs 
assessment was to determine demands for and quantities of drugs used in a public health 
care provider for each fiscal year. Nevertheless, nothing was changed at the PCU since 
needs assessment was still performed by the PTC at the district hospital. 
"... Before the implementation of the UCS, the pharmacy department was solely in charge of needs 
assessment. As a result, heads of other departments and prescribers received numerous complaints 
that the drugs from the pharmacy department did not correspond to either the diseases 
encountered or what prescribers really wanted to use for treatments. " (A Head of the Community 
Pharmacy Department, District Hospital 3) 
"... The collaboration between the pharmacy department and other departments in terms of needs 
assessment has been set up through the PTC. We have quite often discussed the addition or 
removal of' one essential drug to/from the hospital drug list. " (A Head of the Community 
Pharmacy Department, District Hospital 6) 
"... Nothing has changed for me so far regarding the drug selection process except the PCU drug 
list, which was derived from needs assessment and determined by the PTC at the district hospital. I 
hope that in the near future I can involve myself more in needs assessment at the district hospital 
or become a member of the PTC. " (Head of PCU 1) 
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6.4.2 Procurement 
The procurement system changed considerably after the implementation of the UCS in 
2001. The alteration of the system centred on three keys components, Purchase Methods, 
Drug Budgets and Drug Quality. 
Before 2001, each health care provider purchased drugs using their own purchasing 
system which were different from one hospital to another. However, drug purchase was 
still performed under a hospital drug list which was a subset of the provincial drug list's 
protocol. The purchase system considerably altered between 2001 and 2005 because the 
provincial health office introduced Pooled Purchase for drug procurement. The provincial 
health office later requested all health care providers in the province integrate such a 
system into their existing provincial purchase methods. Therefore, from 2001 onwards, all 
health care providers used three methods to purchase drugs. These include: Direct 
Purchase which was used for purchasing drugs from the GPO, and was compulsory for all 
public health care providers; Open Tender was applied for buying drugs from private 
suppliers which can be done individually by each hospital; and Pooled Purchase was 
intended to buy drugs in bulk with private drug companies. 
"... One noticeable change after 2001 is the application of Pooled Purchase to all public health 
care providers in Pathumthani Province. Thus, we are able to afford some expensive brand name 
drugs which are also very beneficial for providing better health care services. " (A Hospital 
Director, District Hospital 5) 
"... Since 2001, Pooled Purchase has been the ideal method to buy drugs and it reflects the good 
collaboration between the provincial health office and all public health care providers. It also 
helps improving drug availability under the notion of good drug quality at a low cost. " (Member 
of health care staff 2, Pathumthani Hospital) 
Before the implementation of the UCS, the budget was allocated based on only the 
budget figures from previous fiscal years. In addition, health care providers complained 
that the fiscal budget did not correspond with health care tasks and the population in the 
health care provider's catchment areas. This resulted in the shortage of drug budget in 
many health care providers. However, between 2001 and 2005, drug budget allocation 
was computed based on the performance of each health care provider in respect of both 
capitation and workload they performed from past fiscal years. This method was 
considered fairer and resulted in fewer complaints from health care providers. 
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"... In the past, some hospitals experienced budget insufficiency due to misestimating the budget. 
As a result, drug shortage was the major problem for all public health care providers. " (A 
Hospital Director, District Hospital 1) 
"... Using both capitation and workload to compute the amount of budget for each health care 
provider is considered a fair system. This is also an indirect way to motivate health care providers 
to improve their performance towards health care services. " (Health Policy Administrator 3) 
In the procurement process, quality of drugs was considered to be one of the most 
important issues by almost all interviewees. To ensure that drug quality meets the 
pharmacological standard, all drug companies including the GPO are required to submit 
GMP and QA certificates to the health care providers that order the drugs. This practice 
has been applied to any drug purchase methods in the province. 
"... The GMP and the QA certificates are necessary to ensure the quality of drugs. Hence, drug 
suppliers including the GPO, must submit these documents along with the drugs when delivering 
them to the hospital. This rule is one part of the governmental purchasing guideline and is applied 
to all public health care providers. " (Member of health care staff 6, Pathumthani Hospital) 
6.4.3 Distribution 
The distribution process has not significantly changed compared to other processes. Drug 
distribution comprised three key components, Distribution Systems, Drug Storage and 
Drug Delivery. Before the implementation of the UCS, the distribution system included 
both Push and Pull systems. The choice of which system to be used depended on the 
appropriateness in the application and the decision of the PCT. Generally, the Pull System 
is applied to both the provincial and district levels but some district hospitals use either 
push or pull when they deal with the PCU. 
"... Before 2001, I used to apply the Push System to the PCU, which was formerly called the 
health care centre'. 1 decided and estimated the demand of drugs on behalf of the PCU and acted 
as a drug supply source for them. " (A Head of the Community Pharmacy Department, District 
Hospital 4) 
"... The Pull System has been applied to many health care providers to allow operational units to 
estimate their own demand for drug delivery. This is more practical and correlates more with drug 
needs in the distribution system. " (A Head of the Community Pharmacy Department, District 
Hospital 6) 
Drug Storage was one of the most crucial processes to maintain drug quality before 
distribution. All health care providers in Pathumthani Province used the stock and sub- 
stock systems for keeping drugs before delivering them to target departments. The sub- 
stock was considered important in the larger hospital because that was where the drugs 
were kept before they were prescribed to patients. 
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"... Both the stock and sub-stock systems are applied to all health care providers. Nothing has been 
changed to the systems at the PCU either before or after the implementation of the UCS in April 
2001. " (A Head of the Community Pharmacy Department, District Hospital 1) 
Regarding drug storage conditions, interviewees reported that seven out of ten health 
care providers (except Pathumthani Provincial Health Office) stated that there were 
inappropriate storage conditions before April 2001 (i. e. shortage of spaces and 
inappropriate conditions of a stock). The situation was much improved after April 2001 
but interviewees from four out of ten health care providers were not yet satisfied with the 
storage conditions of drugs in their stocks since they did not comply with the provincial 
guidelines of proper drug storage. 
"... Storage conditions in the central stock improved greatly after 2001. Such improvement was 
motivated by the Hospital Accreditation (HA) assessment from the MOPH. This inspired the 
administrative board to reorganise the health care system in the hospital to meet the minimal 
standards of such assessment. " (A Head of the Community Pharmacy Department, District 
Hospital 5) 
"... I accept that the central drug stock in my hospital has not improved much in terms of the 
adjustment of the proper drug storage conditions but hopefully it will be gradually developed 
soon. " (A Hospital Director, District Hospital 3) 
For Drug Delivery Methods, members of staff from each operational unit (including 
the PCU) were required to collect drugs from the pharmacy department themselves. 
Drugs were double checked by both a pharmacist and a member of health care staff from 
each operational unit to ensure the types and the precise quantities of the drugs were 
correct before they were collected. 
"... All operational units must collect drugs from the pharmacy department. No drug delivery 
service is performed by the pharmacy department. (Member of health care staff 1, Pathumthani 
Hospital) 
"... We have double checked drugs before delivering them to all target departments since the 
implementation of the UCS in 2001. In addition, drug double checking is also applied to all health 
care providers at the moment to ensure correctness in the drug delivery process. " (A Head of the 
Community Pharmacy Department, District Hospital 2) 
6.4.4 Use 
One of the most important processes in the DMC and is the only process that directly 
deals with patients is the use of drugs. According to the interviewees, there are two 
crucial components relating to drug use, the Drug Use Concept and Generic Drug Policy. 
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Before April 2001, the drug use concept was centred on rational drug use. However, 
health care services supplied to patients were less community-based than after April 
2001. Public health care providers acted as medicines distributors to patients, focusing on 
curative care in health care facilities, and did not sufficiently emphasise the real cause of 
health care problems in the community. Consequently, drugs were used ineffectively with 
the dramatic increase in drug budget and more patients still suffered from those 
preventable diseases such as diarrhoea or acute respiratory infection. In some public 
health care facilities, patients were prescribed drugs according what they requested from 
prescribers. 
"... Patients were treated with drugs and were prescribed whatever they wanted. Every patient 
must receive at least one drug in their prescriptions although they were not likely to be unwell. " 
(A Hospital Director, District Hospital 4) 
"... The hospital used a lot of drugs and this led to a shortage at the end of the fiscal year. We used 
drugs for solving health care problems instead of paying more attention to the real cause of the 
problems. " (A Head of the Community Pharmacy Department, District Hospital 7) 
From April 2001 onwards, the provincial health policy aimed to extend health care 
services to the community. This was based on curative care, prevention and health 
promotion. As a result, the drug use process which was centred on the rational drug use 
concept was also oriented to be more community-based. 
"... I do not think that the situation of irrational drug use is alleviated but at least it is much better 
than it was before April 2001. " (Head of PCU 1) 
"... We need to start community-based tasks at once by inputting basic health care knowledge to 
the community. In addition, health care members of staff and patients need to be more cooperative 
in enhancing rational drug use. " (A Head of the Community Pharmacy Department, District 
Hospital 3) 
Due to the implementation of generic drug policy in 2001, patients with different 
entitlements of the UCS sub-schemes and the uninsured received the drugs from the same 
drug list. The situation was better than before April 2001, when there were more than one 
hospital's drug lists for patients registered with different health care sub-schemes. 
"... It is noticeable that after 2001 there is only one hospital drug list. In addition, one generic 
neune of a drug will be matched with only one brand, whereas in the past this may have been as 
many as four or five brands. " (A Head of the Community Pharmacy Department, District Hospital 
4) 
"... I strongly agree to have only one generic for one brand name of drugs. In the past, it seemed 
that some patients were superior to others. At the moment, if you are prescribed, for example, 
Amoxicillin 250 mg (capsule), other patients will receive this drug under one brand name as 
yours. This practice applies to everyone from a farmer, a civil servant or even the Provincial 
Governor. " (A Hospital Director, District Hospital 2) 
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An increase in the number of PCUs and an expansion of health care services to remote 
areas after April 2001 considerably enhanced patients' opportunities to access drug 
provision. In addition, an enhancement in the provincial drug list by including some 
crucial drugs also improves the flexibility of all health care providers and creates more 
drug choices for prescribers to treat patients. 
"... We have more drugs than in the past and, of course, they corresponded more to diseases than 
what we had before 2001. " (A Head of the Community Pharmacy Department, District Hospital 2) 
"... Equity in drug use is not only to provide one generic drug to one brand name, but it is also 
related to how to distribute drugs to all groups of patients. Therefore, they can use drugs with 
their concern and knowledge under guidance from the health care sector. " (Health Policy 
Administrator 3) 
After the implementation of the UCS in Pathumthani Province in 2001, the drug 
management process has considerably improved. In the drug selection process, additional 
essential drugs that cover some diseases common to all health care providers have been 
added to both the provincial and hospital's drug lists. In addition, only one hospital drug 
list is available and each generic drug item in one particular dosage form was matched 
with only one trade name. In terms of drug procurement, the provincial health office has 
introduced Pooled Purchase for purchasing drugs in bulk in relation to the demands of all 
health care providers in the province. 
In respect to drug distribution, all health care providers apply the Pull System. 
Therefore, the pharmacy department is the central source for drug supplies. Some 
hospitals have also improved the storage condition of drug at the central stock or sub- 
stock. For drug use, all health care providers still base their procedures on the rational 
drug use concept. However, they do emphasise the importance of a community-based 
approach for health care practice. Generic drug policy also plays an important role in 
saving drug budget and increasing access to medicines for the majority of health care 
users regardless of their UCS sub-schemes. 
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6.5 THE ROLES OF PHARMACISTS TOWARDS MEDICINES MANAGEMENT 
IN THE HEALTH CARE SYSTEM AFTER THE IMPLEMENTATION OF THE 
UNIVERSAL COVERAGE SCHEME IN PATHUMTHANI PROVINCE IN 
APRIL 2001 
Regarding the qualitative data obtained from the semi-structured interview with 22 health 
care stakeholders from different levels of Pathumthani health care system, the opinions 
towards the pharmacist's roles in providing the efficiency medicines supply system are 
explained in three aspects: 
" Medicines Management 
" Pharmacy Service 
" Health Promotion 
6.5.1 Medicines Management 
The role of a pharmacist in medicines management, according to health care 
stakeholders' opinions, is perceived as a drug expert whose responsibilities are to deal 
with the pharmacy service including medicines management and clinical pharmacy in a 
health care provider. 
"... A pharmacist is the hospital's drug expert. He is the most suitable person to control and 
manage drug supply in the hospital. " (Health Policy Administrator 3) 
"... 1 do not know about other hospitals, but here the drug management process works very well 
with a pharmacist. " (A Hospital Director, District Hospital 1) 
In addition, opinions from pharmacists themselves towards their roles in medicines 
management were that these roles were still vague in terms of their job description. In 
addition, the provincial standard for medicines management was different from one health 
care provider to another. In some hospitals, drug budget was directly controlled by a 
hospital director. Thus, a pharmacist had less power to manage and decide to purchase 
drugs when they were critically needed. This led to drugs being out of stock in some 
health care providers. 
"... 1 cannot do anything much here regarding the medicines management process. It looks like the 
system is administered by the hospital director and a pharmacist does not involve himself in even 
the drug selection process. The role of a pharmacist here is completely vague. " (A Head of the 
Community Pharmacy Department, District Hospital 3) 
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"... I may not be able to buy any drugs when it is out stock since the drug budget is controlled by 
the hospital director. (A Head of the Community Pharmacy Department, District Hospital 7) 
However, in some health care providers, pharmacists could perform their roles 
effectively and were directly responsible for both the drug budget and its management. 
This was due to a pharmacist's working performance and time spent working in a health 
care provider. 
"... A pharmacist here has their own power to purchase drugs but this is not the main issue. The 
most important problem is how to get other colleagues to accept that this job would be more 
perfect if it was undertaken by a pharmacist. I think the pharmacist's performance in the past 
years is one key success in medicines management. " (A Head of the Community Pharmacy 
Department, District Hospital 4) 
"... Medicines management is not only related to drugs, but it also involves the drug budget. 
Apparently, this is not such a small amount of money but about 30% to 40% of the hospital annual 
budget. My view is that the time and reliability of working in a hospital can help to prove the roles 
of a pharmacist in respect to medicines management. " (A Head of the Community Pharmacy 
Department, District Hospital 6) 
Besides the DMC, the results from the semi-structured interviews indicate that 
medicines management also needs the experience of a pharmacist to steer the drug 
management process. Medicines management under the UCS policy needs professional 
expertise in medicines and management skills, which a pharmacist must possess if they 
are to work successfully in this role. In addition, reliability and transparency of such 
management over time could prove the importance of a pharmacist in a health care 
provider. 
6.5.2 Pharmacy Service 
A pharmacy service is one part of health care services provided by a pharmacist through a 
drug dispensary. The services include providing instructions for and ensuring the 
correctness of drugs in the prescription. Some pharmacists suggested that the drug 
management process also includes the provision of counselling service to increase 
rational use of drugs in patients. Thus, the role of a pharmacist should include correct 
understanding about drug use by integrating medical knowledge into social relations with 
patients. 
"... A pharmacist's role can be performed through dispensing drugs to patients and combining 
clinical knowledge with human relation skills. This is the new role that a pharmacist should learn 
in order to enhance the quality of the pharmacy service in the health care provider under the 
UCS. " (A Head of the Community Pharmacy Department, District Hospital 5) 
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"... Drug management in the stock and the picture that a pharmacist manages to dispense drugs at 
the dispensary are part of the pharmacy service. However, providing a patient with both an 
excellent health care service and proper knowledge of drug use are also what other health care 
professionals and patients expect from pharmacists. (A Head of the Community Pharmacy 
Department, District Hospital 7) 
The pharmacy service in a public health care provider includes both health care 
services and drug management. Therefore, dispensing drugs in accordance with the 
prescription is not now the only role of a pharmacist. The new role should be presented as 
a drug mentor who is able to integrate knowledge and communication skills to enhance 
the rational use of drugs among patients. 
6.5.3 Health Promotion 
After the UCS was implemented in April 2001, the concept of health care has emphasised 
the importance of proactive prevention of diseases in the community rather than reactive 
treatment at the hospital. Thus, the notion of drug management under the health 
promotion concept is also focused on pharmacy work that enhances a patient's health 
status and their awareness of protecting themselves from being ill. 
The role of pharmacists under this new policy has changed dramatically since April 
2001. A pharmacist is required to work at a PCU and sets up the drug management 
system for the community. In addition, the home health care team which comprises all 
major health care professionals is responsible for delivering both health care services and 
knowledge to patients in the community. A pharmacist has the role of a drug mentor and 
whilst in this role learns the pattern of drug use in the community, which in turn enables 
them to set up a local drug management system. 
"... Within the next decade, the role of pharmacists will centre on the community-based approach. 
They need to perform more proactive work and also learn how to manage pharmacy work from the 
community. " (Health Policy Administrator 2) 
"... To promote good health to health care users, a pharmacist has to ensure they use the correct 
balance between their own knowledge and the community requirements. Thus, the pharmacist's 
role in terms of health promotion is inevitable because they act as a drug mentor and facilitate 
patients accessing drug provision in relation to their health care needs. (A Head of the 
Conununity Pharmacy Department, District Hospital 3) 
The roles of a pharmacist towards health care services need to be adjusted in 
accordance with the universal coverage policy. The concept of drug management has 
been changed and centred on the question of `management for who? ' In the past, some 
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pharmacists experienced that the goal of drug management was to prevent a hospital from 
being in deficit, although the investment was totally obtained from the governmental 
budget. However, after April 2001, the UCS has clarified the answers of `management for 
who? ' and has inspired it to be based on drug management for patients' benefits. The 
results from the semi-structured interviews with 22 health care stakeholders demonstrate 
the link between the drug management process and the pharmacy service as well as 
emphasise the importance of the pharmacy service in health promotion. In addition, a 
more proactive health care implementation process focuses on the community and the 
people to a much greater extent than it did before. Thus, the roles of a pharmacist 
regarding these changes should involve an integration of knowledge and proper 
management by focusing more on the community's needs. 
6.6 CONCLUSION 
The availability of medicines for patients is considered one of the key successes in health 
care services under the UCS. This chapter described the process of medicines 
management to enhance the availability of medicines in the public health care system. 
Medicines management was investigate through the DMC which comprises four 
processes, selection, procurement, distribution and use of drugs. The rationale of 
medicines management was explained in relation to the location of such management and 
was divided into three levels: the provincial, district and PCU or community levels. The 
description of the process of managing drug supply in Pathumthani Province by level of 
the health care system demonstrated that the DMC played an important role in all levels 
of the health care system. In addition, opinions from health care stakeholders regarding 
differences and similarities in medicines management before and after the implementation 
of the UCS in April 2001 indicate that the transparency and the knowledge of a 
pharmacist in medicines management were key in successfully achieving availability of 
medicines in the health care system. However, the role of a pharmacist in medicines 
management after the implementation of the UCS should be based on the needs of the 
community. 
The next chapter is the quantitative findings which describe the characteristics of data 
variables obtained from health care users and their opinions towards the medicines supply 
system in public health care providers. 
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CHAPTER 7 
Quantitative Findings: Patients' Attitudes towards 
Medicines Management in Public Health Care Providers 
7.1 INTRODUCTION 
The findings in Chapter 6 centred mainly on opinions of stakeholders from public health 
care providers in Pathumthani Province in respect of the availability of medicines based 
on the Drug Management Cycle (DMC). The DMC comprises four major processes, 
selection, procurement, distribution and use of medicines. Qualitative data from Chapter 6 
also showed that health care providers strived to provide efficient health care services and 
deliver adequate services to consumers under the Universal Coverage Scheme (UCS). 
However, the integration of the DMC into the pre-existing health care system in 
Pathumthani Province may need more time to ensure that all health care components 
function effectively, particularly in the management of medicines, which has been altered 
to a more contemporary approach. Data presented in Chapter 6 also mirrors health care 
providers' opinions with regards to strategies in managing medicines supply under the 
UCS. 
This chapter presents quantitative findings obtained from outpatients with 
hypertension (HT) or diabetes (DM). They provided their opinions as `health care users' 
on a variety of issues including, medicines management at the source of supply or the 
pharmacy department, the quality of medicines prescribed and the overall quality of 
services they received from public health care providers. These findings are divided into 
two separate parts, the general explanation of data characteristics and the patients' 
attitudes towards health care services under the UCS. 
7.2 GENERAL EXPLANATION OF DATA CHARACTERISTICS 
This section describes the characteristics of the data variables obtained from HT or DM 
patients who visited the outpatient departments at public health care providers in 
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Pathumthani Province, Thailand between the l Ot" of January and 19th of February 2006. 
Findings are presented in four main categories: 
" Characteristics of Respondents 
" Data on the Universal Coverage Scheme 
" Data of Incurred Cost from Using Health Care Services 
" Respondents' Clinical Data 
7.2.1 Characteristics of Respondents 
Data about the demographic characteristics of respondents is shown in Table 7.1. The 
results are presented in five categories: gender, age, education, income and respondents' 
district of residency. 
Table 7. I: Characteristics of Respondents 
Category Number of respondents (%) 
1. Gender 
- Male 116 (29%) 
- Female 284 (71%) 
2. Age 
- Under 40 years 23 (5%) 
- 40-49 years 50 (13%) 
- 50-59 years 98 (25%) 
- Over 60 years 229 (57%) 
3. Education 
- No formal education 35 (9%) 
- Primary school 276 (69%) 
- Secondary school 48 (12%) 
- Vocational, university or higher education 41 (10%) 
4. Income 
- Less than 7,000 baht (£100)/month 309 (77%) 
- 7,000 baht (£100)/month or over 91(23%) 
5. Respondents' districts of residency 
- Muang Pathumthani or Thunyaburi (Urban area) 197 (49%) 
- Lumlukka, Klongluang or Latlumkaew (Suburban area) 128 (32%) 
- Samkok or Nongsua (Agricultural area) 67 (17%) 
- Not registered or not in Pathumthani Province 8(2%) 
Of the total number of HT or DM patients studied (400 respondents), approximately 
71% of the respondents were female and 29% were male. About 43% of the respondents 
were aged less than 60 years and 57% were 60 years or over. In terms of education, 69% 
of the total respondents reported that their highest educational background was primary 
school level, while 12% completed secondary school and about 10% graduated from 
vocational colleges, universities or other higher education institutions. Conversely, 9% of 
149 
the total respondents reported that they did not study or attended any educational 
institutions. 
Based on data from the MOPH, the monthly income per capita in Pathumthani 
Province was approximately 7,000 baht (£100) in 2003 (Department of Health Care 
Projects 2004). However, 77% of the respondents earned less than 7,000 baht per month, 
while only 23% earned more than this amount. Classification of the respondents by 
district of residency showed that 49% of the respondents came from Muang Pathumthani 
and Thunyaburi areas, which are regarded as the most densely-populated areas in the 
province. In addition, 32% resided in Lumlukka, Klongluang and Latlumkaew districts 
and 17% lived in Samkok or Nongsua where most of the areas are used for agriculture 
and farming. Only 2% of the total respondents reported that their residences were not 
located in any districts of Pathumthani Province but were in neighbouring provinces, such 
as Ayutthaya, Bangkok, Nakhon Nayok, and Nonthaburi. 
7.2.2 Data on the Universal Coverage Scheme 
This section presents findings about the UCS Data which is divided into three main 
categories, data on the UCS sub-schemes, data on the level of care under the UCS in 
Pathumthani Province, and data on household coverage by the UCS. 
7.2.2.1 Data on the Universal Coverage Sub-schemes 
The data presented in Figure 7.1 shows the categorisation of the respondents' UCS sub- 
schemes. In 2004, the UCS comprised three sub-schemes: the Civil Servants' Medical 
Benefit Scheme (CSMBS), the Social Security Scheme (SSS) and the Thirty Baht 
Scheme (TBS). In brief, CSMBS was the health insurance scheme which covered all 
government officials and permanent workers in the public sector, while SSS was for all 
workers in the private sector. TBS, also known as the Gold Card Scheme (GCS), aimed to 
extend its coverage to Thais who were not covered by any health insurance schemes. 
GCS was in fact a combination of two health insurance sub-schemes, 1) the Gold Card 
Scheme which completely exempted an individual from any incurred costs listed in the 
core package and the sub-scheme called GCSE, and 2) the Gold Card Scheme in which 
the insurer was required to make a co-payment of 30 baht (£0.45) per visit to the health 
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care provider. This sub-scheme was known as GCSP or the Co-payment GCSE (see 
Chapter 2 for further details). 
Figure 7.1: Categorisation of Respondents' Universal Coverage Sub-schemes 
CSMI 
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 GCS 
  CSMBS 
Q Uninsured 
Q SSS 
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Figure 7.1 shows that the majority of respondents were insured by one of the UCS sub- 
schemes. In addition, 84% of the total respondents were covered by the GCS, whereas 
11% and 1% were insured under CSMBS and SSS respectively. However, 4% of 
respondents reported that they had not registered for any UCS sub-schemes and remained 
uninsured. 
GCS beneficiaries were registered with either GCSE or GCSP sub-schemes. 
Respondents covered by GCSE are exempted from the 30 baht co-payment usually 
required per walk-in visit or hospitalisation. The MOPH's inclusion criteria for 
registration under GCSE are: the elderly (over 60 years old), the low paid, children under 
15 years old, the disabled, community leaders and religious priests. Alternatively, 
respondents with a total monthly income between 2,500 and 6,500 baht (£36 and £93) can 
be registered under GCSP and are required to co-pay 30 baht per visit. 
151 
SSS 
Uninsured 1% 
Figure 7.2: Categorisation of Respondents' Gold Card Scheme (GCS) 
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Figure 7.2 shows that approximately 57% of the total respondents were covered by the 
GCSE, of which 55% were elderly and a total of 3% comprised community leaders, the 
disabled and religious priests. 43% of the total respondents reported that they were 
covered under the GCSP sub-scheme and were responsible for the 30-baht co-payment. 
Nevertheless, there were 16 respondents who were not covered by any health 
insurance schemes in Pathumthani Provinces. Figure 7.3 summarises the reasons why 
they had not been insured. 
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Figure 7.3: Respondents' Reasons for not Registering with the Universal Coverage Scheme 
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Those 16 respondents who were not covered by any health insurance schemes counted 
for 4% of the total respondents (Figure 7.1). Figure 7.3 also shows that 69% of the total 
uninsured respondents were registered with one of the UCS sub-schemes in other 
provinces. Some respondents also stated that they had been waiting for the transfer of 
their UCS entitlement from another province, while a few of the respondents came to 
health care providers in Pathumthani Province for prescriptions of antihypertensive or 
antidiabetes drugs whilst living there temporarily (i. e. less than 3 months). Two of the 
uninsured respondents (6%) stated that they had been living in Pathumthani Province for 
several years but had not yet been registered, while one respondent refused to participate 
in the UCS at all. In addition, 19% of the total uninsured respondents had other reasons 
not to register with the UCS such as, unawareness of the UCS, being away from 
Pathumthani Province for several years, and mistakes in the provincial UCS database. 
7.2.2.2 Data on the Levels of Care under the Universal Coverage Scheme in 
Pathumthani Province 
The health care network in Pathumthani is divided into three major levels, primary 
(PCUs), secondary (district hospitals) and tertiary (Pathumthani Hospital). This is based 
on the hierarchy of care in the health system and aims to provide assistance for and 
collaboration among its members. For instance, a PCU may refer a patient to a district 
hospital, who may later be transferred to Pathumthani Hospital. 
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After the implementation of the UCS, the roles of health care providers at each level of 
the health system changed. All health care providers are also responsible for the UCS 
registration and become `a patient's choice', which means they are either a main 
contractor or a sub-contractor for people to choose from. A main contractor is the first 
health care provider that is chosen by an insurer for receiving health care services, 
whereas the second choice refers to the sub-contractor. In addition, another term a `Gold 
Card (GC) distributor' emerges and refers to a place where a UCS card is issued which 
can be referred to either a main contractor or a sub-contractor, depending on an insurer's 
preference. Figure 7.4 displays the comparison between main contractors, sub-contractors 
and Gold Card distributors in favour of respondents' selection. 
Figure 7.4: Respondents' Selection of the Main Contractor, Sub-contractor and Gold Card (GC) 
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Figure 7.4 shows that 65%, 19% and 15% of the total respondents selected district 
hospitals, Pathumthani Hospital and PCUs as their main contractors respectively. 
Interestingly, the proportion of respondents who chose district hospitals as their main 
contractors is approximately three to four times higher than those who chose either 
Pathumthani Hospital or PCUs. Similarly, 63% of respondents chose district hospitals as 
their sub-contractors, while only 19% and 15% selected PCUs and Pathumthani Hospital 
respectively. In terms of the Gold Card distributor, the majority of respondents (66%) had 
received the Gold Card from district hospitals, followed by PCUs (19%) and Pathumthani 
Hospital (14%). 
66% 
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Health Care Providers 
Before 2003, private hospitals or clinics also played a crucial role as one of the main 
contractors, sub-contractors or Gold Card distributors. However, since early 2003, all 
private hospitals and clinics have withdrawn themselves from the UCS. Therefore, no 
private health care provider currently participates in the UCS. The data from Figure 7.4, 
nonetheless, includes private hospitals or clinics because some patients selected these 
health care providers as their main contractors or sub-contractors before they opted out of 
the UCS. Hence, the names of both main contractors and sub-contractors labelled on the 
Gold Card had not been updated. 
7.2.2.3 Data on Household Coverage by the Universal Coverage Scheme 
The data on household coverage by the UCS aims to explain the extent to which the UCS 
covers all family members. Household coverage was measured by focusing on the 
number of family members registered with the UCS in a family. The size of a family was 
then divided into six categories, ranging from no family member insured under the UCS, 
to more than ten people in a family registered with one category of the UCS sub-schemes. 
This data is presented in Table 7.2. 
Table 7.2: Household Coverage under the Universal Coverage Scheme 
Category Number of Respondents (%) 
Number of family members registered with one of 
the UCS sub-schemes (including the respondent) 
None 5(1%) 
1 54 (14%) 
2-4 251(63%) 
5-7 60(15%) 
8-10 24(6%) 
10+ 6(1%) 
Family members are people who live in a family and have their names recorded in the 
same household registration (Ministry of Interior 2004). The data from Table 7.2 
indicates that about 63% of the total respondents have between two and four family 
members covered by the one of the UCS sub-schemes. In addition, 15% of the total 
respondents reported that between five and seven people in their family were insured, 
while merely 1% stated that none of their family members were registered with any UCS 
sub-schemes. 
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7.2.3 Data of Incurred Costs from Using Health Care Services 
Although the UCS provides two options for the insured, a co-payment or free of charge 
health care services, there are some extra costs that patients may incur when seeking such 
services from public health care providers. Figure 7.5 displays three categories of 
respondents' incurred costs, including transportation, health care and other expenses. 
Transportation costs refer to expenses incurred when respondents travelled from their 
residences to a health care provider. They include such as charges as those for buses, 
boats, taxis or trains. Other costs refer to any expenses which are neither transportation 
nor health care costs. This includes other costs of health services, such as charges for food 
or drink while waiting for a lab result. Health care costs are respondents' out-of-pocket 
fees for treatment or prescriptions which are not specified in a health care provider's core 
package. These include treatments such as plastic surgery, traditional medicine or some 
herbal medicines not listed in the essential drug list. 
Figure 7.5: Incurred Costs from Accessing Health Care Services 
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Figure 7.5 shows that 32% of the total respondents spent less than 30 baht on 
transportation, while 28% and 18% incurred 30.01 to 50 baht and more than 90 baht 
respectively. In terms of other costs, 47% of the total respondents paid less than 30 baht 
for these, whereas approximately 53% (derived from the sum of the rest of the categories 
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Categories of Incurred Cost from Access to Health Care Services 
in other costs) reported that they spent more that 30 baht on other costs. In relation to 
health care cost per episode, 18% of the total respondents spent more than 30 baht on 
health care services. However, 82% of respondents spent less than 30 baht or free of 
charge on health care costs. This is about twice the percentage of those who incurred 
other health care costs and about three times the percentage of those who paid out less 
than 30 baht for transportation costs. Conversely, the results also show that the numbers 
of respondents who spent more than 30 baht on transportation and other costs (68% and 
53%, respectively) are substantially higher than those who paid for health care costs 
(18%). In addition, the percentage of total respondents who spent more than 90 baht on 
transportation costs is approximately twice as high as the proportion who incurred health 
care and other costs. These results indicate that although respondents were covered by 
one of the UCS sub-schemes, they still have to be responsible for transportation cost and 
other cost from accessing health care services. Such costs are sometimes more than the 
minimum charge of the 30-baht co-payment. 
7.2.4 Respondent's Clinical Data 
Clinical data was collected from respondents with hypertension (HT) or diabetes (DM) 
alone or in combination with other chronic diseases such as heart disease, gout, renal 
failure or cancer. The data obtained from the respondents comprised disease categories, 
number of medications per prescription, numbers of health care visits and each 
respondent's experiences in seeking care from other health care providers not specified on 
their UCS cards. 
Table 7.3 shows that 24% of the total respondents had HT and the same proportion 
had DM. In addition, 39% were diagnosed to have both HT and DM, while another 12% 
had either HT or DM in combination with other chronic diseases, such as heart disease, 
gout or cancer. 
In terms of the number of medications per prescription, 52% of respondents reported 
that they were prescribed two to five medicinal items per prescription, while about 33% 
received five to seven items in one prescription. About 2% of respondents received more 
than ten drugs per prescription. 
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Table 7.3: Respondents' Clinical Data 
Category Number of Respondents (%) 
Diseases 
Hypertension 97 (24°ßa) 
Diabetes 97 (24%) 
Hypertension and diabetes 157 (39%) 
Hypertension or diabetes with other chronic diseases (i. e. 48 (12%) 
heart disease, gout, etc. ) 
Total cases (N) 399 
Number of drug items being prescribed per prescription 
1 20 (5%) 
2-4 206 (52%) 
5-7 133 (33%) 
8-10 32(8%) 
More than 10 8 (2%) 
Total cases (N) 399 
Number of visits to a health care provider (per year) 
1 (or the first time) 15 (4%) 
2-4 35 (9%) 
5-7 85 (21%) 
8-10 61 (15%) 
11-13 184(46%) 
More than 13 19 (5%) 
Total cases (N) 399 
Number of visits to health care provider for an 
appointment with doctors for HT or DM (per year) 
1 (or the first time) 13 (3%) 
2-4 31 (8%) 
5-7 82(21%) 
8-10 64 (16%) 
11-13 199 (50%) 
More than 13 8 (2%) 
Total cases (N) 397 
Some respondents also visited other health care providers not specified on their UCS 
cards as either a main contractor or a sub-contractor. Table 7.4 describes their experiences 
and reasons why some respondents visited these health care providers. 
About 41 % of the total respondents visited other health care providers that were not 
their main contractors or sub-contractors at least once. However, more than half of the 
total respondents (59%) reported that they had never used health care services from health 
care providers other than those specified on their UCS cards. 
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Table 7.4: Respondent's Experiences in Using Other Health Care Providers (not their Main Contractors 
and Sub-contractors) 
Category Number of Respondents (%) 
Have you ever visited other health care providers apart 
from your current main contractor or sub-contractor? 
Yes 
No 
Total cases (N) 
162 (41%) 
238 (59%) 
400 
a) Health care providers visited apart from the current main 
contractor or sub-contractor 
Regional hospitals or university hospitals 35 (22%) 
General or provincial hospitals 65 (40%) 
Community hospitals 11 (7%) 
Primary care units (PCUs) 2 (1%) 
Private hospitals or clinics 48 (30%) 
Total cases (N) 161 
b) Number of visits to other health care providers apart 
from the current main contractor or sub-contractor (per 
year) 
1 40 (25%) 
2-4 85 (53%) 
5-7 16 (10%) 
8-10 8 (5%) 
11-13 11 (7%) 
More than 13 0 (0%) 
Total cases (N) 160 
c) Reasons for visiting other health care providers apart 
from the current main contractors or sub-contractors (more 
than one option can be chosen) 
Close to the residence 59 (29%) 
Being referred from a main contractor or a sub-contractor 45 (22%) 
Better health care services 36 (18%) 
Less waiting time 36 (18%) 
Other reasons 19 (9%) 
Better medicines 5 (3%) 
Cheaper health care costs 2 (1%) 
Total frequency 202 
Of the respondents who visited other health care providers that were not their main 
contractors or sub-contractors, 40% went to general hospitals or provincial hospitals, 30% 
managed to visit private hospitals or clinics, and 22% decided to use health care services 
from regional or university hospitals. Interestingly, district hospitals and PCUs display 
the lowest two proportions for health care alternatives, chosen by 7% and 1% of the total 
respondents respectively. 
In terms of visits to health care providers not specified on the Gold Card, 53% of 
respondents sought care from health care providers other than their main contractors or 
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sub-contractors two to four times per year, whereas 25% reported only one visit within 
the past year. In addition, about 10% of respondents visited these other providers five to 
seven times per year, while 7% of respondents stated that they had been to other health 
care providers apart from their main contractors or sub-contractors almost every month or 
about 11 to 13 times per year. 
The reasons that motivated respondents to use health care services from other health 
care providers besides their main contractors or sub-contractors vary. About 29% report 
that these health care providers were closer to their homes, and 22% were referred from 
their main contractors or sub-contractors to a higher level of care and so complying with 
the UCS network. 18% of respondents were influenced by shorter waiting time and the 
same proportion of respondents were also swayed by better health care services; whereas 
3% thought that the quality of medicines was better than those preferably chosen health 
care providers. In addition, 12% of respondents had other reasons, such as a 
recommendation, needing emergency treatment or a personal relationship with a provider. 
7.3 RESPONDENTS' ATTITUDES TOWARDS HEALTH CARE SERVICES 
UNDER THE UNIVERSAL COVERAGE SCHEME 
In Chapter 6, the qualitative data obtained from health care stakeholders in Pathumthani 
Province mainly focuses on the DMC which comprises the processes of selection, 
procurement, distribution and use of medicines. The DMC was a model proposed by 
WHO as a guideline for the establishment of an efficient medicines supply system in a 
country, aiming to provide available and affordable medicines for all the population. 
Although access to medicines is possible for all citizens, this is only one aspect of the 
user's assessment of the quality of health care. This section reports respondent's attitudes 
towards three key determinants in relation to the medicines supply system: the quality of 
drugs, the quality of services obtained from the pharmacy department and the overall 
services received from public health care providers in Pathumthani Province. 
7.3.1 Respondents' Opinions towards the Quality of Medicines 
The mean score in Table 7.5 is used to measure respondents' opinions towards the quality 
of drugs dispensed from the pharmacy department in public health care providers of 
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Pathumthani Province. The highest mean score for this category is 2.88, indicating that 
respondents tended to agree that drugs dispensed from the pharmacy department were 
appropriate for their diseases or symptoms every time they visited the health care 
provider. In addition, respondents tended to agree that the quality of drugs prescribed in 
public health care providers was not different from that in private services (a mean score 
of 2.47). Respondents were also likely to agree that the same generic drugs with different 
brand names still have the same quality or potency for treatment (a mean score of 2.46). 
Conversely, the lowest mean score was for respondents' opinions towards the concept 
of providing separate UCS drug lists in relation to patients' entitlements, such as CSMBS, 
SSS or GCS (2.05). In addition, respondents' views to have only one generic name for 
one brand name drug in a health care provider gave a mean score of 2.12, whereas some 
respondents tended to agree with the notion that drugs manufactured from the GPO had 
the same quality as imported medicines (a mean score of 2.23). However, the mean score 
for the overall opinion of respondents towards the quality of drugs in the public health 
care provider was 2.81. 
Table 7.5: Respondents' Opinions towards Drug Quality 
Respondents' opinions toward drug quality 
dispensed by the pharmacy department 
Range 
Mean scores 
of 
respondents' 
attitudes 
I always receive drugs which correspond with my diseases or symptoms 2-3 2.88 
every time I visit this health care provider. 
I think the quality of drugs prescribed in this health care provider is not 2-3 2.80 
different from private hospitals or clinics. 
I think the same generic drugs with different brand names should have 2-3 2.46 
identical qualities or potencies. 
I think if there is a separation of drug lists for patients insured with different 2-3 2.32 
UCS sub-schemes, the quality of drugs from each drug list must be the same. 
I think that the quality of imported drugs is somewhat not different from the 1-3 2.29 
local-made ones. 
I think drugs produced by the Government Pharmaceutical Organisation 1-3 2.23 
(GPO) are of the same quality as those imported ones. 
I think that one drug item in the hospital should have only one brand name. 1-3 2.12 
I think there should be separate hospital drug lists in respect of the UCS sub- 1-3 2.05 
schemes, such as the essential drug lists for CSMBS, SSS and TBS. 
Overall, I am satisfied with the quality of drugs provided by this health 2-3 2.81 
care provider. 
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7.3.2 Respondents' Opinions towards the Pharmacy Services 
Table 7.6 shows the mean scores for respondents' opinions towards the services provided 
by the pharmacy department. The highest mean score is for the opinion that they received 
all drugs in their prescriptions every time they visited the pharmacy department (mean 
score 2.86). Moreover, respondents were likely to agree that they understood how to use 
drugs after being advised by a pharmacist (mean score 2.80) and they also tended to agree 
that pharmacists advised them on the indications of prescribed drugs (mean score 2.72). 
The lowest mean score was for the opinion that the waiting time for drugs from the 
pharmacy department was less than 30 minutes (mean score 2.04). Furthermore, the mean 
score was 2.19 for the view that the respondents needed to bring prescriptions to drug 
stores nearby due to a drug being out of stock and respondents tended to agree that 
waiting for drugs was a time consuming process in the health care system (mean score 
2.24). Nevertheless, the mean score for the overall opinion of respondents towards 
services provided by the pharmacy department in public health care providers was 2.81. 
Table 7.6: Respondents' Opinions towards Pharmacy Services 
Respondents' opinions towards the pharmacy services 
Mean scores of 
p Range respondents' in public health care providers attitudes 
situdes 
a 
I always receive all drug items prescribed every time I come to the 2-3 2.86 
pharmacy department in this health care provider. 
I understand how to use drugs after being advised by a pharmacist. 2-3 2.80 
A pharmacist who gives me advice is polite and uses simple terms 2-3 2.79 
in their explanation. 
I know that when I receive my drugs, there will always be a 2-3 2.72 
pharmacist who will provide me with advice on how to use such 
medicines. 
I know that the pharmacy department provides a private drug 1-3 2.39 
counselling service to patients. 
Waiting for drugs is the most time-consuming step in the whole 1-3 2.24 
process of health services. 
Sometimes I need to bring the prescription to the drug store 1-3 2.19 
because drugs are out of stock. 
I spend less than 30 minutes waiting for drugs. 1-3 2.04 
Overall, I am satisfied with the pharmacy services provided by 2-3 2.81 
this health care provider. 
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7.3.3 Respondents' Opinions towards Health Care Services in Public Health Care 
Providers 
A total of 399 respondents completed this section and their opinions towards health care 
services in public health care providers are presented in Table 7.7. The highest mean 
score was for the view that respondents felt convenient to visit the health care provider 
(mean score 2.75). In addition, they tended to agree that members of health care staff 
were very helpful (mean score 2.72) and all respondents thought that the health care 
services had improved greatly after the implementation of the UCS (mean score 2.71). 
Table 7.7: Respondents' Opinions towards the Overall Health Care Services Received from Public 
Health Care Providers 
Respondents' opinions toward the health care services 
Mean scores of 
Range respondents' in public health care providers attitudes 
I feel it is convenient to visit this health care provider for health 2-3 2.75 
services. 
The members of health care staff are very helpful. 2-3 2.72 
After adopting the UCS policy in 2001, I think that the health care 2-3 2.71 
services from this health care provider have greatly improved. 
I am more satisfied with health care services from this health care 2-3 2.57 
provider than private hospitals or clinics. 
I think the standard of health care services between this health care 1-3 2.45 
provider and private hospitals or clinics is no different. 
I spend less than 2 hours on the whole processes, from arriving at 1-3 1.72 
this health care provider to receiving medicines. 
Overall, I am satisfied with the health care services provided 2-3 2.81 
by this health care provider. 
The lowest mean score was for respondents' views towards time spent on the whole 
health care procedure18 and that it should be less than two hours (mean score 1.72). 
Moreover, respondents tended to agree that there is no difference between the quality of 
health care in public and private health care providers (mean score 2.45). On the other 
hand, some respondents were more likely to agree that they were more satisfied with 
health care services from public health care providers than private hospitals or clinics 
18 The procedure usually starts when a patient arrives at a health care provider and finishes when a patient 
receives all medicines from the pharmacy department with sufficient information about indication of drug 
use (MOPH 2004). 
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(mean score 2.45). Nonetheless, the mean score for the overall opinion of respondents 
towards the services from public health care providers was 2.81. 
7.4 CONCLUSION 
According to the quantitative data, the four categories used to describe respondents in this 
study comprised respondent's demography, UCS categories, respondent's clinical data 
and incurred costs when using health care services. The findings from the general 
explanation of data characteristics found that the majority of respondents were covered by 
one of the UCS sub-schemes: GCS, CSMBS, or SSS. Although, the UCS covered the 
majority of respondents and they were entitled to the 30-baht co-payment or were not 
required to pay for health care services, they were yet responsible for other possible 
incurred costs from accessing care. These costs included transportation and other costs 
which were higher than the 30-baht co-payment paid for one health care visit. The 
findings may imply that the UCS helps some respondents to reduce the burden of health 
care cost, particularly for those who had regular appointment with doctors. 
In terms of respondents' attitudes towards accessing health care services from public 
health care providers, the overall result from the three sections report that respondents 
were, on the whole, satisfied with the quality of drugs, the performance of the pharmacy 
department and the services provided by public health care providers. Nevertheless, 
waiting time for health care services, for instance, was one of the lowest mean scores 
which may suggest that public health care providers should revise and adjust their health 
service systems as a whole to reduce the long waiting time for care. 
Further discussion about the findings will be presented in the next chapter, which will 
include the results from both qualitative and quantitative data, and the implications for the 
health care system under the UCS. 
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CHAPTER 8 
Discussion of Study Findings and Implications for 
the Health Care System under the Universal Coverage Scheme 
8.1 INTRODUCTION 
The aims of this thesis have been to describe the situation of medicines management from 
two aspects of a health care system, public health care providers and health care users. 
The former focuses on the processes involved in managing medicines supply in respect of 
improving equal access to medicines in the public sector under the UCS. The Drug 
Management Cycle (DMC) proposed by WHO was employed as a guideline for such 
processes in public health care providers in Pathumthani Province and also provided 
advice for the supply side. Conversely, the latter illustrates health care users' attitudes 
towards the provision of care services, particularly in terms of the quality of medicines, 
pharmacy services and overall health care services from the public sector. 
To achieve these aims, the following objectives were set out in Chapter 1: 
1) To describe and characterise the processes of drug management in the public health 
care providers of Pathumthani Province. 
2) To describe the experiences of medicines management after incorporating the DMC 
into the drug management system in public health care providers under the UCS. 
3) To measure health care users' attitudes towards the medicines supply system, 
pharmacy services and overall health care services in public health care providers. 
4) To make proposals for: 
a) the revision of the roles of pharmacists in promoting equity in access to medicines 
provision under the UCS in Pathumthani Province 
b) recommendations of applying the DMC to improve equity of access to medicines 
in the public health care system under the UCS 
The objectives have been pursued as follows: Chapter 2 aimed to describe the 
background of Thailand and its health care system, including the reasons and factors that 
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led Thailand to reform its health care system in 1997. As a result, the UCS has covered all 
provinces since 2001. Although the UCS has expanded its coverage to the majority of 
Thais, some people are still unable to access basic health care services. Therefore, 
Chapter 3 presents further explanation of the importance of equity in access to health care 
by focusing on this concept in relation to availability, utilisation and outcomes of health 
care services. Nevertheless, this study emphasises that access to health care is merely a 
question of the supply side and relates to the availability, affordability and quality of 
health care services provided by the public health sector. 
Since medicines are crucial for both health care providers and health care users, this 
study focuses on medicines management in the public sector which is the major health 
care provider in Thailand. Chapter 4 explains the importance of medicines in a health care 
system and the significance of an efficient medicines management system in improving 
equity of access to medicines, using the DMC as a principal guideline. Chapter 5 explains 
the methods used for the investigation which comprises both qualitative and quantitative 
approaches. The qualitative semi-structured interviews were used to obtain opinions from 
health care stakeholders regarding the processes of medicines management in public 
health care providers. These qualitative findings were presented in Chapter 6 and focused 
on the DMC which itself comprises four major management processes, selection, 
procurement, distribution and rational use of medicines. Conversely, quantitative methods 
were employed through the questionnaires to obtained health care users' attitudes towards 
health care services in respect of the quality of medicines, pharmacy services and the 
overall health care service they received from public health care providers. The findings 
were presented in Chapter 7. 
In this chapter, the findings from both the qualitative and quantitative methods are 
discussed. In addition, the implications of these findings propose a possible revision of 
the drug management system in public health care providers of Pathumthani Province, 
which could guarantee that equity of access to medicines is achieved. 
8.2 DISCUSSION OF QUALITATIVE AND QUANTITATIVE FINDINGS 
The findings from this study have been divided into two major parts, qualitative and 
quantitative data. The qualitative findings, presented in Chapter 6, reflect the opinions of 
health care stakeholders towards medicines management under the UCS. In addition, the 
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quantitative findings mentioned in Chapter 7 illustrate health care users' opinions on the 
quality of medicines, pharmacy services and the overall health care service given by 
public health care providers. In this section, the discussion of both types of findings is 
presented in accordance with the research questions as follows: 
8.2.1 What were the Processes of Drug Management in Public Health Care 
Providers in Pathumthani Province? 
Since the implementation of the UCS in 2001, the provincial health office has 
encouraged all public health care providers in Pathumthani Province to apply the DMC as 
a guideline for medicines management in their health care system. The DMC was not a 
mandated provincial policy; therefore, some hospitals and PCUs were not required to 
integrate it into their health care systems. However, many public health care providers 
did adopt the DMC and employed it as a key approach in medicines management. Here, 
the discussion of the qualitative findings, which were obtained from the semi-structured 
interviews with health care stakeholders, relate to the processes of the DMC. 
8.2.1.1 Selection 
Public health care providers could independently choose drugs required for health care 
services, providing that they were included in the provincial drug list. However, public 
providers employed different methods to choose certain drugs. At the provincial level, 
the essential drug list was based on requirements from prescribers rather than the true 
demands of all the operational units. Thus, the presence of high cost drugs (both essential 
and non-essential) in the hospital drug list was mainly due to the requests of the 
prescribers. Consequently, many costly and unnecessary medicines (e. g. combined 
muscle relaxants, cold remedies or cosmetics) were included in Pathumthani Hospital's 
drug list. 
Members of health care staff at the provincial level argued that as Pathumthani 
Hospital is at the centre of the provincial health care network, the essential drug list must 
be flexible and must include a wide range of drugs in relation to their pharmacological 
effects. In addition, emergency cases were often referred from districts hospitals so 
prescribers should not be restricted due to a limited selection of drug items available. 
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These findings contradict the provincial drug policy which encourages the use of 
essential medicines and in particular generic drugs. 
Conversely, most of the drugs in the district hospital's drug list were generic or locally 
made. Although some health care stakeholders agreed that the essential drug lists at both 
the provincial and district levels covered almost all main diseases and health situations in 
the province, they still preferred brand names to generic drugs. At the PCU level, the 
drug list was limited to 95 items (Table 6.1, Chapter 6) and was determined by district 
hospitals. All drugs available at the PCU level were essential medicines and had to be a 
subset of the district hospital's drug list. 
Drug selection at the provincial, district and PCU levels did not entirely comply with 
the DMC. The PTC at the provincial hospital should have performed better in terms of 
drafting the hospital drug list and therefore providing drugs which corresponded to the 
actual needs of the operational units. In addition, this may have helped the provincial 
hospital from overspending on drug budget or high cost medicines. While at the district 
and PCU levels, the PTCs played an important role in determining the drug list which 
represented the demand from the operational units and included more generic drugs. 
8.2.1.2 Procurement 
The factors affecting the drug procurement process focus on three major components, the 
purchase system, drug budget and the quality of drugs. Firstly, the purchase system 
applied to Pathumthani Province was the Pooled-Purchase method. The disadvantage of 
pooled purchase is that larger public health care providers could gain more benefit than 
smaller health care facilities. The reason for this is that they represent the majority on 
both the demand on drugs and the value of drug budget, which may undermine the 
requests from smaller health care providers. Therefore, drugs with higher demand in 
small health care facilities may not be included in the pooled-purchase drug list. 
However, the advantage is that pooled purchase can decrease the prices of drugs used by 
all health care providers, particularly for chronic diseases (e. g. diabetes, hypertension and 
heart disease) or drugs for other severe diseases such as antiretroviral or antibiotic 
medicines. 
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Secondly, the drug budget was allocated by the provincial health office in accordance 
with the data on capitation and workload from public health care providers. Many health 
care providers, especially those in sparsely populated areas were directly affected by 
budget allocation. Interestingly, although the allocation for the drug budget was 
estimated, based on capitation and workload data from previous years, health care 
providers still experienced inadequacies in their budgets. This was possibly caused by 
improper management of the drug selection process, such as choosing high cost drugs 
(e. g. brand names drugs) which could easily have been replaced by generic ones. In 
addition, these inadequacies also resulted from requirements to pay debts for drug 
purchases from previous years. 
Finally, the quality of drugs focused on generic drugs procured from the GPO. 
Although the GPO always submitted the GMP and QA certificates to assure the quality 
of drugs, public health care providers were not convinced by or confident with such 
evidence. This was because the processes to certify both the GMP and QA were often the 
in-house procedures, which means that the drugs were inspected by the GPO's own 
laboratory. The reluctance among some health care stakeholders to use generic drugs 
from the GPO was somewhat due to bureaucratic regulations which force public health 
care providers to purchase some generic drugs only from the GPO. 
8.2.1.3 Distribution 
Factors influencing the drug distribution process comprise three major components, the 
distribution system, storage and delivery. Firstly, the distribution system in public health 
care providers at the provincial, district and PCU levels was the Pull System. At the 
provincial and district levels, drug demand was determined by operational units in public 
health care providers and all drugs were distributed from the pharmacy department. 
Similarly, a pharmacy department at a district hospital was responsible for drug 
distribution to local operational units and was also requested to be a source of drug 
supply for PCUs. However, the drug management system differed considerably from one 
PCU to another, depending on the distance between a PCU and a district hospital. 
Although all public health care providers applied the Pull System for drug 
distribution, it may not be entirely suitable for all circumstances. Often, the demands for 
drugs from operational units in a hospital exceed the ability of a pharmacy department to 
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handle the supply. In addition, this situation is sometimes exacerbated by the limit of the 
drug budget or drugs being out of stock at the suppliers. As a result, this leads to a 
shortage of drugs in a public health care provider as no drugs are delivered from a 
pharmacy department to operational units. The Push System is appropriate in this case 
and can be applied as an alternative distribution system which allows a pharmacy 
department to alleviate the shortage of drugs and determine proper solutions to allocate 
drugs to all requested units. 
Secondly, storage of drugs in a public health care provider comprises two systems, the 
sub-stock and central stock systems. At the provincial and district levels, the sub-stock 
system was a key method used to prevent shortages of essential drugs in operational 
units. However, shortages of drugs in a sub-stock still occurred, particularly in larger 
health care providers, where the volume of drug consumption was high and collaboration 
between a pharmacy department and operational units (where sub-stocks are located) was 
not formally established. The central stock is considered to be the main source for the 
drug distribution process. However, inappropriate storage conditions such as limited 
space or high temperatures, posed crucial concerns to health care providers. Such 
improper storage conditions are manageable but they were neglected, which resulted in 
the loss or degradation of drugs. This loss influenced the availability of drugs in public 
health care providers. 
Finally, the delivery system requires collaboration between a pharmacist and members 
of health care staff from operational units in terms of performing the check and balance 
system. Double-checking aims to diminish mistakes and errors between a pharmacy 
department and an operational unit in the quantities and categories of drugs. This was key 
in improving rational drug use in health care services. Conversely, this practice was less 
likely to be applicable to a PCU because no pharmacist worked on-site there. In this case, 
members of health care staff at a PCU must be responsible for double-checking drugs and 
managing drug stock. However, a pharmacist should be a key person who provides 
counselling services and makes regular visits to the PCU for possible assistance 
regarding the management of the delivery system. 
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8.2.1.4 Use 
Health care stakeholders perceived that drug use referred to `rational drug use' which 
defines the last process before the drugs are prescribed to patients. At the provincial 
level, drug use emphasised the only process in the DMC that exhibits the collaboration 
between health care providers and patients. Health care providers assure patients that 
good quality drugs are always available and affordable, whereas patients collaborate with 
a public health care provider by adhering to treatment and having basic self-care 
knowledge. Similarly, district hospitals and PCUs stated that rational drug use indicates 
the role of patients to adhere to treatment. In addition, they emphasised that rational drug 
use should initially be undertaken in communities and patients should have basic 
knowledge in self-care, such as nature of diseases or important indications of drugs 
regularly used (e. g. antihypertensive or antidiabetes drugs). 
Although the DMC has been adopted as a guideline for drug management in 
Pathumthani Province since 2001, it requires additional management support from both 
the MOPH and the Provincial Health Office. The MOPH indirectly supervises the 
provincial health care system through the health care policy which is regarded as the 
protocol for health care implementation. Alternatively, the Provincial Health Office 
provides direct support for health care policy, budget allocation or monitoring the 
progress of health care implementations. 
The qualitative findings show that although drug management in Pathumthani 
Province did not totally comply with the DMC, results from such management exhibited 
considerable improvement in the provincial drug supply system. Good quality drugs were 
available in all public health care providers with affordable prices under the UCS. In 
addition, better collaboration between the public sector and the community has been 
established under the concept of self-care, which emphasises the importance of health 
promotion and the implementation of health care activities in communities. 
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8.2.2 Did the Application of the Drug Management Cycle as a Guideline for 
Medicines Management Improve the Equity of Access to Medicines in Public Health 
Care Providers under the Universal Coverage Scheme? 
It can be shown that a public health care provider can manage to have equal access to 
medicines for all of the population, by focusing on the drug management processes in a 
health care system. The DMC has been used as a guideline for establishing the 
comprehensive drug supply system in the province, which centres on the quality, 
availability and affordability of drugs in public health care facilities. To comply with the 
DMC, public health care providers applied the four major processes for drug 
management. Firstly, the Drug Selection Process determined by the PTC had an impact 
on the reduction in the usage of non-essential or branded-name drugs. This was shown by 
the increase in essential drugs on a hospital drug list. 
Secondly, the Procurement Process involves the combination of Pooled Purchase with 
other pre-existing methods (Direct Purchase and Open Tender). Although Pooled 
Purchase was to some extent lowering the price of those high cost or substantial demand 
medicines, it could not cover all drug items in a drug list of a public health care provider. 
Alternatively, Open Tender was employed as the option for the main drug procurement 
process, whereas Direct Purchase was employed as a method for purchasing drugs only 
from the GPO. The concerns about the transparency of drug purchases mainly centred on 
the process of price negotiation between public health care providers and drug suppliers. 
Thus, the PTC, which includes representatives of drug-related health care professionals, 
plays an important role in enhancing this transparency. It does this by determining 
tenders offered from drug companies based on pharmacological evidence and a 
provincial database on drug use. 
Thirdly, the Distribution Process emphasises that availability of drugs in a health care 
provider mainly relies on the collaboration between a pharmacy department and all 
operational units regarding the check-and-balance system at a drug sub-stock. The 
precise drug volume obtained from a pharmacy department depends on the demands of 
the operational units where data regarding drug consumption is recorded and submitted to 
a pharmacy department. In addition, another crucial component for drug distribution is 
storage. This plays an important role in maintaining the quality of drugs before they are 
delivered to operational units. However, many health care providers disregarded storage 
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conditions as a critical issue since the hospital administrator did not permit a pharmacy 
department to adjust the conditions for a central stock. This resulted in drug loss or drugs 
being out-of-stock due to preventable causes. 
Finally, Rational Use of Drugs is an approach that requires collaboration between 
public health care providers and patients. Rational drug use means that members of 
health care staff can use correct drugs with appropriate indications and dosages, correctly 
dispense the drugs and include appropriate information for each patient. Conversely, 
patients are required to use the drugs properly and adhere to treatment with basic 
knowledge about diseases and the use of medications. In fact, problems of non-adherence 
to medication still persist particularly among the elderly with chronic diseases. However, 
the policy currently encourages the community-based approach which means that 
patients are required to have basic knowledge of self-care, particularly with diseases that 
they have already experienced. 
Access to medicines from this study is centred mainly on the supply side or public 
health care providers. In addition, availability, affordability and good quality of 
medicines are the three crucial concerns for the provision of drug supply. Although drug 
management under the UCS in Pathumthani Province may not totally comply with the 
DMC proposed by WHO, it demonstrated attempts to expand adequate provision of good 
quality essential drugs to all the population with affordable prices or no charge. In 
addition, the high proportion of both value and volume of drug purchases compared to 
other health care commodities suggests that without government involvement and 
investment in the UCS, the poor would be denied access to medicines. 
Equity of access to medicines in Pathumthani Province is dependent on both drug 
management and the coverage of the UCS given by public health care providers. 
However, the results from this study suggest that drug management helped in providing 
good quality medicines that were both available and affordable for all of the population, 
regardless of income, social status or entitlements. Therefore, the drug management 
system in Pathumthani Province clearly improved the equity of access to medicines from 
how it was before the implementation of the UCS. The success of managing drug supply 
nevertheless relied mainly on both collaborative assistance from communities and the 
efficient management of the UCS by the public sector. In addition, achievement in 
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managing drug supply cannot be addressed in isolation either from the rest of the health 
system or from the overall health circumstance. 
8.2.3 Were Patients Satisfied with Medicines Management and Health Care Services 
from Public Health Care Providers in Pathumthani Province? 
Findings from the quantitative data on patients' attitudes towards medicines management 
and health care services in public health care providers suggests that patients were likely 
to be satisfied with the quality of drugs, pharmacy services and overall health care 
services. However, these results are only a basic assessment for services given by public 
health care providers which may only partially represent the quality of care from patients' 
perspectives. Although patients were satisfied with medicines supply and health care 
services, the quantitative findings also suggest that patients still want to see an 
improvement in health care services, such as a faster, more competitive service and 
greater accessibility to other pharmacy services (e. g. drug counselling or drug 
information services). 
Admittedly, long waiting times in public health care providers were likely to pose 
major problems to both patients and members of health care staff and in fact, they did 
result in the lowering of the patients' satisfaction towards the overall health care services. 
This situation was due to the dramatic increase in the number of people covered by the 
UCS within recent years and the shortage of members of health care staff to provide the 
health care services. However, to assure equity of access to essential drugs for patients, a 
proper drug management system which focuses on quality, availability and affordability 
of medicines in a public health care provider must be established by using the DMC as a 
guideline. 
8.2.4 What were the Factors Affecting Patients Accessing Medicines? 
Factors affecting patients' access to medicines can be viewed in two ways: factors 
regarding drug management in a health care provider and factors relating to health care 
users' access to health care services. The former refers to major factors of this study 
which relate to the medicines supply system in public health care providers. The latter 
identifies factors that health care users experience when seeking help from health care 
providers. The explanations of these two main factors are presented as follows: 
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8.2.4.1 Factors Regarding Medicines Management in Public Health Care Providers 
The data from the qualitative findings explains that the key factors affecting patients 
accessing medicines are the availability, quality and affordability of drugs. The 
Availability of medicines is considered to be crucial in a health care system. Having drugs 
available at all times in a health care provider may encourage patients to use health care 
services and participate in health care activities. In addition, availability of medicines 
could help to promote trust and confidence in patients to use health care services. Quality 
of drugs is important because it influences the success of treatment and patients' 
adherence to medication. Inefficient drugs may lead to severe consequences such as 
adverse drug reactions, drug interactions or overspending on drug budget. In terms of 
affordability, a pharmacist sometimes faces a dilemma in drug management due to cost- 
effectiveness of medicines. For instance, by trying to lower drug costs to save drug 
budgets, a pharmacist may find that the quality of drugs gets worse. However, the 
decision should be based on drug quality with the possibilities of lower costs without 
adversely affecting the quality of drugs. 
Adjustment of the drug management system with regard to the DMC could result in an 
efficient drug supply system which would in turn help to improve equity of access to 
medicines for all the population. However, one would argue that this seems to be unfair 
since it looks like health care benefits have been downgraded. Conversely, the poor 
would state that their health has been secured by the UCS and thus they are satisfied that 
everyone who seeks care receives drugs from the same drug list with non-selective 
services. For example, drugs in public health care providers have been changed regarding 
the generic drug policy in recent years. As a result, CSMBS beneficiaries who used to be 
prescribed branded-name drugs shifted to using generic drugs similar to other patients. A 
decrease or increase in health care benefits could occur when the health care reforms are 
implemented. However, the most important concern is whether such changes result in 
increasing benefits for the majority of the population, while the benefits from some 
groups of population decrease or remain the same. Yet these changes must occur without 
deteriorating the overall health status. Regarding this aspect, equity of access to health 
care has been alleviated. 
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8.2.4.2 Factors Relating to Access to Medicines by Health Care Users 
The data from the quantitative findings indicate that there are three key factors 
influencing patients to access medicines from public health care providers. First, the UCS 
covered the majority of population in Pathumthani Province and was expected to expand 
its coverage to the entire population within the next few years. The uninsured and people 
already insured but who migrated from other provinces are not allowed to use health care 
services free of charge or to claim for the thirty baht co-payment unless the health care 
services are needed for an emergency or complied with the referral system. As a result, 
this comes to the second factor which refers to incurred costs. Such costs occur when 
health care users decide to seek care from public health care providers. These costs also 
refer to transportation costs, health care costs and other costs (e. g. food or drink while 
waiting for care) which are patients' out-of-pocket expenses. In addition, illnesses, 
particularly chronic diseases such as hypertension, diabetes or heart disease determine the 
number of visits to a health care provider and access to medicines. In this study, patients 
were required to repeat their medications with respect to the appointments arranged by 
doctors. 
The frequency of patients' visits to a health care provider depended on the amount of 
drugs prescribed. For example, patients with hypertension usually receive 
antihypertensive drugs to cover the disease for a period of one to two months, while for 
diabetes, patients are required to repeat their medication every single month. Obviously, 
patients, especially those with chronic diseases, visit health care providers regularly 
because they need medicines for treatment. Nonetheless, in some situations (e. g. 
emergency or referral) patients may visit other health care providers which are neither 
their main contractors nor sub-contractors. In these cases, convenience of access is their 
first priority. 
8.2.5 What were the Roles of Pharmacists in Promoting Equity in Access to 
Medicines Provision under the Universal Coverage Scheme in Pathumthani 
Province? 
A pharmacy department is a central unit for drug supply in a health care provider. Thus, a 
pharmacist plays an important role in improving equity in access to medicines provision 
through medicines management, pharmacy services and health promotion. First of all, the 
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role of a pharmacist in medicines management is to be in charge of selection, 
procurement, distribution and use of medicines. In addition, these processes aim to 
improve the availability and affordability of good quality medicines in public health care 
facilities and determine drug costs which are affordable for the majority of the 
population. However, to some extent, the role of a pharmacist in drug management was 
influenced by close supervision from a hospital administrator or the provincial health 
office. Requests to procure drugs which did not correspond to the needs of public health 
care providers led to problems in drug management, such as excesses in drug stock, dead 
stock or shortages of essential drugs. To alleviate this administrative problem, a health 
care provider should have set up a PTC to determine the rational use and to secure the 
transparency of drug purchases, while the pharmacist remained a key person in providing 
drug information to aid the decision of the PTC. 
Secondly, pharmacy services in a public health care provider emphasise that a 
responsibility of a pharmacist is to promote rational use of drugs to both health care staff 
and patients. The role with health care professionals is centred mainly on drug 
information services and monitoring drugs for possible side effects. In terms of working 
with patients, pharmacy services are a combination of community pharmacy work and 
clinical knowledge, focusing on promoting rational drug use to patients inside public 
health care providers and in the community. Obviously, pharmacy services in a health 
care provider demonstrate the role of pharmacists in drug dispensing and clinical 
pharmacy, while responsibilities outside health care facilities are based on community 
participation in health care services and health promotion. 
Thirdly, regarding the orientation of the contemporary health policy, public health 
care providers are responsible for community-based health care services which encourage 
pharmacists to work with people in villages or at a PCU. In addition, a pharmacist is 
expected to be a drug counsellor able to provide drug information to both health care staff 
and patients at the PCU level. However, under this policy, a shortage of pharmacists to 
fulfil such requirements caused difficulties for them as they had to work for both a 
hospital and a PCU. 
Although it appeared that the roles of pharmacists are essential to both health care 
providers and communities, too many responsibilities could lead to inefficiencies in work 
performance, particularly when the shortage of pharmacists is a severe problem. Unlike 
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other health care professionals, the job description of a pharmacist includes a wide range 
of responsibilities from clinical pharmacy (e. g. drug counselling, monitoring drug use or 
providing drug information services) and community pharmacy (drug dispensing) to 
consumer protection (surveillance and inspection of dangerous food, drugs and cosmetics 
in communities). However, a pharmacist may need to prioritise the importance of their 
individual responsibilities in relation to the UCS policy. 
8.2.6 What are the Recommendations for a Province Applying the Drug 
Management Cycle to Improve Equity of Access to Medicines in the Public Health 
Care System under the Universal Coverage Scheme? 
This study proposes recommendations based on availability and affordability of good 
quality medicines which were performed through the DMC. Hence, recommendations for 
improving equity of access to medicines in a province are presented in relation to the four 
processes of the DMC as the follows: 
" The Selection Process: The estimation for the demands of drugs was based on data 
regarding drug consumption from previous years. In addition, the PTC was involved 
in determining a drug list for a health care provider which includes all essential 
medicines used for that provider. However, no representatives from any PCUs were 
appointed as a member of the PTC at the district level where a district hospital 
selected drugs on behalf of the PCU. This meant that the drug list for PCUs may not 
correspond with the community's needs of which could lead to an unavailability of 
medicines particularly at the PCU level. Thus, the drug selection process at any levels 
of a health care system should include a drug-related member of staff from the place 
where the list is to be applied. In addition, the process of choosing drugs for creating 
a drug list must comply with the actual needs of the operational units that require 
them and must be based on existing data on drug consumption. 
" The Procurement Process: Drug procurement in Pathumthani Province consisted of a 
combination of the Pooled Purchase, Direct Purchase and Open Tender methods. 
Pooled Purchase is a system for acquiring drugs in bulk. However, the transparency 
of pooled purchase is demonstrated through the practice that the provincial health 
office is not involved with the decision of the PPTC. This decision relates to choosing 
the most eligible companies for Pooled Purchase and negotiating drug prices. For 
Direct Purchase and Open Tender, bureaucratic rules and regulations from the GPO 
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regarding drug procurement should be revised and adjusted to alleviate those time- 
consuming drug delivery processes. Moreover, drug quality must be confirmed by 
having them retested in the MOPH central lab or regional medical science centres. 
" The Distribution Process: The method of drug distribution used in Pathumthani 
Province was the Pull System, which needs a well-established collaboration between 
a pharmacy department and operational units (including PCUs) for it to work 
effectively. In addition, storage conditions (e. g. temperature, space and cleanliness) 
must be improved to maintain drug quality. 
" Rational Drug Use: This focuses mainly on rational drug use by both health care 
professionals and patients. For health care professionals, the monitoring of drugs and 
the double checking of prescriptions can be performed by a pharmacist in 
collaboration with other operational units. In addition, continued education or special 
courses in clinical drug use and updating their knowledge of diseases may help health 
care professionals to boost their awareness and understanding which could result in 
improving rational drug use among staff in health care facilities. Rational drug use in 
patients also requires collaboration with health care staff. The ideal is that the 
majority of patients in communities have basic knowledge in self-care, adhere to 
treatment and participate in health care activities. 
The DMC proposes useful approaches for efficient medicines management in health 
care facilities. However, each process in drug management should be adjusted to 
correspond with the circumstances in health care facilities before implementation. After 
applying the DMC to a health system, an evaluation of the drug management system is 
necessary. In order to successfully manage drug supply in the public health system and 
improve access to medicines, the quality, availability and affordability of such should be 
focused on. 
Other concerns beyond the DMC are health care resources that support the medicines 
supply system. In reality, shortages of health care professionals (e. g. doctors, dentists, 
pharmacists and nurses) to work in public health care facilities have considerably 
affected health care tasks. Excessive workload from routine jobs to work in a hospital and 
an additional task at a PCU for a pharmacist could undermine the total performance of 
drug management and other pharmacy services in the long run. In addition, the funding 
for drug procurement is obtained totally from taxation. Such a system has already caused 
severe problems in many public health care providers, mostly regarding inadequacies of 
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drug budgets. Alternative sources of funding such as donation, establishing a public- 
private collaboration or setting up a health care network with the non-governmental 
organisations (NGOs) should be determined by public health care providers. 
8.3 IMPLICATIONS OF THE DRUG MANAGEMENT CYCLE FOR THE 
HEALTH CARE SYSTEM UNDER THE UNIVERSAL COVERAGE SCHEME 
In the presence of a concerted effort to ensure that a health care system reaches 
disadvantaged groups more effectively, the UCS demonstrates that it has strived to 
expand health care coverage to the majority of the population and aims to diminish 
inequalities in access to health care among health care users. Although it is perceived that 
the expansion of the UCS to cover all the population is a desirable goal to narrow the gap 
in access to health care services between the rich and the poor, there are substantial 
criticisms about the sustainability of the UCS. One major concern is that the MOPH 
budget for the UCS increases every year, while health care resources remain limited and 
the annual budget to support the UCS is obtained only from taxation (MOPH 2002). 
Other concerns relate to the goal of health care coverage and the difference in health 
care benefits between each UCS sub-scheme. The former refers to the MOPH's aims to 
expand the UCS coverage to the most of the Thai population, ideally to reach 100% 
coverage. This goal motivates all public health care providers to increase the number of 
people registered for the UCS in their areas. As a result, health care coverage increases 
dramatically but it is only confined to the area where people register with their main 
contractors or sub-contractors. In reality, the number of people in a province is not static 
and people often migrate from one place to other areas. Under the UCS's conditions, 
these people can only make limited use of services from public health care providers, 
such as accident and emergency services or the provincial referral system from health 
care providers in other areas. Although the overall health care coverage increases, the 
inflexibility of governmental rules and regulations around the cross-border health care 
policy may hinder people from accessing health care services based on their needs, 
necessities and convenience. 
The latter refers to the differences in health care services between each UCS sub- 
scheme. Although the MOPH states that health care services in a public health care 
provider employs the same standards for every patient, the attitudes towards the health 
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care system for some patients remain unchanged from the past. The quality of health care 
services used to vary in relation to the sub-scheme that a patient was registered with. For 
instance, if two patients, a civil servant under the CSMBS and a patient under the free 
health insurance scheme for the poor, came to a public hospital at the same time with the 
same health problems, the civil servant would have spent less time waiting for a doctor 
than the poorer patient. This situation had continued for many decades and the perception 
that some patients received poor quality health care services from public health care 
providers was common and this perception still persists for current health care services. 
To improve the image of health care services, health care providers should emphasise and 
demonstrate that the same standard is applied to everyone equally in the provision of 
health care services. For instance, the high quality care at the OPD must be applied to all 
patients and patients must comply with the queuing system. Moreover, good quality drugs 
under the generic drug policy must be available and affordable for all patients. 
Medicines are essential not only to the health care system but the UCS also relies 
mainly on the availability and affordability of good quality medicines to fulfil the needs 
of both prescribers and patients. In addition, medicines could help promote trust and 
patients' participation in other health care activities (such as self-care and a surveillance 
programme for infectious diseases). Efficient medicines management in public health 
care providers is one indicator for assessing equity in access to health care from patients. 
Hence, the expansion of the UCS coverage can rectify the limitations of the previous 
health insurance scheme which excluded most of the disadvantaged and the poor in the 
Thai society. One of the crucial aims of such an expansion is to improve access to good 
quality medicines under a proper medicines management system in a public health care 
provider. Thus, these demonstrate the importance of medicines and emphasise that a 
proper medicines management system could help improve equity in health care, as stated 
in Chapter 3. 
This thesis has proposed that in relation to the previous drug management system 
(before the implementation of the UCS in April 2001), inequity of access to medicines 
may have existed. In these circumstances, the DMC, which is a guideline for medicines 
management and has been implemented in many developing countries for decades, is 
applied to the Thai health care system. The qualitative study centred mainly on the actual 
process of medicines management which enhances the explanatory potential of the DMC 
to the health care system. This has been achieved by focusing on the four processes of the 
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DMC, selection, procurement, distribution and rational use, with proper adjustment to the 
situations at different levels of a health care system. The DMC could be adapted for both 
public and private health care providers to prove that their medicines management 
systems are proper and ensure that good quality medicines are available and affordable 
for patients. Moreover, this can be linked to further explanation of equity in access to 
medicines provision in health care facilities. 
Quantitative data from the survey aims to describe the outcome of medicines 
management by focusing on health care users' attitudes towards health care services in 
public health care providers. The findings provide a fundamental assessment of care and 
can be used as evidence for improving medicines management and health care services in 
public health care providers. In addition, factors preventing patients from seeking care 
were the UCS entitlements, incurred costs and the diseases themselves. These findings 
suggest that the future policy should not only address inequalities across health insurance 
schemes, but should also focus more on differences between the UCS sub-schemes 
themselves. In addition, to improve the satisfaction in access to health care, the cross- 
border policy for accessing health care services besides the main contractor or sub- 
contractor should be implemented and allow people to have more freedom to choose the 
available health care services based on their preferences and convenience. 
Although the rapid expansion of the UCS coverage in a province reflects that there are 
more people participating in the health care sub-schemes, it does not necessarily indicate 
that they could access to medicines from their main contractors or sub-contractors. The 
combination of qualitative and quantitative findings with the routine data from 
Pathumthani Province could help the province to discover the specific situation in access 
to medicines in health care facilities. For instance, patients in a village may be able to 
visit a PCU easily from their homes. However, they may not be prescribed medicines if 
medicines are not available or out-of-stock. In some cases, medicines may be available 
but they are stored in an improper condition which results in the degradation of drugs 
before their expiry date. The data from the three sources are useful in planning a policy 
for improving equity of access to medicines provision by having the DMC as a guideline 
for proper medicines management. However, issues around the universality of health care 
services across the levels of the health care system and the efficient medicines supply 
system when people migrate between housing registration areas will need to be further 
explored. 
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8.4 STUDY LIMITATIONS 
Certain limitations of cross-sectional survey need to be acknowledged as follows: 
" First, since all private health care providers in Pathumthani Province opted out of the 
UCS before the data collection, both qualitative and quantitative data were only 
collected from public health care providers that participated in the UCS. Therefore, it 
is not possible to be certain that medicines management in the private sector applied 
the same approaches as in the public sector. 
Second, before the qualitative interview with health care stakeholders, all PCUs in 
Pathumthani Province were asked whether they wished to participate in this study 
However, only two heads of a PCU accepted to take part in the semi-structured 
interview. The qualitative data regarding the opinions towards the DMC at the 
community or PCU level obtained may represent the situation of medicines 
management from these two PCUs. 
" Third, from literature review, equity in health care can be viewed from many aspects. 
However, this study centred on medicines which are regarded as one of the most 
crucial components in a health care system. In addition, the study is based on the 
hypothesis that if medicines are managed properly, this will help improving equity of 
access to health care services. Other health care services such as consultation with 
GPs or specialists and access to investigation (e. g. X-ray or lab test) or surgery were 
not included in this study. However, the overall health care service of public health 
care providers was assessed by the respondents. 
" Fourth, since the majority of respondents in the quantitative survey were elderly; they 
may not have the same views as younger patients who accessed and used health care 
services at public health care facilities. The reasons were that this study was intended 
to collect data from patients who regularly use health care services in the public 
sector. Thus, they could acknowledge and point out any changes, such as medicines in 
their prescriptions, the quality of health care services and the efficiency of health care 
staff after the UCS implementation. Beyond these reasons, both diabetes and 
hypertension were among the top five diseases of which consumed the second highest 
drug budget value between 2002 and 2004 (Department of Health Care Projects 
2004). 
" Fifth, with specific reference to qualitative investigation, sampling in qualitative 
involves purposive selection of health care stakeholders who were key members of 
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the PTC. In addition, the investigation should have expanded to other members of 
health care staff who also involve in drug use, such as nurses, dentists, or heath care 
technicians, to obtain more information regarding their views towards an application 
of the DMC to the health care facilities. 
" Sixth, the meaning of `needs assessment' in the selection process of the DMC was 
defined by health care stakeholders in the sense of demands for medicines supply 
rather than health needs assessment in depth. Qualitative data also showed that the 
majority of respondents considered drug volume and value of purchase from previous 
years to create a drug list. Thus, this was called needs assessment which might not 
convey the precise meaning of the term. However, future studies should focus on 
health care needs from patients with different UCS sub-schemes. 
Notwithstanding these limitations, the findings have important implications for the 
explanation of the processes of managing medicines supply which help improving access 
to medicines provision in the public health care system. 
8.5 RECOMMENDATIONS 
With the limitations of this study, recommendations for future research are described as 
follows: 
" Although, the data were only collected from health care users (DM or HT 
patients) and health care providers (nominated health care stakeholders), findings 
are useful to explain the relationship between these two sectors. Selected health 
care stakeholders involved directly in the DMC, while DM or HT patients were 
regular and long-term health care users who were aware of any changes in the 
health care system. The general 1seability of findings should be focused on 
availability and affordability of good quality medicines under the DMC which is 
key to the success in improving equity of access to essential medicines. In 
addition, the satisfaction of patients who access medicines is a complimentary 
explanation of how efficient the drug management system in a province is. 
Differences and similarities of these two key aspects can be made by comparing 
the medicines management situations with other provinces or regions. 
" Alternatively, a qualitative study of patients' satisfaction towards the use of health 
care services would be conducted. The data obtained from the interviews could 
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further an explanation from this study in some issues that were confined by the 
limitation of the questionnaires from this study. The main topics may include in 
depth attitudes towards the quality of medicines (including side effects, drug 
compliance or patients' behaviours that worsen or improve the condition of 
diseases, etc. ) and health care services (including complaints, praise, other 
feelings towards care received, etc. ). 
" This study was not conducted in the private sector because they opted out of the 
UCS in Pathumthani Province in 2005. Hence, it is strongly recommended that 
future research, if possible, include private health care providers. The expansion 
of the study to other provinces or regions would be useful for further explanation 
of the suitability of the DMC in increasing equity of access to medicines by 
improving availability and affordability of good quality medicines. 
" Herbal or traditional medicines are part of local health care wisdom and a few 
health care providers have integrated them to their health care services. However, 
with the concept of alternative medicine and the room for non-essential drugs in a 
health care provider, the DMC may include the management of herbal medicines 
which will provide more options for curative care to patients. A study of the 
feasibility of including traditional medicines in a hospital's drug list should be 
conducted to explore the attitudes of both health care providers and patients 
towards herbal treatment. A survey in communities to registered herbal medicines 
formulae shall also be conducted through PCUs alongside the mentioned survey in 
a health care provider. 
" One major problem in health care found in Pathumthani Province is illegal 
immigrants from neighbouring countries. Obviously, these people are not covered 
by any UCS sub-schemes and need to pay in full for any incurred health care 
costs. In reality, they may not be able to afford the whole cost of treatment, 
especially for chronic diseases such as hypertension, diabetes or heart disease. 
Thus, a study based on these immigrants should be conducted by focusing on how 
to improve their access to health care services and whether or not the DMC can be 
generalised to increase availability and affordability of medicines for them. 
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8.6 CONCLUSION 
Equity of access to medicines provision in Pathumthani Province focuses mainly on 
medicines management in the public sector. Factors affecting equity of access to 
medicines in public health care facilities relate to the quality, availability, and 
affordability of medicines. To improve equity of access to medicines, the DMC has 
played a crucial role in adjusting the medicines management system in the province. 
However, the implementation of the DMC in a health care system relies mainly on the 
levels of care it is applied to. Conversely, factors relating to health care users' access to 
medicines refer to the UCS sub-schemes, incurred costs when access health care services, 
and diseases themselves. Moreover, a pharmacist is a key person in the drug management 
process who strives to establish collaboration between a pharmacy department and other 
operational units as well as integration of various responsibilities, such as medicines 
management, health care services, and clinical knowledge into pharmacy services. 
Patients' satisfaction towards health care services is also regarded as a crucial issue 
which reflects the performance of a health care provider. A survey conducted before 2001 
among the public, private for-profit and private non-profit hospitals showed that 
outpatients were less satisfied with health care services received from public hospitals 
than private for-profit ones (Tangcharoensathien et al. 1999). However, after 2001, a 
survey conducted by the National Health Security Office in 2005 reported that more than 
90% of respondents were satisfied with the UCS and more than 85% were satisfied with 
their prescribed medicines (NHSO 2005). This was also supported by a subsequent study 
in 2006 which resulted in higher patients' satisfaction for both UCS and medicines (92% 
and 87% respectively) (NHSO 2006b). The increase in patients' satisfaction was due to 
the expansion of the UCS coverage. More people have been included in the scheme with 
an enormous improvement in health care services. To ensure that care is provided 
consistently across all health care providers (both public and private sectors), Hospital 
Accreditation (HA) which is an assessment from MOPH has been imposed to all health 
care providers under MOPH's supervision. The criteria specified in HA practice cover all 
health care services, including both curative care and health promotion. For medicines, 
both generic drug and one hospital drug list policies demonstrate that no difference 
among patients across the UCS sub-schemes for access to medicines. All patients with 
any health care entitlements use drugs from the same drug list. Thus, patients satisfaction 
has increased since 2001 onwards. 
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To evaluate equity in access to health care, both Daniels (1995) and Mooney (1983) 
emphasise that equity would be best measured from the supply side (Daniels 
1995; Mooney 1983). The term `supply side' refers to a health care provider who provides 
health care services for patients. In addition, WHO (1997) states that one of the most 
important and indispensable health care services that both public and private sector 
provide for patients often refers to medicines (WHO 1997e). Thus, WHO proposes the 
Drug Management Cycle which is a guideline for medicines management and plays an 
important role in improving equity in access to medicines through its four processes, 
selection, procurement, distribution and rational drug use. 
This thesis demonstrates that an efficient and appropriate medicines management 
system in a public health care provider could lead to an improvement in the equity of 
access to medicines. In addition, this may also encourage patients to participate in other 
health care activities. Expanding access to medicines requires attention to a diverse set of 
policies beyond the DMC. Challenges and solutions should start with an understanding of 
the local health care situation including demographic, economic, regulatory and cultural 
contexts. Improving equity of access to medicines also involves ongoing support from a 
range of health care stakeholders and cannot be addressed in isolation either from the rest 
of the health care system or from overall health circumstances. Although much more will 
inevitably need to be learned by applying the DMC to other settings, this thesis provides 
the basis for establishing a method of examining equity in access to health care services 
by focusing on medicines management in the public sector. 
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Approval Letter for Data Collection from Pathumthani Province 
Rctcrencc No, ! '1'002T1tt;, SS I'ttthtunthani City l lall, 
Pnthumthani-Samkok Road, 
Amphue Muang. 
Pathumthani 12000 
THAILAND 
27`x' December 2005 
Subject: Permiosi< n fur the data collection in Pathuntthani Province 
Dear dead of Department of ti: laidemiology, Public I lealth & Primary Care, 
Imperial College London 
Re: hir Sur sak SOON'l HORN 
I am writing, concerning Mr Surasak SOONTHORN's request liar the 
permission of his data collection in Pathuntthani Province between IQ" January and 
19" February 2006, The project was reviewed by the Provincial Ethical Committee 
and has been approved. 
I would he grateful if the complete copy of the thesis be submitted to 
l"uhunrtharn Province for future relerencc. 
Yours sincercl), 
ujwý 
owtioký (Dr Wichai Wechosotsa da) 
I)ir¬; ctor of I'athunnthani Public Health Office 
Acting on behalf ¬of 
Chief cal' Pnthumthani Province 
fiuntan Resource IJcwciap®nnt hittisu m 
Pntht > thani Public Hxalih OTce 
Tel "6( 2 581-äd54 cxm 404,408 
Fax, .:,. 66 2 581 6130 ext 200 
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APPENDIX B 
Letter from Supervisor to Pathumthani Province 
Imperial College 
15 November 2005 
Department of Department of Epidemiology, 
Public Health & Primary Care 
Imperial College London 
3rd floor, Reynolds Building 
Charing Cross campus 
St Dunstan's Road 
London W6 8RP 
Tel: +44 (0)20 7594 3368 Fax: +44 (0)20 
7594 0854 
a. majeed@imperial. ac. uk 
Azeem Majeed MD FRCGP FFPH 
Head of Department 
Pathumthani City Hall 
Muang, Pathumthani 
12000 
Thailand 
Dear Chief of Pathumthani Province, 
Re: Mr Surasak Soonthorn - PhD Project 
I am writing concerning Mr Surasak Soonthorn, a full-time PhD student in the Department of 
Epidemiology, Public Health & Primary Care, Faculty of Medicine, Imperial College London, 
University of London, UK. His research project is titled `Equity in Access to Medicines 
Provision under the Universal Coverage Scheme in Pathumthani Province Thailand' and is 
related to Thailand's Health Care System after implementing the Thirty Baht Scheme in 2001. 
As part of the PhD studies, Mr Soonthorn has planned to collect his data between January and 
February 2006 in Pathumthani Province. He will administer questionnaires to patients with 
hypertension or diabetes from the outpatient department (OPD) to obtain information on attitudes 
towards drug provision and satisfaction with health care services. In addition, the semi-structured 
interviews will be applied to health care stakeholders from each health care level to obtain 
opinions towards medicines management. 
The aim of the study is to assess medicines management applied to the health care system which 
has been expected to help improve equity in access to health care. The study will provide 
information of general interest and I expect the results to be published in academic journals. 
I should be grateful if you would kindly permit Mr Soonthorn to carry out his research project in 
Pathumthani Province. Should you need further information, please do not hesitate to contact me. 
Yours sincerely, 
(Azeem Majeed) 
Professor Azeem Majeed MD FRCGP FFPH 
Head of Department & Professor of Primary Care 
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APPENDIX B (Continued) 
Letter from Supervisor to BMA Medical College and Vajira Hospital, Bangkok 
(For pre-testing of the questionnaires) 
Department of Department of Epidemiology, 
Imperial College 
Public Health & Primary Care 
Imperial College London 
3rd floor, Reynolds Building 
Charing Cross campus 
St Dunstan's Road 
London W6 8RP 
Tel: +44 (0)20 7594 3368 Fax: +44 (0)20 
7594 0854 
a. majeed@imperia1. ac. uk 
5th January 2006 Azeem Majeed MD FRCGP FFPH 
Head of Department 
BMA Medical College and Vajira Hospital 
681 Samsen Road, 
Dusit, Bangkok 
10300 
Thailand 
Dear Dean/Director of BMA Medical College and Vajira Hospital 
I am writing concerning Mr Surasak Soonthorn, a full-time PhD student in the Department of 
Epidemiology, Public Health & Primary Care, Faculty of Medicine, Imperial College London, 
University of London, UK. His research project is titled `Equity in Access to Medicines 
Provision under the Universal Coverage Scheme in Pathumthani Province Thailand' and is 
related to Thailand's Health Care System after implementing the Thirty Baht Scheme in 2001. 
As part of the PhD studies, Mr Soonthorn has planned to pilot his data collection on 10th January 
2006 at Vajira Hospital. He will administer the pilot questionnaires to five to ten patients with 
hypertension (HT) or diabetes (DM) from the outpatient department (OPD) to obtain information 
on attitudes towards drug provision and satisfaction with health care services. In addition, 
between 16th January and 19th February the total of 400 questionnaires will be applied to the 
hypertension and diabetes patients from the OPD in Pathumthani Province as a field survey. 
The aim of the study is to assess medicines management applied to the health care system which 
has been expected to help improve equity in access to health care. The study will provide 
information of general interest and I expect the results to be published in academic journals. 
I should be grateful if you would kindly permit Mr Soonthorn to carry out his pilot study in BMA 
Medical College and Vajira Hospital. Should you need further information, please do not hesitate 
to contact me. 
Yours sincerely, 
(Azeem Majeed) 
Professor Azeem Majeed MD FRCGP FFPH 
Head of Department & Professor of Primary Care 
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APPENDIX C 
The Semi-structured Interview Topic List for Health Care Stakeholders (English 
Version) 
I. THE PROCESSES OF MEDICINES MANAGEMENT IN PATHUMTHANI PROVINCE AFTER 
THE IMPLEMENTATION OF THE UNIVERSAL COVERAGE SCHEME 
1. SELECTION 
1.1 Drug List 
1.1.1 Management structure of the Essential Drug List (EDL) 
Has the EDL been officially adopted and distributed in the province? 
Is there an official drug committee (e. g. the Pharmacy and Therapeutic Committee; 
PTC) whose duties include updating the EDL? 
Has the EDL been updated and distributed throughout the province in the past three 
years? 
How to select drugs for a hospital's drug list (using ABC or VEN)? Is the process 
complied with the provincial policy? 
1.1.2 Outcomes of the selection process 
Does the health care provider have the EDL? How to classify drugs into groups? (e. g. 
by strengths and generic names) 
How may drug items on the EDL? What is the proportion of ED: NED? 
Is there more than one EDL in a health care provider? 
1.1.3 The use of the EDL for the public sector 
What is the tendency of drug use in a health care provider? 
What is the average drug budget value spent on drug purchase for one year? 
Do you think that the EDL is necessary? 
1.2 Needs Assessment 
" What is the definition of needs assessment? 
" Who perform needs assessment'? 
" What is the process of needs assessment in a health care provider? 
" What are factors affecting the process of needs assessment in a health care provider? 
2. PROCUREMENT 
2.1 Procurement Systems 
" Which methods do you use for drug procurement? (e. g. open tender, pooled purchase or direct 
purchase) 
" What are the main drug supply sources or supporters? 
" What are the problems in drug purchase'? 
2.2 Drug Budget 
" What is/are your source(s) for drug budget in the procurement process? 
" How to comply with the governmental rules and regulations in using drug budget? 
" Is the drug budget sufficient for each fiscal year? If not, how will you manage to deal with the 
problems? 
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What are the problems and obstacles in the allocation of drug budget from the provincial 
health office? 
2.3 Quality of Drugs 
How to examine the quality of drugs? 
Are the drugs from GPO different from those manufactured by private drug suppliers? 
If there are problems regarding the quality of drugs, how will you manage or alleviate the 
situations? 
3. DISTRIBUTION 
3.1 Drug distribution system 
" How do you manage the drug distribution process in your hospital? Is it the Push or the Pull 
systems? 
" Is there the distribution of drugs to the health care providers in the lower levels of the health 
care system? 
" Is the distribution of drugs to the health care providers in the lower levels of the health care 
system different from the system before an implementation of the UCS? 
" What is the desirable distribution system from your point of view? 
3.2 Storage 
" What is the process of drug storage in this health care provider? 
" Have you ever experienced drugs being out-of-stock? How do you deal with such a problem? 
" If you have experienced any problems in drug storage, which solutions did you use to solve 
the problem? 
3.3 Delivery 
" Which method do you use for drug delivery, collection or delivery? 
" Who involves in this process? 
" How will you check that drugs delivered to the operational units are really used for health care 
services? 
" In case you have a sub-stock, how will you check the expiry date for drugs? 
" Do you think the sub-stock is useful? 
4. USE 
" What is the meaning of drug use in health care facilities? 
" Are you satisfied with the current situation of drug use in your health care facilities? What are 
the strengths and weaknesses of the use of drugs in your hospital'? 
" What is rational drug use? How will your hospital achieve this concept? Is it possible to 
implement it to your hospital? 
" Who should involve in drug use in health care facilities? 
" How will you improve prescribers or dispensers to use drugs correctly and suitably? 
" How will you encourage patients to comply with medications or treatment? 
" What are the roles of a pharmacist in promoting rational drugs use? 
II. DIFFERENCES AND SIMILARITIES OF MEDICINES MANAGEMENT IN PATHUMTHANI 
PROVINCE AFTER AN IMPLEMENTATION OF THE UCS 
" In each process of the DMC, what are differences and similarities from the previous system? 
" Do these changes in medicines management result in an improvement of the medicines supply 
system in the province? 
" Is it proper that what remains unchanged in the drug management process will need to be adjusted 
for an improvement of drug management? Or should it remain the same as it is? 
" Is it possible to apply these changes to be implemented in other provinces? What recommendations 
can you provide for other provinces? 
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III. THE ROLES OF PHARMACISTS IN IMPROVING EQUITY OF ACCESS TO MEDICINES 
PROVISION 
" What are the roles of pharmacists in promoting and enhancing equity of access to medicines? 
" Does the role of pharmacists change after the implantation of the UCS? 
" What are key factors that help improving access to medicines? 
" What is your opinion about the community-based approach that the MOPH encourages all public 
health care providers to apply it to their health care system? How will you apply this approach to 
pharmacy services`? 
" Which responsibility of the pharmacy services should be promoted to improve equity of access to 
medicines and health care services? 
" Are there any members of health care staff in a health care system who influence the pharmacist's 
roles in medicines management? 
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APPENDIX C (Continued) 
The Semi-structured Interview Topic List for Health Care Stakeholders (Thai 
Version) 
ýum 
I. Drug Management Cycle (DMC) 
1 n-vsOimLAan n (Selection) 
1.1 ¶ 1umsm (Drug List) 
1.1.1 fOsýr (Essential Drug List: EDL) 
" °iuäývrýýýJvýýsýü"1ýýýý5äývýýv¬uýi¬ýývaýnýýýäývs7 1 Eftii wing ý5arý¬ý-i, jiý 
" VI 1Jý5ý9tiVf111J 1cý9JF1il1vf1555Jf1"15G1"1Lth i"ll1dS 1d1dVi5e713J 12J1d G1i11ýf1555Jf1 156f1s %Sf15571 
16aM-159J'11YM (PTC) deJV{1111/IZ1Jf115iNa15ill"11ý51J1ý5ý99JiU2 ¬J"121eýdý5JtiMEl 11J 1ý 
" (lýlfl"151ý5111ýSJ]JiUi fJ"19J"1ý7VISr7'ý7J lu5aii 3 U1441'nawi 
f-I5AMLA@n Li(ABC or VEN) 6oon3AiAzTm A¬nnu 
(s11LdE11%Jr7Jäd1ýf7G11ýfSe7ýSJ ad-1,315 
1.1.2 wýý7ýs"vý7Rýýsýi n6 anE/-7 
7JfJ lýld]J£1J% FJ m6nT@131551NFJ IU-1a1A @U lLcývfl"15ä(1ll9JJlltidl/1'leý¬11d t (62ýtidGl 15 
F171ýILL 1Jeld¬111ýf5e]G119J%ýe7sý1ýJE11ý 
ri'lluilcuINVIdViýJGlflSlEln 16cýnlo5i 7u ED: NED 6iJuýiLlJ@56 uni 
ýIfl 15äG11/1 19J¬1J2%fJ"1ý5ý91Nu 11J 1cý7J lflfl ä"1 11 fU- Vi5e@17J L' BULL Jf15UuVi7'1djn al21L nl() 
6lcývGlYbý219J(l5V1 I3 
y 
1.1.3 fl75,721fi7t17atiPj.? 7E/7ui; rh7ur'f7ranfi7zi7 '2Ith15 
" LLWf -aumi -seiA uiTu-Brnm4fliJ 5,31q¬J1v-IaLUUad1,315 
" ii cawiln-ilIIO1«äFJ «ViavilfilULVi-115 
" Y/1111(l(91'1111¬ll%ýEI1VIýf11JG1717Jý16iI1l1ý5e1ý5J 11N51výv"ls 
1.2 (Needs Assessment) 
" ýýäýtiýý7ýýýaý needs assessment giaav15 
" Z(r15ý1J11G1tid(116ti111f115(111df1151I5v67111G1ä"11Jý1e7df1"15 
" 2111(1e71lZldfl151ý5v6ýJ1dG1713J(1euwi5eJeul5f w 
" 7aäýZýtiýýýi ýwýýiatýý5i15ý69J11ý1 ä 11J(le7Jfl 15Z11cýf11ldYVfl l1J lsý 
2. n, säci, u, (Procurement) 
2.1 Procurement Systems 
(open tender, pooled purchase 
or direct purchase) 
LLM, FiJä(1 a[J'1 1ýV5eý ýG151Jn 15sý111Jcýlbl! (911tid£J 1 5J 1ý 1fll6VfýdZG19J 1J 
iinjw «ývaýJ 55wýZunýSäý a¬ýý 
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2.2 Drug Budget 
" ýtvvýJ6vuvýu°iuýý5äý ý¬ýýýýaýývi°iý 
" 16 fY15ZUf115ý2fd1J1ý5vaýýýuýiý¬ýýýý¬ýZ sfýSýi1 i1 
" J1J1ýSv7J"lill6iNEId1Ne1Vf5e1ý71 M-Inlfllle@WLLAI7J@d'1J1l 
" 1ýE11WiLLývE iýc'I crlJeýJfllSý[9151Jf1ý5ä(1cý55J1J1ý5ýýfl 
2.3 Quality of Drugs 
" asýýsýs as ývý¬usýývvýýýý"lýý¬ -fI 
" G17-1511L(lf1GlýJ21e7J(1i11f1ýYV¬IlSvV{ýýý9e]JG1fl151f1c Jf1559J66cýv1J51`YS/ 1 fl? JtL 
" Vi 1fl7J1ýiUlý"16f1fflf lJc ftU11V EJ"1 Vl"191ýJ äfiL6f117fUVf"le7¬J bj1 
3 nýsnsýaýuuý (Distribution) 
3.1 sývvnýsnsýaýuuý (Distribution System) 
" SvlJlJffl f15va'1¬IEI1 1fJZL1 b 1A1 fl1J"1cýeJ%JldfleýlbfJ 1J'ý5 
" 7Jt-n n5ýa'lfJ¬Ilcý5ý1ýZ1d1ý{Lb7E1115f1155ý(91115e7ý9VI5eý1 i inu uliume@Lbad-1d15 n-15 
iJtidcýý9l/Il e7 fJ"1ý9ý5 
SvlJlJf175f15ýý7fJ¬17c cýf17tid1J5f1155ý (11JSe1df1e7ldl6cýýV{ýý7ýG15df1ý5 30 1171/IlV{ýeawmlla 
(l"ldfll. deý¬IldýS ýJr7v"15ýýýi. ls"výJýý 
l/11LdGlG1715v1J9J1/It1G17561ý5deýth t5 
3.2 n, uft4nw u, (Storage) 
" 2J1JGleýldýllf1156f11J5n ±lEivfie1fJ 1Jý51J 1J 
" V1ýtidlF1EI1ý5ýcý111ýE1IVl1flý21ý(91cý(leýf19JýJ A 1,3J llcývýG161f11ýf111iýeýd- ft5 
" Vf1flMEUm6e7, imuf11JE111/Iý1dý61ý2ý5f1ý5llflý%J1ýiU1ý{1eýE1ý4ý5 
3.3 m, 5d-jjrvun (Delivery) 
" viýu°tsnýs°iý°tunýsýýýv¬ýý collection or delivery? 
" IA51j-wY=iOn'rj- mjIv! 9um@ut 
" viýuiý7srýýsý57a6 wýýdýý"lsýý¬ _Il7 Jýv"lilý6ä7iýnýs ý"lýJiýsv°sný5wýu"lýasý 
" °tunscgVU sub-stock, 
" viýuiýý7ýýýýývýuýeiýJ"lsýiýnýsiý sub-stock 
4. nn-w1 u-, (Use) 
" G17ý7JViýJýEJ21eýJf1ý5ý2f¬Iýýtibsý¬1ýtid1J5f1ý5cýý5ý5i11sý21Fleýeývý5 
" VI 1LdfP1(17 1f115Z%1fJ"1ýllcýi11111JSf115%Je7JVlllJ61ý11V111"11Ne7ZaLlý J1ý5 fUJ eJe1ýý5V161ý5daý1 
ll°1JJ6Ls7vaGleýe]11ýf19J1J 
" f115Z2ffJle1ýJ"1JcýýJIVi(1s"ý9JWcýhleýelvý51/I11JG1(171av1/llýGýe7¬m t5 66sýýaýVl1ýG1Vi5eýt ii 
c3¬119d1Nu 11J"1cý21eýJVlm 
" l/115bG1(17 1ýG15G1 ä59Js JlllflfJ7iJeýJ9J 1Jf11Jf115ý21fJ"1Z11cýä1ý1d1MEl"liJýcý 
" VI"lllavl/Ile1¬I"1Jý561Ne7ýViCJ3J151J1JSf1"15ý%1EI1'ý(le1¬I1JQf1G1eýJ IVi1J"lýcý3J 
" viýuaývýýý¬iýJ"15ýýiý°i w Jýý¬ýýý/wäý¬ý¬ýý Zýs¬ýý"lýýeiýJ¬ýrýýiýJ LA J1ý J 
" 1/1"111Aml-1Lfl f15kY ulliviin /i@d-1Jl56f1¬J7f19JfY15lfjEFIIULLcavu@fl fl1 B1U-1v1a 
mumA-j%mn 
nh5d1Lfl cs3n, 5täml, %--Augvnivichu )%1 
" tu6ýýiavýiuýýuýýý DMC 
" WAlFJuLL Ja, 3UvhZvif-iiUm5iý-iu¬rilu-Zo mlmMuvri abi 
" ývi¬7ý"1ýi6ýJý¬ýu«ýJýýý75ýný56ýJäeýuLdýJýývas fL3J výsýýý5ýý"176ýiýýulýý 
" atccl'151"15011-1c6d VILdAlFJ dLUJaOlUVl'1J1%1M1JiU. [InOil 1%401Aä(912) 1. dUM e]bi ad-1.315 
III. YJVIYJ"1Yý1°lJeýý96ä1s%1f15ZYýf1'15eý96eý58Jh1'ä'18J6V1'16VIg18J19dZ9df1'156ß1'1ä1ý9fJ'1 
" vviv1v 7J 3' LnMdnstumsdJ 6-83AR7Ill L1/hLflFJIJ fiu°iUn-15«-I¬ß FYI U-; I-ln i1ol 
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" 9JV19J-im ai1flcel%Sf1561ýý¬1L1611ýcýJ'11ýVV5e]ýýJ11iý5f1ý5G1ýLldlbýF15Jn-1511iandufllbmin-ltih 
¬1"ýtibV{til"1 
" iýýaä¬ýZývi ýýý5¬ýviýtvýrýý5« ¬ýJUýýýýwiJýýiýwý7ýý niA ln7iu 
" l/ilU3JA-3-131Af91MAUa¬l, 3150i0LL1 3 G1ä-ijAA n- 5La-ItIJ7JUL D11G(11tin w (community- 
based approach) an5výn57ý ýsý5¬u ý üv uu°ivs ¬ýýurrýývýý ýaýýý15ý¬inýil 
fTijn-15Wbj5f1"15 Llcýý1/I 111G1G17 lavcý'17J 15flld lllld ä(1G1i17J 11ýSv¬Jf1Glý ff111f115ýVi1J5f115 
9/1ýý9 lfl e"ý2f f1557J'ý(ýl e7 ¬I'ld'ý5 
" ý9"111ZG1%Je7dGý"1fJLn iJf155wtIcn5s \96cý55Jl1Neii'i"1ýVflf1t1G1I1eJ61/1ý11%IEIýJf1ld1tidfl156%1ýiliU1 
" 911icwi ln5l(1ýf11J"ld1! 17JGJcýG1eýlJl/I1J 1W1Je7 i1f1c 2ff15ý1115e7Jf115ý(1f115(11¬I¬n 
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APPENDIX D 
The Questionnaire for the Survey of Patients' Attitudes towards the Drug Quality, 
Pharmacy Services and Health Care Services (English Version) 
Dear Respondents, 
The questionnaire titled "Health care users' Attitudes towards Health Care Service 
Providers under the Universal Coverage Scheme (UC)" is one part of the study on Equity 
in Health Care which emphasises on the National Medicines Policy. This research is to 
fulfill the Doctor of Philosophy (PhD) degree of the School of Medicine, Imperial 
College London, United Kingdom. 
Your information provided for the questionnaire will be confidentially and anonymously 
protected. However, the overall results and findings from this survey will be used to 
evaluate the performance of the health care providers in Pathumthani Province after the 
implementation of the Universal Coverage Scheme. 
The questionnaire comprises 5 parts: 
Part 1: Respondents' demographic data 
Part 2: Data on the Universal Coverage Scheme 
Part 3: Data of incurred costs from using health services 
Part 4: Respondents' clinical data 
Part 5: Respondents' Attitudes towards drug quality, pharmacy services and the overall 
health care services in public health care providers 
Data obtained from you will be very useful to adjust and improve the current health 
service system, particularly on the pharmacy services. 
Your responses, information and time for this questionnaire are greatly appreciated. 
Thank you very much. 
Surasak Soonthom 
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QUESTIONNAIRE 
The Questionnaire for the Survey of Patients' Attitudes towards the Drug Quality, 
Pharmacy Services and Health Care Services (English Version) 
Explanation: Please mark (X) over the most appropriate choice or choices you consider 
matching with your opinion. 
Part 1: Respondents' General Data 
1. Gender 
(a) Male 
(b) Female 
2. Your age 
(a) Less than 40 
(b) 40-49 years 
(c) 50-59 years 
(d) Over 60 years 
3. Your highest educational background 
(a) No formal education 
(b) Primary school 
(c) Secondary school or High school 
(d) Vocational school or University 
4. Your average income per month 
(a) Less than 7,000 baht/month (f96/month) 
(b) 7,000-15,000 baht/month (£96-£206/month) 
(c) 15,001-25,000 baht/month (£206-£343/month) 
(d) 25,001-50,000 baht/month (£343-£685/month) 
(e) More than 50,000 baht/month (£685/month) 
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5. In which district of Pathumthani is your residence? 
(a) Muang 
(b) Thunyaburi 
(c) Lumlukka 
(d) Latlumkaew 
(e) Samkok 
(f) Klongluang 
(g) Nongsua 
(h) Other provinces 
Part 2: The Universal Coverage Scheme (UC) data 
6. What is the UCS sub-scheme that you have registered with? 
(a) The Gold Card Scheme (if you have registered with this sub-scheme, please 
continue to complete Question 6.1: The categories of the Gold Card) 
(b) The Civil Servant Medical Benefit Scheme (CSMBS) 
(c) Social Security Scheme (SSS) 
(d) Traffic Accident Protection Scheme (TAPS) 
(e) Not registered to any sub-schemes (please complete Question 6.2: The 
reasons for not reXisterin' with the UCS, and then skip to Part 3: Incurred 
cost from using health services) 
6.1 Your gold card category is (only for fold card holders): 
(a) The elderly (over 60 years) 
(b) Community leaders 
(c) Religious leaders 
(d) The disabled 
(e) 30-baht co-payment 
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6.2 The reason for not being insured by the UCS (only for respondents who 
are not registered with the UCS, then skip to Part 3: Respondents' Incurred 
Costs) 
(a) Non-Pathumthani citizen 
(b) Being registered in another province 
(c) Living in Pathumthani but have not been registered yet 
(d) Refusing to join the UCS 
(e) Other reasons (please specify) .............................................. 
7. The main contractor you have chosen is categorised as: 
(a) the central hospital 
(b) the general hospital or the provincial hospital 
(c) the community hospital or the district hospital 
(d) the primary care unit (PCU) or the village health centre 
(e) the private hospital 
8. The sub-contractor you have chosen is categorised as: 
(a) the central hospital 
(b) the provincial hospital 
(c) the district hospital 
(d) the primary care unit (PCU) 
(e) the private hospital 
9. Who provided you with the Gold Card? 
(a) the central hospital 
(b) the provincial hospital 
(c) the district hospital 
(d) the primary care unit (PCU) 
(e) the private hospital 
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10. How many members of your family (including yourself) have been registered 
with the UCS? 
(a) 1 person 
(b) 2-4 persons 
(c) 5-7 persons 
(d) 8-10 persons 
(e) More than 10 persons 
Part 3: Data of Incurred Costs from Using Health Care Services 
11. How much do you spend on transportation cost each time you visit this health 
care provider? 
(a) Less than 30 baht (£0.45) 
(b) About 30-49.99 baht (£0.45-£0.60) 
(c) About 50-69.99 baht (£0.60-£0.90) 
(d) About 70-90 baht (£O. 90-£1.20) 
(e) More than 90 bakt (£1.20) 
12. How much do you spend on other costs (excluding medicines and other health 
care costs) each time you visit this health care provider? (e. g. food, drink, etc) 
(a) Less than 30 baht (£0.45) 
(b) About 30-49.99 baht (£0.45-£0.60) 
(c) About 50-69.99 baht (£0.60-£0.90) 
(d) About 70-90 baht (£0.90-£1.20) 
(e) More than 90 baht (£1.20) 
13. How much do you spend on health care cost each time you visit this health care 
provider? (e. g. your out-of-pocket expenses on drugs, lab tests, X-rays, etc. ) 
(a) Free of charge 
(b) 30-baht co-payment (£0.45) 
(c) 1-150 bath (£0.01-£2) 
(d) 150.01-300 baht (£2-f 4) 
(e) 300.01-450 baht (£4-£6) 
(f) More than 450 baht (£6) 
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Part 4: Respondents' Clinical Data 
14. Which disease(s) do you suffer from? 
(a) High blood pressure 
(b) Diabetes 
(c) High blood pressure with diabetes 
(d) High blood pressure or diabetes with other chronic diseases (e. g. heart disease, 
cancer, gout, etc. ) 
15. How many drugs are you usually prescribed each time of your visit to this health 
care provider? 
(a) I item 
(b) 2-4 items 
(c) 5-7 items 
(d) 8-10 items 
(e) More than 10 items 
16. How often do you come to this health care provider within a year? 
(a) Once or the first time 
(b) 2-4 times/year 
(c) 5-7 times/year 
(d) 5-10 times/year 
(e) 11-13 times/year 
(f) More than 13 times/year 
17. How often do you come to this health care provider within a year, regarding the 
follow-up appointment with your doctor for the disease(s) your have? (The disease(s) 
refer(s) to what you have answered in Question 14) 
(a) Once a year or this is my first time. 
(b) 2-4 times/year 
(c) 5-7 times/year 
(d) 8-10 times/year 
(e) 11-13 times/year 
(f) More than 13 times/year 
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18. Have you ever visited other health care providers apart from your current main 
contractor and sub-contractor? 
(a) Yes 
. 
(if yes, please complete Questions 18.1,18.2 and 18.3) 
(b) No 
. 
(if no, please skip to Part 5: Attitudes towards health services under the 
UCS 
18.1 If you have ever visited other health care providers, which categories are 
they classified into? (You may choose more than one choice) 
(a) central hospital 
(b) provincial hospital 
(c) district hospital 
(d) primary care unit (PCU) 
(e) private hospital/clinic 
18.2 Within the past one year, how many times did you visit other health care 
providers apart from your main contractor and sub-contractors? 
(a) Once 
(b) 2-4 times/year 
(c) 5-7 times/year 
(d) 8-10 times/year 
(e) More than 10 times/year 
18.3 Reasons to visit other health care providers? 
(a) Being referred from the main contractor or sub-contractor 
(b) Closer to my home and more convenient 
(c) Less waiting time because of fewer patients 
(d) Better health care services 
(e) Better drug quality 
(f) More economical for health care cost 
(g) Other reasons (please specify ......................................... ) 
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Part 5: Attitudes towards Health Care Services under the UCS 
Please mark (X) over the number that you consider best explaining your opinions 
towards the health services provided by this health care provider 
***Please note that one mark (X) is required to evaluate one topic only*** 
Explanation: 
The scores you give to each topic range from 3 to 1. The explanation of the meaning of 
these scores is described as the follows: 
3 means that you agree with this opinion. 
2 means that you do not have any opinions regarding this matter. 
1 means that you do not agree with this opinion. 
19. Your opinions towards the quality of drugs prescribed by the pharmacy 
department 
Your opinions towards the quality of drugs Your opinions 
prescribed from the pharmacy department 3 2 
F 19.1 I always receive drugs which correspond with my diseases or 
symptoms every time I visit this health care provider. 
19.2 The quality of drugs prescribed in this health care provider is not 
different from private hospitals or clinics. 
19.3 The same generic drugs with different brand names should have 
identical qualities or potencies. 
19.4 If there is a separation of drug lists for patients insured with 
different UCS sub-schemes, the quality of drugs from each list will be 
the same. 
19.5 The quality of imported drugs is not different from the local-made 
ones. 
19.6 Drugs produced by the Government Pharmaceutical Organisation 
(GPO) are of the same quality as those imported ones. 
19.7 One drug item, having the same generic name, dosage form, and 
strength, should be available in the hospital only one trade name. 
19.8 There should be separate hospital drug lists in respect of patients' 
entitlements to the UCS, such as essential drug lists for CSMBS, SSS 
and TBS. 
19.9 Overall, I am satisfied with the quality of drugs provided by T' 
this health care provider. 
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20. Your opinions towards the services provided by the pharmacy department 
Your opinions towards the services Your opinions 
provided by the pharmacy department 3 2 
20.1 1 always receive all drug items prescribed every time I come to the 
pharmacy department in this health care provider. 
20.2 I understand how to use drugs after being advised by a pharmacist. 
20.3 A pharmacist who gives me advice is polite and uses simple terms 
in their explanation. 
20.4 I know that when I receive my drugs, there will always be a 
pharmacist present who will provide me with advice on how to use such 
medicines. 
20.5 I know that the pharmacy department provides a private drug 
counselling service to patients. 
20.6 Waiting for drugs is the most time-consuming step in the whole 
process of health services. 
20.7 Sometimes I need to bring the prescription to the drug store 
because drugs are out of stock. 
20.8 I spend less than 30 minutes waiting for drugs. 
20.9 Overall, I am satisfied with the pharmacy services provided by 
this health care provider. 
21. Your opinions towards health care services received from this health care 
provider 
Your opinions toward the overall health care services Your opinions 
received from this health care provider 3 2 
21.1 I feel it is convenient to visit this health care provider for health 
services. 
21.2 The health care members of staff are very helpful. 
21.3 After implementing the UCS in 2001, I think that health services 
from this health care provider have greatly improved. 
21.4 I am more satisfied with health services from this health care 
provider than private hospitals or clinics. 
21.5 I think the standard of health services between this health care 
provider and the private hospitals or clinics is no different. 
21.6 1 spend less than 2 hours on the whole processes, from arriving at 
this health care provider to receiving medicines. 
21.7 Overall, I am satisfied with the health care services provided by 
this health care provider. 
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APPENDIX D (Continued) 
The Questionnaire for the Survey of Patients' Attitudes towards the DMC and 
Health Care Services (Thai Version) 
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LLuuaouälimcfl13Jf nL u 
dsýýýýýaýýýýýeýýa vv°snasýiýnaýZývsni zJaý ¬ý1U1J nas asauIu J 
ýýJsvýiu ýsýawýiauýüa AauZc'ihs-i nasu 
cha uiu: njewiwi-dnsa-im j1u X 
ttn 1 ýiýaýawu 1uU J1J Jfl13J 
(n) ? I-iu 
(ii) va¬vý 
2. a-iqvmjvhu0ia 
(ri) ohn h 40 il 
(ý) 40-49 iJ 
(ý) 50-59 iJ 
('3) W1flf-i-i 60 iJ 
3. nisaýnýriýuýý 
(n) bi"(, ) tzn-n 
(ý) i15vn i rnn 
4. 
(n) i aaon i 7,000 vlvi/66i 
(ý) 7,000-15,000 v- V1/Lgiau 
(ý) 15,001-25,000 v-IVn/iAmu 
(ý) 25,001-50,000 vrwn/tA@u 
(a) nnni-i 50,000 YIVI/Olau 
5. ýi1uý11u11Jsiü 
(n) ý 1LfiI 
('ii) s¬tivs 
(i) ihnni 
('i) JLLfh 
(; i) r13J'cln 
(ý) ýaýývra aý 
t%Aci 2 'uýäninm¬iauiü, 
6. 
(ri) llmimaJ 30 u-ni (u-7n'i, 7usonntihü nisw , 7. tia 6.1 
(2J) YI15"12ff115/5 äcýrnAra 
(Gl) 1ýSvf111cJG1ýJ 
(J) 1JSvfllle'1ITALVi(1VI-1,350006 
(u-7nti7u7aiÜens? L? un7s4nivininv7a nfni7 
2h, u7Y/oozisazvur vh 6,2 sýgcvýý7ýi7ýisv rýss1ý n"ý výýýv ssýýüu) 
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6.1 Yý5v6älYýle Yý159Jfv15Yle'1ý9i1e1ý91Yý1'IYd . 
rye7Y/692Y1/7výif9J3! lv75YIc7ýY) 
(n) wgio-iq (nnuv-i 60 tJ) 
(u) wuýýtýýsu 
(ci) wvsvý5ýünv7ýsýnýýýsi Iin 
(5) CJ1Nf1"15V{Sr7VIYJccrnv 
(a) 5-njý -aj 30 v-vi 
6.2 (inn-7-n `7ai7tisvftns 
41s siu1v, n7nv U A%rg7na11nw 4 izF i7V , 7daui 3 2rDMad'7un T2Vý7z/7un7W7 
41Jvsn7sO7s7sfU#g) u 
(n) vi-vkn 
(ý) ¬iZuäývsäýýJvýýsýüd6ýi¬iý"lýi"lýsv vas (výaýý¬ý¬ýJiý ýý¬iluvýv6v¬ýuvýuý6ý7) 
(J) ý9JG1eýdfl"15511eýii 
(a) auq ...................................................... 
7. s"i¬1'11d9J5f1'159iýf1YlYl'1Yý6ýe1f1fv118J9JG15 
Via 
(n) l5J1NEl-iinao., ug 
(ý) ýSJVvýývýývi7"lýJ/ýSJVv¬ýývýýäJVräý 
(Gl) ýSJtiVfJ"11J'isý2fý123Ld/ýSJ1NfJ"11J lcý huieý 
(J) Elýuv5f1ý51ýý1Jf19J/c1n fly n Th 
(a) '5J"FJ-iv-IaL@n7fl 
(n) lava nv-iactu¬i 
(Fl) ýSJ1N¬1'11J 1cý2f7J2ft! /ýSJv 111"lcýý"lLi 
(a) ýsJýv¬ýývýýL nO1 u 
9. vi, u"lýsvainýýýýa1fl hU'J1uZh 
(n) 15awN¬j-lv-lcnju¬i 
10. ýauau ýaý3ýZuýsývwýýavý"lýsv ýn°sýänýJsvýiu ýsýawv¬ýauýüa (ýaaýýnýýawni 
(n) 1 cu 
(2i) 2-4 Au 
(c) 5-7 cu 
(ii) 8-10 
(a) w nn n 10 nu 
1n 3 
(n) ü@unfi 30 uni 
(ij) ihni-i t 30-49.99 invi 
(A) ilnnntu 50-69.99 vnii 
(, j) lhnncu 70-90 vnvi 
(a) 3nnh h 90 vnvi 
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(ý) ilunri u 30-49.99 vrm 
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(v) iJsvafl 70-90 J-vi 
(a) 3nnnyi 90 m vi 
13. G1'19J5f1'15ZYdf1'155f19ý'1gN¬I19.11e7dýýElfvle'1G15ý°tle'1ý9 f1'158J'159JýJSf1'15 (6°th4ci, u 1 ci-ui, au n-i 
6 sgit-w J tfluCvlu) 
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(A) lc jl i-irJ'11 nwifu 1-150 v1vi 
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(a) LA00-li ihni-i u 300.01-450 vivi 
(ý) ditwi-i¬nirinnl1 450 ii-nn 
htc4 
14. viwiheiL Jul, %c 
(n) 
(%J)'SG1611"1V{7"lu 
(Gl) ýSG1G17 leJ(9111ýcýVf(1 J577Jf11Jý5G11111W11Ld 
(J) 15AATIIJOfUlafi9loJ IA5Dl5ALlJ'lM Th 
15Al hVi LUUI i) 
Sä1Jf11Jý5G115eý5Je7Ldei (vth cif ýSk19I L \i 
15. iý¬ýwiaýlýJýiau"týsv¬ýadýwavýni "nviaudUuAjuMMn'w-acl 
(ri) 1 if- 
('n) 2-4 ii1w 
(c) 5-7 ii 
(ý) 8-10 -, Am 
(a) w nn i 10 7Am 
16. viauaýasvtýasýsaaý ¬ýi iu ivaadd. ýütýäýiJaýnn 
(n) 1 G15J%45@L h c15JL15n 
(i) 2-4 ci iiail 
(ý) 5-7 At%36@TJ 
(J) 8-10 ci th il 
(a) 11-13 c5-J36@TJ 
(Q) 3nnntt 13 n5'-j6@ J 
(n) 1 A1,3 5M JiLG15i1L5f1 
(ý) 2-4 A5\36@TJ 
( i) 5-7 ci i iotJ 
(ý) 8-10 
(a) 11-13 AS\Ioi@iJ 
(a) nnn t 14 Ai\36@U 
18. wiýudýý"lýJs"výýsýsaaýn ¬ýýuw¬ý u-udder, )muuznLwflaain iniuw¬ lliladd -jü 
TAOU 
(n) LAU ITh i]El i75ä11 ýl¢7e711ýýä779Jfia7u7le7 18.1,18.2 it 18.3 
(T) ULAU 
. 
(1777zi1A1/ nsIU 7ti7a17zl670vi7¬77M 7ui 5uz 5OTWO1676; u2tOt7O7UOOn75'1/7rL 
1 sn7sA t77UWLI7v t'J? 7rß76T YO 5; rkn1/5'--AU0Z177Wn? U7rü7 
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"u-jýI L n) 
(ii) lumnv-i cjwi 
(2j) 
(A) 1S, 3wFJ- If)aLan7su/nAf4n 
18.2 iusývýüýilwýeiauýa viaudwý¬"lýJsýýasýsaaý¬ýauwu¬ýavaauýýýu 
(n) 1 Aso 
(i) 2-4 cs, j 
(ý) 5-7 wýSJ 
(ý) 8-10 c 
(a) viflfTl 10 Asp 
18.3 1 th) 
(ui) Zrýývýuýýrýýýý ýGl Jf1ZLdf1"156G11dY/1 ld 
(G1) 5JG1Ldý2111e7fin i ý5J6c Elläcý"1Z11f1155eý51J1J5f115 
(s9) 1J5f1 15(1 lllfl"155f11ý"1VJEI"11J lcý(lfl J"1 
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(7i) äug (11J505v11) 
......................................................................................... 
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GYl e759J'1 £J 
G1ý66tid11V11/1"11aýVi(117JVi721eýf1151ý5v6ýJllaveJGlýllflJs'fG1Gleý 3 "lýJauýiJýýýýý 1J 
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3 2 1 
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20.3 151c %1f151/IýViGIýllllvllýl5e7dElý1NGlaýc"ifl liN61s7ýliJlýaý9"1¬J 
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n-i5221¬1"Atidn"15cb11M 
v 
20.6 f1155eý51JEJ"161ýldiJtidGle7Ldl! 1ý2f1äcý17JlflýlcýGl ýldfl"159J"1511f115 
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